≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other and unspecified visual disturbances

EFO MESH Endpoint Browser PheWeb

H7_VISDISTNAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H53.8, H53.9
  • Hospital discharge: ICD-9 — 368[8-9]
  • Cause of death: ICD-10 — H53.8, H53.9
  • Cause of death: ICD-9 — 368[8-9]

2 out of 7 registries used, show all original rules.

4833

4. Check minimum number of events

None

4833

5. Include endpoints

None

4833

6. Filter based on genotype QC (FinnGen only)

4694

Control definitions (FinnGen only)

Control exclude
H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 20937 12748 8114
Only index persons 20164 12389 7775
Unadjusted period prevalence (%)
Whole population 0.31 0.37 0.23
Only index persons 0.39 0.46 0.30
Median age at first event (years)
Whole population 57.71 58.25 57.03
Only index persons 58.13 58.64 57.31

-FinnGen-

Key figures

All Female Male
Number of individuals 4694 3075 1619
Unadjusted period prevalence (%) 0.97 1.09 0.74
Median age at first event (years) 62.33 60.78 65.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4833
Matched controls
48330
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.4
314.5
913
2418
H53.4
ICD-10 Finland
Visual field defects
68.3
307.7
228
35
H53.1
ICD-10 Finland
Subjective visual disturbances
25.0
307.7
1182
618
AA1AD
NOMESCO Finland
CT of head and brain
3.9
307.7
2265
9003
H53.9
ICD-10 Finland
Visual disturbance, unspecified
492.2
307.7
3929
423
H53.8
ICD-10 Finland
Other visual disturbances
85.7
307.7
1066
159
H53.2
ICD-10 Finland
Diplopia
31.8
307.7
285
95
G45.3
ICD-10 Finland
Amaurosis fugax
13.8
307.7
334
259
H43.8
ICD-10 Finland
Other disorders of vitreous body
4.2
297.3
919
2545
F05
ICPC
Visual disturbance other
7.5
281.4
425
617
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.3
272.4
1372
5226
PA6AD
NOMESCO Finland
CT of neck arteries
6.8
271.8
452
727
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
4.6
265.4
710
1753
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
4.4
239.8
675
1728
R51.80
ICD-10 Finland
Headache
3.1
233.3
1233
4781
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.6
195.0
751
2381
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.4
192.4
795
2635
R42
ICD-10 Finland
Dizziness and giddiness
2.6
181.9
1520
7357
XCK00
NOMESCO Finland
Perimetry
4.4
180.0
491
1218
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
4.9
164.6
381
827
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.8
160.2
530
1509
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.3
154.8
644
2128
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.3
140.4
389
972
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.9
138.0
317
682
R20.2
ICD-10 Finland
Paraesthesia of skin
3.3
128.9
548
1826
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
128.4
1649
9345
B01AC04
ATC
clopidogrel; oral
2.5
126.5
945
4249
H46
ICD-10 Finland
Optic neuritis
12.2
123.7
124
104
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
120.8
2541
17151
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.6
119.4
295
673
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
111.8
569
2097
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
12.1
110.0
111
94
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
108.7
2046
13135
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
106.4
778
3441
R53
ICD-10 Finland
Malaise and fatigue
2.1
104.8
1469
8481
M79.6
ICD-10 Finland
Pain in limb
1.9
102.2
2408
16550
G44.2
ICD-10 Finland
Tension-type headache
2.3
98.0
858
4102
N01
ICPC
Headache
2.4
97.6
745
3352
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.7
96.4
568
2255
F29
ICPC
Eye symptom/complaint other
2.5
93.2
688
3045
H57.1
ICD-10 Finland
Ocular pain
3.6
92.3
314
903
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.2
86.4
241
602
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
84.8
1351
8051
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
30.9
84.0
55
18
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
82.6
2228
15617
R07.3
ICD-10 Finland
Other chest pain
2.4
81.6
636
2874
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
80.5
816
4117
R06.0
ICD-10 Finland
Dyspnoea
1.9
78.2
1445
8995
Z71.8
ICD-10 Finland
Other specified counselling
1.8
77.6
1839
12343
CKC12
NOMESCO Finland
Photocoagulation of retina
3.4
77.5
289
881
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
76.9
1040
5833
TAB00
NOMESCO Finland
Lumbar puncture
3.3
76.8
297
927
N17
ICPC
Vertigo/dizziness
2.2
75.9
775
3914
G43.9
ICD-10 Finland
Migraine, unspecified
2.8
75.3
408
1544
A02BC02
ATC
pantoprazole; systemic
1.8
74.3
3416
27567
XCH00
NOMESCO Finland
Eye pressure measurement
3.1
73.0
319
1071
R52.9
ICD-10 Finland
Pain, unspecified
2.3
72.8
624
2931
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
71.8
1021
5809
M54.5
ICD-10 Finland
Low back pain
1.7
71.7
1931
13363
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.7
70.1
401
1559
H34.1
ICD-10 Finland
Central retinal artery occlusion
12.8
70.0
68
54
L17
ICPC
Foot/toe symptom/complaint
1.8
69.3
1626
10798
C10AA05
ATC
atorvastatin; oral
1.7
68.2
2051
14572
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
66.3
726
3751
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
65.3
738
3857
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.1
64.7
717
3720
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
64.5
1468
9623
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.0
64.0
305
1075
N02AX02
ATC
tramadol; systemic, rectal
1.7
63.2
2094
15173
M79.1
ICD-10 Finland
Myalgia
2.0
62.8
849
4726
A11
ICPC
Chest pain NOS
2.3
62.3
508
2329
R03AC02
ATC
salbutamol; inhalant
1.7
61.8
2718
21125
CS494
NOMESCO Finland
Other visual field testing
4.0
61.7
182
473
H43.1
ICD-10 Finland
Vitreous haemorrhage
4.0
61.6
180
465
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
61.3
1125
6905
R02
ICPC
Shortness of breath/dyspnoea
2.0
60.5
755
4082
WX140
NOMESCO Finland
Parabulbar anesthesy
2.9
59.8
291
1037
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.2
59.6
124
244
N03AX12
ATC
[U] gabapentin; oral
1.9
58.9
848
4813
D01
ICPC
Abdominal pain/cramps general
2.0
58.3
714
3832
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
57.5
1336
8754
C07AB07
ATC
bisoprolol; oral
1.6
56.2
2263
17048
L03
ICPC
Low back symptom/complaint
1.7
55.1
1531
10501
N03AX16
ATC
[U] pregabalin
1.8
54.8
1143
7252
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.6
54.6
186
534
UJF32
NOMESCO Finland
Coloscopy
1.7
54.1
1287
8465
M25.5
ICD-10 Finland
Pain in joint
1.6
53.3
1690
11963
D06
ICPC
Abdominal pain localized other
2.1
53.3
527
2607
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.9
52.9
157
410
Z3231
NOMESCO Finland
Registered nurse
1.7
52.7
1300
8624
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
10.5
52.6
58
56
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
52.1
2463
19145
H02AB06
ATC
prednisolone; systemic
1.6
52.0
2278
17393
H34.2
ICD-10 Finland
Other retinal artery occlusions
9.1
50.7
62
69
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
50.6
2121
15994
A04
ICPC
Weakness/tiredness general
1.8
50.5
857
5102
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.2
50.4
210
684
N02BE01
ATC
paracetamol; systemic, rectal
2.1
50.2
4349
39289
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
49.6
798
4669
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
49.6
1143
7425
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
49.5
347
1483
H47.2
ICD-10 Finland
Optic atrophy
14.8
49.4
44
30
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
49.3
874
5268
R00.2
ICD-10 Finland
Palpitations
2.2
49.2
457
2203
R05
ICPC
Cough
1.7
49.1
1294
8705
S18
ICPC
Laceration/cut
1.6
49.0
2285
17612
L01
ICPC
Neck symptom/complaint
1.8
48.5
879
5331
G35
ICD-10 Finland
Multiple sclerosis
4.6
48.3
117
262
A02BC05
ATC
esomeprazole; systemic
1.6
48.1
1945
14496
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
48.1
938
5811
H53.3
ICD-10 Finland
Other disorders of binocular vision
15.9
47.8
41
26
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
47.6
712
4067
K80
ICPC
Cardiac arrhythmia NOS
2.1
47.4
484
2420
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
5.2
47.1
98
193
N03AX09
ATC
lamotrigine; oral
2.6
46.5
272
1066
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
46.4
1422
9909
H53
ICD-10 Finland
Visual disturbances
6.3
45.7
77
124
WX002
NOMESCO Finland
Sedation and analgesia
1.7
45.7
930
5820
S29
ICPC
Skin symptom/complaint other
1.7
45.3
1054
6841
A01
ICPC
Pain general/multiple sites
2.0
45.1
557
2982
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.5
45.0
109
244
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
7.1
44.9
67
95
XF404
NOMESCO Finland
Ambulatory ECG
2.1
44.6
437
2148
J01MA02
ATC
ciprofloxacin; systemic
1.6
44.5
1775
13125
J01DB01
ATC
cefalexin; oral
1.7
44.4
3962
35074
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
44.4
1085
7131
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
44.3
488
2507
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.6
44.1
263
1041
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
43.8
998
6434
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.3
43.7
165
506
K30
ICD-10 Finland
Functional dyspepsia
1.9
43.5
610
3406
N06AX11
ATC
mirtazapine; oral
1.6
43.4
1645
12007
R51
ICD-10 Finland
Headache
2.4
43.3
320
1399
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
43.3
3462
29700
ZXA10
NOMESCO Finland
Bilateral
1.7
43.3
878
5483
H34.8
ICD-10 Finland
Other retinal vascular occlusions
3.6
43.2
142
398
J01AA02
ATC
doxycycline; systemic
1.6
43.2
3659
31808
H26.4
ICD-10 Finland
After-cataract
2.0
42.8
512
2708
H54.7
ICD-10 Finland
Unspecified visual loss
9.1
42.5
52
58
Z2221
NOMESCO Finland
Medical doctor
1.6
42.4
1276
8819
XCK10
NOMESCO Finland
Photography of fundus of eye
2.1
42.3
455
2315
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
42.3
949
6088
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
42.1
2615
21170
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
42.1
948
6087
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
42.0
1066
7059
N06AX21
ATC
duloxetine; oral
1.9
41.7
615
3488
H53.0
ICD-10 Finland
Amblyopia ex anopsia
13.0
41.7
40
31
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.9
41.5
623
3552
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
41.5
343
1573
C10AX09
ATC
ezetimibe; oral
1.7
41.3
819
5075
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
41.2
903
5751
R4110
NOMESCO Finland
Physiotherapy
1.6
41.2
1317
9222
Z01.2
ICD-10 Finland
Dental examination
1.5
40.7
2258
17812
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
40.6
889
5657
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.6
40.6
136
386
N05BA04
ATC
oxazepam; oral
1.6
40.5
1258
8743
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.1
40.4
422
2124
H33.3
ICD-10 Finland
Retinal breaks without detachment
2.8
40.2
203
737
H25.1
ICD-10 Finland
Senile nuclear cataract
1.6
40.2
1199
8251
XA800
NOMESCO Finland
Neuropsychological investigation
2.7
40.1
227
875
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
39.5
2191
17244
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.3
39.2
150
464
M54.2
ICD-10 Finland
Cervicalgia
2.0
39.2
439
2266
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
39.2
452
2358
L28
ICPC
Limited function/disability (L)
1.7
39.2
914
5911
XF402
NOMESCO Finland
ECG with work load test
1.9
38.7
500
2711
R07.0
ICD-10 Finland
Pain in throat
2.1
38.5
393
1960
A02BC03
ATC
lansoprazole; oral
1.6
38.3
1299
9192
L02
ICPC
Back symptom/complaint
1.9
38.2
552
3105
R01AD09
ATC
mometasone; nasal
1.5
38.0
2148
16923
M03BX02
ATC
tizanidine; oral
1.5
37.8
2902
24284
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
37.7
540
3030
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
37.7
1085
7387
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
37.6
643
3809
S06.0
ICD-10 Finland
Concussion
1.9
37.6
537
3010
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.9
37.4
544
3067
R21
ICPC
Throat symptom/complaint
1.6
37.3
1044
7056
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
37.1
1209
8466
C07AA05
ATC
propranolol; systemic
1.6
37.1
966
6415
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
37.0
575
3308
L12
ICPC
Hand/finger symptom/complaint
1.7
36.9
866
5599
P01AB01
ATC
metronidazole; oral, rectal
1.5
36.8
1865
14347
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
36.6
1404
10189
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
3.7
36.6
115
313
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.5
36.5
1490
10957
C09CA06
ATC
candesartan; oral
1.6
36.4
1154
8024
ZXA00
NOMESCO Finland
Right side
1.6
36.1
1180
8261
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
36.0
2040
16023
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
35.7
1189
8355
109
Kela drug reimbursment
Multiple sclerosis
4.6
35.7
85
188
J01FA10
ATC
azithromycin; systemic
1.5
35.6
2690
22313
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.8
35.5
659
3996
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
35.4
1207
8528
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
35.2
1026
6989
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
5.1
35.1
73
144
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
34.6
646
3920
ZXA05
NOMESCO Finland
Left side
1.6
34.4
1076
7447
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
34.3
1959
15365
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.2
34.3
315
1507
R4120
NOMESCO Finland
Occupational therapy
2.1
34.2
336
1650
PAW37
NOMESCO Finland
Biopsy of temporal artery
6.4
34.1
56
88
R55
ICD-10 Finland
Syncope and collapse
1.8
33.8
517
2957
H01
ICPC
Ear pain/earache
1.8
33.8
601
3596
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.9
33.8
159
556
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.9
33.7
467
2587
R74
ICPC
Upper respiratory infection acute
1.5
33.7
1567
11792
R11
ICD-10 Finland
Nausea and vomiting
1.9
33.7
448
2449
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
33.7
1826
14166
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
33.6
626
3796
R83
ICPC
Respiratory infection other
1.5
33.4
1210
8645
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
4.9
32.9
73
152
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
32.8
3391
29635
N30.0
ICD-10 Finland
Acute cystitis
1.6
32.8
868
5768
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
32.7
1162
8261
L04
ICPC
Chest symptom/complaint
2.1
32.4
345
1746
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
32.1
676
4236
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
31.9
280
1315
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
31.9
469
2648
Z3226
NOMESCO Finland
Physiotherapist
1.6
31.6
819
5410
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
31.6
881
5923
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
6.8
31.4
49
73
A02BC01
ATC
omeprazole; systemic
1.5
31.4
1224
8864
R52.2
ICD-10 Finland
Other chronic pain
2.5
31.2
205
849
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
31.2
1226
8891
Z00.8
ICD-10 Finland
Other general examinations
1.9
31.1
401
2169
R13
ICD-10 Finland
Dysphagia
2.0
31.1
356
1849
H43.3
ICD-10 Finland
Other vitreous opacities
3.8
30.9
94
250
J01FA06
ATC
roxithromycin; oral
1.4
30.9
1781
13911
C01DA14
ATC
isosorbide mononitrate; oral
1.7
30.9
603
3698
K08.80
ICD-10 Finland
Toothache NOS
1.9
30.9
451
2539
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
30.9
482
2771
R03DC03
ATC
montelukast; oral
1.6
30.8
787
5176
N02BF01
ATC
gabapentin; oral
1.8
30.5
521
3075
A03
ICPC
Fever
1.6
30.5
816
5427
EB1VA, ,
NOMESCO Finland
1.6
30.3
855
5758
M70.6
ICD-10 Finland
Trochanteric bursitis
1.7
30.3
666
4217
H29
ICPC
Ear symptom/complaint other
1.7
30.0
599
3696
R60.0
ICD-10 Finland
Localized oedema
1.7
29.9
605
3744
R03BA02
ATC
budesonide; inhalant
1.6
29.9
824
5515
K89
ICPC
Transient cerebral ischaemia
4.4
29.9
75
173
F01
ICPC
Eye pain
2.6
29.8
172
669
J01FA09
ATC
clarithromycin; systemic
1.5
29.7
1415
10643
G47.3
ICD-10 Finland
Sleep apnoea
1.5
29.6
1021
7190
R03BA05
ATC
fluticasone; inhalant
1.6
29.5
831
5589
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
29.3
1419
10700
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.1
29.3
284
1386
J02AC01
ATC
fluconazole; systemic
1.4
29.3
1822
14394
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
4.5
28.9
71
161
S21
ICPC
Skin texture symptom/complaint
1.6
28.9
738
4848
D11
ICPC
Diarrhoea
1.7
28.8
588
3646
R12
ICD-10 Finland
Heartburn
1.8
28.8
423
2384
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
28.6
1929
15441
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
5.6
28.4
54
98
N89
ICPC
Migraine
2.4
28.4
196
830
XCW10
NOMESCO Finland
Assessment of vision
3.5
28.4
100
294
R05
ICD-10 Finland
Cough
1.5
28.2
1016
7209
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
28.2
360
1939
M79.7
ICD-10 Finland
Fibromyalgia
2.4
28.2
192
809
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
28.1
574
3559
L08
ICPC
Shoulder symptom/complaint
1.5
28.1
1084
7805
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
28.0
1647
12855
C08CA01
ATC
amlodipine; oral
1.4
27.9
1681
13171
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
27.9
748
4967
P01
ICPC
Feeling anxious/nervous/tense
1.7
27.7
613
3882
P06
ICPC
Sleep disturbance
1.7
27.4
619
3938
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.6
27.4
164
650
K04
ICPC
Palpitations/awareness of heart
2.1
27.3
277
1375
Z01.7
ICD-10 Finland
Laboratory examination
1.6
27.2
794
5377
A02BA02
ATC
ranitidine; systemic
1.6
27.0
816
5566
U02
ICPC
Urinary frequency/urgency
1.6
27.0
727
4829
R96
ICPC
Asthma
1.7
27.0
487
2917
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
27.0
391
2194
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
26.9
1018
7290
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
26.9
569
3559
H50.52
ICD-10 Finland
Exophoria
4.4
26.9
68
158
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
4.5
26.8
65
146
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
26.8
1395
10631
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
26.7
658
4278
SFA10
NOMESCO Finland
One-surface restoration
1.4
26.5
2542
21489
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
26.4
369
2047
S01ED51
ATC
timolol, combinations; ophthalmic
1.9
26.3
341
1846
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
26.2
797
5442
A97
ICPC
No disease
1.5
26.2
950
6740
UKC02
NOMESCO Finland
Cystoscopy
1.6
26.2
643
4177
SPAT1260
SPAT
Consultation of another employee
1.6
26.1
782
5323
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
26.0
491
2977
R06AX27
ATC
desloratadine; oral
1.4
26.0
1318
9985
J01CA04
ATC
amoxicillin; systemic
1.5
25.8
3835
34890
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
5.2
25.7
52
100
M54.6
ICD-10 Finland
Pain in thoracic spine
1.9
25.7
363
2019
G50.1
ICD-10 Finland
Atypical facial pain
3.2
25.6
103
329
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
25.5
455
2714
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
25.5
325
1748
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.2
25.4
217
1008
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.3
25.4
199
892
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.7
25.1
455
2726
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.7
25.1
466
2811
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
25.1
410
2385
E0000UV, ,
ATC
1.4
25.1
1909
15493
CKD40
NOMESCO Finland
Endophotocoagulation of retina
3.5
25.0
86
249
M01AH05
ATC
etoricoxib; oral
1.4
25.0
2840
24574
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
3.7
24.9
78
212
R01AD12
ATC
fluticasone furoate; nasal
1.4
24.9
1429
11048
L15
ICPC
Knee symptom/complaint
1.4
24.9
1181
8821
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
24.9
605
3917
A99
ICPC
Disease/condition unspecnature/site
1.7
24.9
498
3067
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
24.7
401
2328
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.5
24.6
86
252
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
24.6
1254
9491
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
24.6
3102
27265
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
3.1
24.5
104
343
K07.60
ICD-10 Finland
Snapping jaw
2.0
24.5
259
1306
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.2
24.4
206
952
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
6.3
24.4
41
66
A29
ICPC
General symptom/complaint other
1.6
24.3
625
4100
K10.3
ICD-10 Finland
Alveolitis of jaws
2.1
24.2
242
1195
H21.0
ICD-10 Finland
Hyphaema
7.6
24.2
34
45
R06AE07
ATC
cetirizine; oral
1.4
24.2
2004
16458
N05AH04
ATC
quetiapine; oral
1.5
24.1
776
5356
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
24.1
1514
11876
G45
ICD-10 Finland
Transient cerebral ischaemic attacks and related syndromes
5.5
24.1
46
84
N06AX16
ATC
venlafaxine; oral
1.6
24.0
648
4298
SFA20
NOMESCO Finland
Two-surface restoration
1.4
24.0
2670
22954
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
24.0
282
1476
J01FF01
ATC
clindamycin; systemic
1.4
24.0
1180
8865
H35.6
ICD-10 Finland
Retinal haemorrhage
5.4
24.0
47
88
WX892
NOMESCO Finland
Monitored bed care
1.9
24.0
334
1850
N06AB10
ATC
escitalopram; oral
1.5
23.9
921
6599
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
23.9
484
2988
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
23.9
2368
19989
D02
ICPC
Abdominal pain epigastric
1.9
23.8
316
1724
T78.4
ICD-10 Finland
Allergy, unspecified
2.1
23.7
226
1096
M01AB05
ATC
diclofenac; systemic, rectal
1.4
23.7
2965
25941
G43.3
ICD-10 Finland
Complicated migraine
3.1
23.7
99
324
L14
ICPC
Leg/thigh symptom/complaint
1.8
23.5
390
2279
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.7
23.4
73
198
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
23.4
274
1432
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
23.4
1556
12310
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
23.4
211
1002
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
23.3
454
2773
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
5.5
23.3
45
83
K02.1
ICD-10 Finland
Caries of dentine
1.4
23.3
2692
23232
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
23.3
1214
9211
H02AB04
ATC
methylprednisolone; systemic
1.6
23.2
631
4191
S16
ICPC
Bruise/contusion
2.4
23.2
161
685
WX402
NOMESCO Finland
General anaesthesia
1.5
23.1
1010
7415
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
23.0
462
2845
A98
ICPC
Health maint/preventive medicine
2.3
23.0
4689
45100
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
2.0
23.0
240
1205
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
3.6
22.9
74
206
B01AB05
ATC
enoxaparin; parenteral
1.4
22.9
1380
10733
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.5
22.8
139
556
D12
ICPC
Constipation
2.2
22.8
187
854
N06AB06
ATC
sertraline; oral
1.6
22.8
516
3279
R03AC03
ATC
terbutaline; inhalant
1.6
22.7
613
4063
B01AA03
ATC
warfarin; systemic
1.5
22.7
700
4785
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
22.6
416
2501
SFA30
NOMESCO Finland
Three-surface restoration
1.4
22.6
1882
15415
M48.0
ICD-10 Finland
Spinal stenosis
1.6
22.6
531
3406
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.0
22.5
102
350
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
22.5
1051
7808
M54.8
ICD-10 Finland
Other dorsalgia
2.1
22.5
232
1160
L05
ICPC
Flank/axilla symptom/complaint
1.9
22.4
315
1750
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
22.3
681
4641
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
22.3
2649
22885
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
2.6
22.1
132
523
R50.9
ICD-10 Finland
Fever, unspecified
1.5
22.1
664
4510
A05
ICPC
Feeling ill
1.9
22.0
290
1578
G43.8
ICD-10 Finland
Other migraine
3.1
21.9
92
302
H92.0
ICD-10 Finland
Otalgia
1.9
21.8
309
1719
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
21.8
824
5870
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.8
21.8
376
2219
S82
ICPC
Naevus/mole
1.5
21.7
662
4508
SPAT1310
SPAT
Counselling related to known health issue
1.4
21.7
1393
10925
XA402
NOMESCO Finland
ENMG
2.6
21.7
127
499
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.8
21.7
340
1953
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
21.6
1685
13636
ZXE00
NOMESCO Finland
One hour or less
1.4
21.6
1657
13375
H47.1
ICD-10 Finland
Papilloedema, unspecified
5.3
21.5
43
82
L18
ICPC
Muscle pain
2.1
21.4
208
1016
L13
ICPC
Hip symptom/complaint
1.5
21.4
881
6384
C10AA07
ATC
rosuvastatin; oral
1.4
21.3
1470
11663
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
21.2
837
6011
H02
ICPC
Hearing complaint
1.5
21.2
647
4405
R04.0
ICD-10 Finland
Epistaxis
1.8
21.2
330
1890
K59.1
ICD-10 Finland
Functional diarrhoea
1.9
21.2
272
1466
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
21.2
744
5220
R01AD58
ATC
fluticasone, combinations; nasal
1.4
21.1
1123
8524
X58
ICD-10 Finland
Exposure to other specified factors
1.5
21.0
649
4432
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.9
20.9
291
1610
D07AC01
ATC
betamethasone; topical
1.4
20.9
1606
12948
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
20.9
478
3044
D19
ICPC
Teeth/gum symptom/complaint
1.4
20.8
1390
10963
R07.2
ICD-10 Finland
Precordial pain
2.7
20.7
111
417
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.8
20.7
323
1853
WX290
NOMESCO Finland
Other blockage of nerve
1.3
20.6
2125
17892
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
20.6
360
2132
J45
ICD-10 Finland
Asthma
1.6
20.6
479
3061
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
2.3
20.6
156
690
U07
ICPC
Urine symptom/complaint other
1.7
20.6
397
2418
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.9
20.5
262
1411
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
20.5
679
4705
R51.81
ICD-10 Finland
Facial pain NOS
2.5
20.5
128
519
J05AB01
ATC
aciclovir; systemic
1.4
20.4
963
7150
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.9
20.4
256
1371
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.7
20.4
374
2247
J45.1
ICD-10 Finland
Nonallergic asthma
1.8
20.4
321
1846
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
4.4
20.3
51
118
R52.0
ICD-10 Finland
Acute pain
2.2
20.3
167
764
N06AB04
ATC
citalopram; systemic
1.4
20.3
883
6459
N05CF01
ATC
zopiclone; oral
1.4
20.3
1352
10650
K85
ICPC
Elevated blood pressure
1.5
20.1
745
5279
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
20.1
251
1341
SPAT1097
SPAT
Recording of ECG
1.5
20.1
605
4106
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
2.1
20.1
181
860
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.0
20.0
216
1097
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.5
20.0
121
483
Z71.9
ICD-10 Finland
Counselling, unspecified
1.7
20.0
376
2274
C07AB02
ATC
metoprolol; systemic
1.5
19.9
782
5606
SPAT1307
SPAT
Psychosocial counselling and guidance
1.9
19.9
275
1519
G04CA02
ATC
tamsulosin; oral
1.5
19.9
785
5635
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
4.8
19.8
44
92
WZC00, ,
SPAT
1.5
19.8
688
4810
H02.4
ICD-10 Finland
Ptosis of eyelid
2.4
19.8
139
594
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
19.8
414
2574
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
3.7
19.8
62
169
Z50.1
ICD-10 Finland
Other physical therapy
1.9
19.8
238
1256
C03CA01
ATC
furosemide; systemic
1.4
19.8
1175
9075
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.5
19.6
123
500
D07AD01
ATC
clobetasol; topical
1.5
19.6
748
5332
C10AA01
ATC
simvastatin; oral
1.3
19.6
1655
13507
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.2
19.5
52
126
J01DA01
ATC
[U] cefalexin
1.3
19.5
2693
23563
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
19.5
584
3956
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
2.6
19.5
111
430
M54
ICD-10 Finland
Dorsalgia
1.6
19.5
565
3801
P03
ICPC
Feeling depressed
1.6
19.4
457
2927
I20.09
ICD-10 Finland
Unstable angina
2.0
19.4
228
1193
R4110, ,
SPAT
1.5
19.4
613
4202
D09
ICPC
Nausea
2.0
19.3
228
1195
R03AK08
ATC
formoterol and beclometasone; inhalant
2.0
19.3
212
1084
N64.4
ICD-10 Finland
Mastodynia
2.2
19.3
164
761
R01AD08
ATC
fluticasone; nasal
1.4
19.3
1243
9722
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.7
19.2
339
2014
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
19.2
268
1485
N03AX11
ATC
topiramate; oral
2.5
19.2
118
475
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
19.2
341
2030
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
19.1
163
757
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
6.7
19.1
30
45
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
19.0
1494
12044
S01EC01
ATC
acetazolamide; systemic
2.8
19.0
98
361
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.9
19.0
228
1202
N07CA01
ATC
betahistine; oral
1.8
18.9
310
1803
N02BF02
ATC
pregabalin; oral
1.8
18.9
311
1811
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.4
18.9
1165
9042
C01CA24
ATC
epinephrine; parenteral
1.8
18.9
279
1573
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.2
18.9
161
748
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.7
18.8
387
2396
R03BA08
ATC
ciclesonide; inhalant
1.7
18.8
390
2421
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
18.7
307
1785
J01EA01
ATC
trimethoprim; systemic
1.4
18.7
1128
8719
DFF00
NOMESCO Finland
Pure tone audiometry
1.6
18.7
442
2833
B01AF02
ATC
apixaban; oral
1.5
18.7
560
3792
H81.3
ICD-10 Finland
Other peripheral vertigo
2.3
18.7
136
591
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.5
18.7
114
457
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
18.7
458
2962
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
18.7
469
3051
C09AA05
ATC
ramipril; oral
1.4
18.7
976
7367
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
18.6
260
1440
H35.7
ICD-10 Finland
Separation of retinal layers
3.7
18.6
58
158
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
18.6
422
2680
S80.0
ICD-10 Finland
Contusion of knee
1.7
18.5
342
2057
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
18.5
913
6819
207
Kela drug reimbursment
Chronic arrhythmias
1.5
18.4
624
4337
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
5.5
18.3
35
64
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
5.5
18.3
35
64
Z02.7
ICD-10 Finland
Issue of medical certificate
1.7
18.3
330
1971
H52.1
ICD-10 Finland
Myopia
2.1
18.3
164
778
H35.8
ICD-10 Finland
Other specified retinal disorders
5.0
18.3
39
79
R25.2
ICD-10 Finland
Cramp and spasm
2.5
18.2
118
487
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
18.2
666
4703
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
4.6
18.2
43
95
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
18.1
287
1652
SPAT1240
SPAT
Therapeutic discussion
1.6
18.1
446
2887
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
18.1
602
4167
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
18.1
1160
9049
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.9
18.1
218
1151
R35
ICD-10 Finland
Polyuria
1.8
18.1
291
1683
I49.1
ICD-10 Finland
Atrial premature depolarization
2.1
18.1
181
895
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
18.1
418
2665
N03AG01
ATC
valproic acid; systemic, rectal
1.9
18.1
246
1352
M01AE02
ATC
naproxen; oral, rectal
1.3
18.0
2510
21889
SPAT1301
SPAT
No procedures
1.4
17.9
1318
10503
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
2.6
17.8
105
414
A08
ICPC
Swelling
1.8
17.8
262
1475
H54.4
ICD-10 Finland
Blindness, monocular
18.1
17.7
27
15
E66.01
ICD-10 Finland
Obesity due to excess calories
1.6
17.7
419
2687
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
17.7
156
735
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
17.7
1272
10097
C08DA01
ATC
verapamil; systemic
2.1
17.7
174
855
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.0
17.7
192
978
Z00.0
ICD-10 Finland
General medical examination
1.4
17.7
830
6142
S22.3
ICD-10 Finland
Fracture of rib
1.7
17.6
306
1809
H25.0
ICD-10 Finland
Senile incipient cataract
1.8
17.6
274
1569
S04
ICPC
Lump/swelling localized
1.6
17.6
500
3345
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.3
17.6
1289
10260
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
17.6
339
2063
N06AB03
ATC
fluoxetine; oral
1.5
17.5
519
3504
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
17.5
215
1143
M54.1
ICD-10 Finland
Radiculopathy
2.0
17.4
185
935
H03AA01
ATC
levothyroxine sodium; systemic
1.4
17.4
1015
7791
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.5
17.4
111
455
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
17.4
1136
8883
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
17.3
216
1155
K29
ICPC
Cardiovascular sympt/complt other
2.0
17.3
188
959
ZY010
NOMESCO Finland
Hospital outpatient
1.9
17.2
227
1235
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
3.6
17.2
56
157
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.6
17.2
101
398
G81.9
ICD-10 Finland
Hemiplegia, unspecified
3.5
17.2
57
162
L82
ICD-10 Finland
Seborrhoeic keratosis
1.4
17.2
822
6100
K05
ICPC
Irregular heartbeat other
2.1
17.1
153
726
L16
ICPC
Ankle symptom/complaint
1.5
17.1
542
3715
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
17.0
246
1378
H50.1
ICD-10 Finland
Divergent concomitant strabismus
4.6
17.0
40
88
XKD00
NOMESCO Finland
Uroflowmetry
1.5
16.9
543
3731
H54.5
ICD-10 Finland
Severe visual impairment, monocular
6.1
16.8
29
48
A02BC04
ATC
rabeprazole; oral
1.6
16.8
377
2386
K07
ICPC
Swollen ankles/oedema
1.9
16.8
214
1152
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
16.8
1199
9496
H93.1
ICD-10 Finland
Tinnitus
1.7
16.8
310
1865
XQ800
NOMESCO Finland
Prick test
1.7
16.8
317
1919
WX704
NOMESCO Finland
Intubation
1.7
16.7
352
2192
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
16.7
303
1814
KH1AD
NOMESCO Finland
CT of urinary organs
2.1
16.6
155
747
SPAT1263
SPAT
Sampling
1.3
16.6
1798
15100
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
16.6
772
5698
N05BA01
ATC
diazepam; systemic, rectal
1.5
16.5
519
3547
J20
ICD-10 Finland
Acute bronchitis
1.6
16.5
452
2999
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
16.5
949
7262
J01MA06
ATC
norfloxacin; oral
1.5
16.5
533
3666
F13
ICPC
Eye sensation abnormal
2.2
16.5
137
631
L29
ICPC
Musculoskeletal sympt/complt other
1.6
16.4
401
2590
-1, ,
NOMESCO Finland
1.3
16.4
1403
11401
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
16.4
297
1777
P29
ICPC
Psychological sympt/compl other
1.7
16.4
335
2070
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.9
16.4
205
1097
ZXD05
NOMESCO Finland
Urgent procedure
1.3
16.4
1214
9662
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
3.8
16.3
49
130
AN1
HP
Coronary angiography
1.6
16.3
397
2562
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.9
16.2
203
1086
J46
ICD-10 Finland
Status asthmaticus
2.2
16.2
136
629
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.7
16.2
304
1837
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.1
16.2
146
695
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.6
16.2
389
2504
H40.0
ICD-10 Finland
Glaucoma suspect
1.6
16.1
347
2173
P20
ICPC
Memory disturbance
1.5
16.1
568
3978
P99
ICPC
Psychological disorders other
2.1
16.0
143
678
R44.1
ICD-10 Finland
Visual hallucinations
4.8
15.9
35
73
K24
ICPC
Fear of heart disease
2.3
15.9
122
544
KMAK, ,
NOMESCO Finland
1.3
15.8
2202
19065
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.7
15.8
308
1879
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
3.3
15.8
59
181
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
6.4
15.8
26
41
D03
ICPC
Heartburn
2.0
15.8
183
954
G43
ICD-10 Finland
Migraine
1.8
15.7
233
1315
U01
ICPC
Dysuria/painful urination
1.6
15.7
365
2328
A27
ICPC
Fear of other disease NOS
1.8
15.7
232
1308
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.5
15.7
607
4325
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
3.5
15.6
53
153
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.0
15.6
169
861
AA1CG, ,
SPAT
3.1
15.6
63
203
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
15.6
473
3208
R03BA01
ATC
beclometasone; inhalant
1.5
15.5
576
4071
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
15.5
515
3562
M01AC06
ATC
meloxicam; systemic, rectal
1.3
15.4
1527
12638
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.3
15.4
1218
9769
L50.0
ICD-10 Finland
Allergic urticaria
2.2
15.4
123
557
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
15.4
594
4229
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.4
15.4
103
432
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
15.4
401
2629
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
15.3
951
7355
N06AA09
ATC
amitriptyline; systemic
1.6
15.3
389
2535
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.6
15.3
327
2043
I95.1
ICD-10 Finland
Orthostatic hypotension
2.0
15.3
154
764
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.3
15.3
111
483
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.4
15.3
106
452
R25.1
ICD-10 Finland
Tremor, unspecified
2.1
15.3
141
677
L86
ICPC
Back syndrome with radiating pain
1.7
15.3
275
1643
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
15.2
285
1720
Z2445
NOMESCO Finland
Psychologist
2.0
15.2
161
813
S01
ICPC
Pain/tenderness of skin
1.8
15.2
214
1190
H33.5
ICD-10 Finland
Other retinal detachments
3.8
15.2
46
123
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
15.1
196
1061
GD1AA, ,
SPAT
1.4
15.1
686
5034
N03AF02
ATC
oxcarbazepine; oral
2.1
15.1
135
641
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
5.6
15.1
28
50
K90
ICPC
Stroke/cerebrovascular accident
2.2
15.0
120
544
H43.9
ICD-10 Finland
Disorder of vitreous body, unspecified
3.3
15.0
56
172
R06AX22
ATC
ebastine; oral
1.4
14.9
719
5330
EBA00
NOMESCO Finland
Extraction of tooth
1.3
14.9
1572
13105
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
3.8
14.9
45
120
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.8
14.9
72
257
R4150
NOMESCO Finland
Neuropsychological rehabilitation
3.9
14.9
43
111
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
14.9
562
3986
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
14.8
100
422
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.5
14.7
94
386
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
14.7
292
1790
A23
ICPC
Risk factor NOS
1.5
14.7
414
2762
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
4.1
14.7
40
99
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.1
14.7
130
615
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.3
14.6
109
480
A28
ICPC
Limited function/disability NOS
1.4
14.6
713
5296
K91
ICPC
Cerebrovascular disease
2.9
14.6
66
227
L29.9
ICD-10 Finland
Pruritus, unspecified
2.1
14.6
132
629
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
14.6
832
6344
R03BB04
ATC
tiotropium bromide; inhalant
1.6
14.6
375
2451
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
14.6
2145
18632
J01DA09
ATC
[U] cefadroxil
1.3
14.5
1076
8543
SPAT1312
SPAT
General health counselling
1.3
14.4
1334
10918
X21
ICPC
Breast sympt/compl female other
2.3
14.4
109
483
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.8
14.4
212
1195
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
3.8
14.4
43
114
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
14.3
256
1527
R29
ICPC
Respiratory symptom/complaint other
1.7
14.3
297
1843
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.6
14.2
340
2184
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
14.2
332
2122
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
14.2
344
2218
L60.0
ICD-10 Finland
Ingrowing nail
1.8
14.1
209
1180
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
14.1
576
4144
R01AD11
ATC
triamcinolone; nasal
1.6
14.1
357
2326
J05AB11
ATC
valaciclovir; oral
1.4
14.0
615
4482
R41.3
ICD-10 Finland
Other amnesia
2.1
14.0
131
633
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
4.1
14.0
38
94
I63.8
ICD-10 Finland
Other cerebral infarction
3.7
14.0
44
121
R30.0
ICD-10 Finland
Dysuria
1.8
14.0
191
1053
H01.0
ICD-10 Finland
Blepharitis
1.6
13.9
295
1839
PD5AD
NOMESCO Finland
CT of aorta
2.3
13.9
105
465
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
13.9
935
7308
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
13.9
472
3275
P74
ICPC
Anxiety disorder/anxiety state
1.8
13.9
208
1179
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.5
13.8
435
2971
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.5
13.8
462
3197
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.1
13.8
130
630
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.0
13.8
59
197
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.5
13.7
421
2860
R20.0
ICD-10 Finland
Anaesthesia of skin
3.5
13.7
46
132
D18
ICPC
Change in faeces/bowel movements
2.1
13.7
126
605
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
13.7
544
3893
A06AD11
ATC
lactulose; oral
1.4
13.7
556
3996
N03AE01
ATC
clonazepam; systemic
1.7
13.6
225
1312
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
13.6
192
1068
R09.1
ICD-10 Finland
Pleurisy
2.5
13.6
84
340
N06AX26
ATC
vortioxetine; oral
1.6
13.6
323
2072
S10
ICPC
Boil/carbuncle
1.7
13.6
253
1526
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
13.6
1260
10304
M02AA07
ATC
piroxicam; topical
1.3
13.5
1453
12108
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.7
13.5
269
1651
L04AX07
ATC
dimethyl fumarate; oral
5.4
13.5
26
48
L50.9
ICD-10 Finland
Urticaria, unspecified
1.9
13.5
166
884
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.4
13.5
91
384
N27
ICPC
Fear of neurological disease other
2.4
13.5
88
366
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
13.5
430
2947
K59.0
ICD-10 Finland
Constipation
1.7
13.4
230
1355
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
2.8
13.4
66
238
U05
ICPC
Urination problems other
1.8
13.4
217
1258
U71
ICPC
Cystitis/urinary infection other
1.6
13.4
312
1992
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
1.9
13.4
155
809
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.7
13.4
236
1402
M01AH01
ATC
celecoxib; oral
1.4
13.4
710
5344
S01EE01
ATC
latanoprost; ophthalmic
1.7
13.4
248
1494
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
4.0
13.3
37
93
CK2P4
NOMESCO Finland
Optic nerve head light layer imaging (OCT)
4.0
13.3
37
93
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
13.3
384
2575
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
13.2
173
940
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
13.2
597
4370
PA2AD
NOMESCO Finland
CT angiography of brain
3.3
13.2
49
150
P76
ICPC
Depressive disorder
1.6
13.2
287
1801
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.7
13.2
247
1491
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.0
13.2
58
197
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.2
13.2
106
483
H16.0
ICD-10 Finland
Corneal ulcer
1.8
13.1
204
1169
R06.4
ICD-10 Finland
Hyperventilation
2.7
13.1
69
258
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.0
13.1
56
187
N03AX14
ATC
levetiracetam; systemic
2.1
13.1
116
549
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
13.1
835
6470
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
13.1
149
774
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.4
13.1
687
5163
L03AX13
ATC
glatiramer acetate; parenteral
4.6
13.0
30
65
H02AB07
ATC
prednisone; oral
1.4
13.0
526
3774
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.6
13.0
307
1966
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
2.9
13.0
59
204
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.0
13.0
143
734
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.8
13.0
192
1085
H27.1
ICD-10 Finland
Dislocation of lens
5.2
12.9
26
50
353
Kela drug reimbursment
Cladribine and fingolimod
6.1
12.9
22
36
WZC30
NOMESCO Finland
Teaching
1.4
12.9
690
5198
H54.0
ICD-10 Finland
Blindness, binocular
50.1
12.8
15
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.0
12.8
135
682
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
12.8
274
1713
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.5
12.8
79
320
N05BA12
ATC
alprazolam; oral
1.5
12.7
398
2714
C10AA03
ATC
pravastatin; oral
1.6
12.7
277
1739
F03
ICPC
Eye discharge
1.6
12.7
294
1873
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.4
12.7
82
339
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
2.8
12.7
64
234
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.7
12.7
219
1293
D16
ICPC
Rectal bleeding
2.1
12.7
113
536
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
12.7
505
3614
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
2.8
12.7
61
218
A13
ICPC
Concern/fear medical treatment
2.3
12.6
95
421
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.8
12.6
182
1021
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
12.6
140
721
N86
ICPC
Multiple sclerosis
3.8
12.6
37
97
M03BX01
ATC
baclofen; systemic
2.4
12.6
85
359
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.3
12.6
913
7206
F04
ICPC
Visual floaters/spots
4.5
12.6
30
67
R2110
NOMESCO Finland
Giving the first information
1.6
12.6
274
1722
K58
ICD-10 Finland
Irritable bowel syndrome
2.1
12.5
117
566
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.0
12.5
136
696
H15.1
ICD-10 Finland
Episcleritis
2.7
12.5
66
248
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.7
12.5
223
1331
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
12.4
243
1485
F28
ICPC
Limited function/disability (F)
3.8
12.4
37
98
WZC30, ,
SPAT
1.5
12.3
364
2453
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
1.9
12.3
142
741
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
1.9
12.3
153
819
ZX120
NOMESCO Finland
Intravenous
1.5
12.3
366
2471
H35.9
ICD-10 Finland
Retinal disorder, unspecified
4.1
12.3
33
81
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
12.3
134
686
S01ED01
ATC
timolol; ophthalmic
2.0
12.3
127
638
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
12.3
396
2719
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
12.3
235
1429
S01EA05
ATC
brimonidine; ophthalmic
2.2
12.2
98
446
XQ848
NOMESCO Finland
Dermatological photography
2.0
12.2
126
632
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
5.1
12.2
25
49
C08CA13
ATC
lercanidipine; oral
1.4
12.2
579
4276
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.4
12.1
83
353
K07.61
ICD-10 Finland
Cracking jaw joint
2.2
12.1
95
429
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
12.1
320
2106
XCD20
NOMESCO Finland
Photoangiography of eye
2.7
12.0
64
241
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.1
12.0
112
541
S20.2
ICD-10 Finland
Contusion of thorax
1.7
12.0
213
1268
I34.1
ICD-10 Finland
Mitral (valve) prolapse
2.1
12.0
106
502
B02.9
ICD-10 Finland
Zoster without complication
1.6
12.0
291
1877
OAB93, ,
SPAT
1.6
12.0
268
1695
N05CF02
ATC
zolpidem; oral
1.4
12.0
702
5365
P25
ICPC
Phase of life problem adult
1.8
11.9
182
1038
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
3.1
11.9
49
160
J01MA12
ATC
levofloxacin; systemic
1.4
11.9
702
5367
J01DA06
ATC
[U] cefuroxime
1.4
11.9
564
4161
M75.8
ICD-10 Finland
Other shoulder lesions
1.8
11.9
167
929
WX872
NOMESCO Finland
Intensive care
1.8
11.9
190
1099
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
11.8
669
5081
L57.0
ICD-10 Finland
Actinic keratosis
1.5
11.8
413
2880
R03AC12
ATC
salmeterol; inhalant
1.8
11.8
169
946
L84
ICPC
Back syndrome without radiat pain
1.7
11.8
212
1267
N30
ICD-10 Finland
Cystitis
1.5
11.8
357
2419
R10.2
ICD-10 Finland
Pelvic and perineal pain
2.1
11.8
106
506
S88
ICPC
Dermatitis contact/allergic
2.2
11.7
94
428
R39.1
ICD-10 Finland
Other difficulties with micturition
2.0
11.7
119
594
A07EA06
ATC
budesonide; oral, local oral
1.9
11.7
155
847
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.9
11.7
138
726
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
11.7
1643
14086
R01AD05
ATC
budesonide; nasal
1.6
11.7
297
1937
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.8
11.7
185
1068
WX702
NOMESCO Finland
Supraglottic ventilation device
1.7
11.6
233
1433
S89.9
ICD-10 Finland
Unspecified injury of lower leg
1.9
11.6
151
820
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.0
11.6
115
569
M54.3
ICD-10 Finland
Sciatica
1.6
11.6
248
1552
R04
ICPC
Breathing problem other
1.8
11.6
163
908
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.5
11.5
69
276
M01AH02
ATC
rofecoxib; oral
1.4
11.5
476
3428
S00.0
ICD-10 Finland
Superficial injury of scalp
2.1
11.5
104
497
S01EC54
ATC
brinzolamide, combinations; ophthalmic
2.7
11.5
60
224
D10
ICPC
Vomiting
1.6
11.5
243
1517
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
11.4
227
1393
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
2.5
11.4
70
283
F27
ICPC
Fear of eye disease
2.9
11.4
51
175
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.7
11.4
231
1426
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
11.4
728
5635
R09
ICPC
Sinus symptom/complaint
1.5
11.4
351
2388
N06
ICPC
Sensation disturbance other
2.8
11.3
54
192
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.8
11.3
157
870
S01EC04
ATC
brinzolamide; ophthalmic
1.8
11.3
156
863
164
Kela drug reimbursment
Fingolimod
5.4
11.3
22
41
K78
ICPC
Atrial fibrillation/flutter
1.6
11.3
278
1800
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
3.5
11.3
37
105
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
1.6
11.3
264
1689
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.0
11.2
122
624
K01
ICPC
Heart pain
2.7
11.2
57
210
R07.1
ICD-10 Finland
Chest pain on breathing
2.5
11.2
67
268
A03FA02
ATC
cisapride; oral, rectal
1.6
11.2
274
1771
WYA10
NOMESCO Finland
Emergency care or similar visit
1.6
11.2
294
1932
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
1.6
11.2
228
1410
K04.08
ICD-10 Finland
Other specified pulpit
1.5
11.2
312
2078
J01CA08
ATC
pivmecillinam; oral
1.2
11.1
1784
15498
R15
ICD-10 Finland
Faecal incontinence
2.0
11.1
125
648
C09CA01
ATC
losartan; oral
1.3
11.1
1026
8357
ZX114
NOMESCO Finland
Intramuscular
2.7
11.1
59
223
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
11.1
409
2885
H25.8
ICD-10 Finland
Other senile cataract
1.5
11.0
408
2878
E87.6
ICD-10 Finland
Hypokalaemia
1.9
11.0
142
770
H54.6
ICD-10 Finland
Moderate visual impairment, monocular
5.7
11.0
20
35
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
11.0
150
828
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.7
11.0
196
1170
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
10.0
11.0
21
21
K04.1
ICD-10 Finland
Necrosis of pulp
1.4
11.0
440
3151
L20
ICPC
Joint symptom/complaint NOS
1.8
11.0
164
931
L09
ICPC
Arm symptom/complaint
1.7
11.0
206
1247
J01FA01
ATC
erythromycin; systemic
1.4
11.0
544
4044
M35.7
ICD-10 Finland
Hypermobility syndrome
2.5
11.0
66
265
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
3.0
10.9
47
158
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.7
10.9
210
1279
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
2.0
10.9
110
549
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.5
10.9
373
2593
D07AC13
ATC
mometasone; topical
1.3
10.8
1166
9671
S97
ICPC
Chronic ulcer skin
1.6
10.8
240
1515
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.7
10.8
206
1251
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
5.1
10.8
22
43
R63.4
ICD-10 Finland
Abnormal weight loss
1.8
10.7
164
937
A92
ICPC
Allergy/allergic reaction NOS
1.9
10.7
133
713
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
3.2
10.7
42
134
Z2446
NOMESCO Finland
Social worker
1.6
10.7
241
1529
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
10.7
787
6215
K84
ICPC
Heart disease other
2.0
10.6
111
560
N05AX12
ATC
aripiprazole; systemic
1.8
10.6
155
873
GD1LA
NOMESCO Finland
GD
2.7
10.6
57
216
CE2W4
NOMESCO Finland
Eye movement mapping
12.9
10.6
18
14
LCA06
NOMESCO Finland
Biopsy of endometrium
1.4
10.6
463
3366
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.7
10.6
172
1000
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
4.1
10.6
28
68
L95
ICPC
Osteoporosis
1.7
10.6
171
993
F16
ICPC
Eyelid symptom/complaint
1.6
10.5
217
1345
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
10.5
158
898
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.6
10.5
247
1582
L10
ICPC
Elbow symptom/complaint
1.6
10.4
219
1364
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.4
10.4
499
3685
K99
ICPC
Cardiovascular disease other
2.0
10.4
102
503
K04.09
ICD-10 Finland
Pulpit UNS
1.7
10.4
184
1096
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
1.8
10.4
159
909
M31.6
ICD-10 Finland
Other giant cell arteritis
5.4
10.4
20
37
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
10.4
375
2633
SPAT1283
SPAT
Restricted health certificate
1.3
10.4
664
5135
I20.00
ICD-10 Finland
Unstable angina
2.1
10.4
99
484
L04AG12
ATC
ofatumumab; parenteral
16.1
10.3
16
10
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.5
10.3
330
2262
N63
ICD-10 Finland
Unspecified lump in breast
1.5
10.3
277
1830
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
10.3
1382
11751
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
10.2
205
1262
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.6
10.2
244
1568
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.2
10.2
87
407
N18
ICPC
Paralysis/weakness
2.3
10.2
78
349
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
3.8
10.2
30
79
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
10.2
1623
14053
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.1
10.2
88
414
UJD02
NOMESCO Finland
Gastroscopy
1.7
10.2
181
1080
H3603, E103,
ICD-10 Finland
3.1
10.2
42
138
M77.4
ICD-10 Finland
Metatarsalgia
1.6
10.2
255
1658
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
10.2
483
3563
K64.9
ICD-10 Finland
Haemorrhoids, unspecified
1.7
10.2
171
1005
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.6
10.2
250
1619
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
10.1
1191
9970
S22
ICPC
Nail symptom/complaint
1.5
10.1
270
1780
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.6
10.1
230
1462
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
5.3
10.1
20
38
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.7
10.1
194
1182
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
10.1
982
8037
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.5
10.1
286
1912
SPAT1254
SPAT
Administration of medicine
1.4
10.1
573
4352
R06.5
ICD-10 Finland
Mouth breathing
1.5
10.1
345
2398
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.7
10.1
183
1099
C07AB12
ATC
nebivolol; oral
1.9
10.1
119
628
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
10.0
257
1679
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
1.8
10.0
147
830
TQW40, ,
SPAT
1.4
10.0
414
2980
H57.0
ICD-10 Finland
Anomalies of pupillary function
3.5
10.0
33
94
M10.9
ICD-10 Finland
Gout, unspecified
1.6
10.0
248
1608
R19.4
ICD-10 Finland
Change in bowel habit
1.9
10.0
130
707
G44.8
ICD-10 Finland
Other specified headache syndromes
2.4
10.0
67
283
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.6
10.0
229
1458
M05BX04
ATC
denosumab; parenteral
1.6
10.0
258
1689
M05BA04
ATC
alendronic acid; oral
1.5
10.0
338
2343
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.1
10.0
92
444
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.4
10.0
455
3333
C01BC04
ATC
flecainide; systemic
1.9
10.0
130
708
A06AC51
ATC
ispaghula, combinations; oral
1.7
10.0
188
1140
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.7
10.0
180
1079
F32.1
ICD-10 Finland
Moderate depressive episode
1.6
9.9
240
1547
F45.0
ICD-10 Finland
Somatization disorder
4.0
9.9
27
67
N03
ICPC
Pain face
2.9
9.9
45
156
N20.1
ICD-10 Finland
Calculus of ureter
1.8
9.9
136
753
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.8
9.9
135
746
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
9.9
1964
17380
C05AA08
ATC
fluocortolone; rectal, topical
1.4
9.9
518
3885
FN1AD
NOMESCO Finland
CT of coronary arteries
2.2
9.8
79
361
PA7DG
NOMESCO Finland
Very extended MRI examination of vessesl in brain and neck with high intensity magnet
12.2
9.8
17
14
CKD15
NOMESCO Finland
Injection of vitreous substitute
4.3
9.8
25
59
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
5.1
9.8
20
39
SBB10
NOMESCO Finland
Dental impressions
1.5
9.8
261
1720
315
Kela drug reimbursment
Clopidogrel
3.0
9.8
42
141
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.8
9.8
135
748
SDA03
NOMESCO Finland
Periodontal treatment
1.2
9.8
1733
15152
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.2
9.8
1505
12973
N02CC07
ATC
frovatriptan; oral
1.7
9.8
160
934
R06.2
ICD-10 Finland
Wheezing
1.7
9.7
179
1078
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
2.9
9.7
45
158
SPAT1153
SPAT
Removal of sutures
1.2
9.7
1242
10489
IGY02
NOMESCO Finland
Psychiatric monitoring contact
1.9
9.7
128
700
J45.8
ICD-10 Finland
Mixed asthma
1.9
9.7
121
650
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
2.0
9.7
102
517
R06AX13
ATC
loratadine; oral
1.3
9.7
595
4571
H50.2
ICD-10 Finland
Vertical strabismus
3.7
9.7
30
82
B01AC07
ATC
dipyridamole; systemic
1.9
9.7
118
629
H50.30
ICD-10 Finland
Intermittent esotropy
7.4
9.7
22
30
K11.2
ICD-10 Finland
Sialoadenitis
1.8
9.7
133
737
SPAT1058
SPAT
PEF monitoring instruction
1.5
9.7
311
2135
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.6
9.7
244
1590
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.7
9.6
155
900
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.5
9.6
346
2427
N06AX12
ATC
bupropion; oral
1.5
9.6
277
1858
H52.2
ICD-10 Finland
Astigmatism
2.2
9.6
77
352
G50.0
ICD-10 Finland
Trigeminal neuralgia
2.2
9.6
74
333
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
3.2
9.6
36
112
WX142
NOMESCO Finland
Sub-tenon anesthesy
3.3
9.6
35
107
XQ802
NOMESCO Finland
Epicutan test
1.7
9.5
160
940
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.8
9.5
135
755
J30.3
ICD-10 Finland
Other allergic rhinitis
1.8
9.5
141
799
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.8
9.5
146
836
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
2.4
9.5
62
259
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.4
9.5
475
3533
J01
ICD-10 Finland
Acute sinusitis
1.6
9.5
230
1484
SPAT1009
SPAT
Measurement of intraocular pressure
2.5
9.5
56
223
A91
ICPC
Abnormal result investigation NOS
1.6
9.5
222
1421
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.7
9.5
157
919
R03AC13
ATC
formoterol; inhalant
1.7
9.5
189
1163
R31
ICD-10 Finland
Unspecified haematuria
1.4
9.5
353
2493
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.6
9.5
206
1296
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
2.9
9.5
44
155
H02AB09
ATC
hydrocortisone; systemic
2.0
9.5
94
467
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
1.9
9.4
114
606
R68.2
ICD-10 Finland
Dry mouth, unspecified
3.2
9.4
37
118
A46
ICD-10 Finland
Erysipelas
1.4
9.4
551
4201
X15
ICPC
Vaginal symptom/complaint other
1.7
9.4
166
989
TKC22
NOMESCO Finland
Catheterisation instruction
2.1
9.4
86
414
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.7
9.4
165
982
S02
ICPC
Pruritus
1.8
9.4
146
840
R52.1
ICD-10 Finland
Chronic intractable pain
2.9
9.4
42
145
G83.4
ICD-10 Finland
Cauda equina syndrome
4.2
9.4
24
57
E66.8
ICD-10 Finland
Other obesity
1.6
9.4
223
1434
CHC05
NOMESCO Finland
Iridotomy
2.4
9.4
62
261
N76.0
ICD-10 Finland
Acute vaginitis
1.5
9.4
261
1739
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
3.1
9.3
38
124
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
9.3
163
969
E000001, ,
ATC
1.3
9.3
766
6129
114
Kela drug reimbursment
Glaucoma
1.5
9.3
311
2151
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
9.3
396
2866
XG405
NOMESCO Finland
Education on PEF monitoring
2.4
9.3
64
274
M01AB55
ATC
diclofenac, combinations; oral
1.5
9.3
244
1604
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.0
9.3
40
135
I20.0
ICD-10 Finland
Unstable angina
3.3
9.3
34
104
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
9.3
219
1405
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.6
9.3
228
1477
H34.9
ICD-10 Finland
Retinal vascular occlusion, unspecified
8.7
9.3
19
22
G93.2
ICD-10 Finland
Benign intracranial hypertension
8.7
9.3
19
22
N06AX03
ATC
mianserin; oral
1.7
9.3
174
1055
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
9.2
275
1858
G04CB01
ATC
finasteride; oral
1.5
9.2
302
2080
H40.9
ICD-10 Finland
Glaucoma, unspecified
2.2
9.2
73
332
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.6
9.2
238
1559
B80
ICPC
Iron deficiency anaemia
1.9
9.2
111
590
R4120, ,
SPAT
2.4
9.2
61
257
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.3
9.2
66
288
R04.2
ICD-10 Finland
Haemoptysis
1.8
9.2
122
670
WVA20
NOMESCO Finland
Medicine administration
1.9
9.1
115
620
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
2.2
9.1
76
353
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
9.1
952
7848
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.0
9.1
101
522
W01
ICPC
Question of pregnancy
3.0
9.1
38
126
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.1
9.1
82
393
CEC00
NOMESCO Finland
Recession of extraocular muscle
5.0
9.1
19
38
-69
ICPC
Other reason for encounter NEC
1.8
9.1
143
826
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
9.1
237
1557
K25
ICPC
Fear of hypertension
1.7
9.1
160
954
S08
ICPC
Skin colour change
1.6
9.1
222
1437
N02AA05
ATC
oxycodone; systemic
1.3
9.1
687
5437
SGA01
NOMESCO Finland
Emergency treatment
1.3
9.0
638
4999
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.6
9.0
222
1438
L11
ICPC
Wrist symptom/complaint
1.4
9.0
394
2864
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
2.3
9.0
68
303
A03CA02
ATC
clidinium and psycholeptics; oral
1.6
9.0
207
1320
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
9.0
482
3625
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.2
9.0
74
342
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
1.7
9.0
150
881
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.9
9.0
115
624
SXC05
NOMESCO Finland
Other oral or dental procedure
1.5
8.9
262
1765
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
8.9
500
3787
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.2
8.9
71
324
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.2
8.9
75
350
K04.0
ICD-10 Finland
Pulpitis
1.4
8.9
347
2472
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
4.2
8.9
23
55
XCW12
NOMESCO Finland
Assessment of colour vision
24.0
8.9
12
5
SFA00
NOMESCO Finland
Small restoration
1.3
8.9
568
4388
SPAT1285
SPAT
Provision of consultation response
1.6
8.9
196
1238
L85.3
ICD-10 Finland
Xerosis cutis
2.6
8.9
50
195
R4130
NOMESCO Finland
Speech therapy
1.9
8.9
103
541
SAA04
NOMESCO Finland
Special examination of mouth
1.6
8.9
200
1270
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.3
8.8
66
293
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.8
8.8
122
678
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
8.8
510
3882
M01AX01
ATC
nabumetone; oral
1.7
8.8
152
901
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
2.8
8.8
43
156
N06AX22
ATC
agomelatine; oral
2.0
8.8
95
487
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.2
8.8
71
326
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.9
8.8
101
529
H36.01
ICD-10 Finland
Diabetic maculopathy
2.5
8.8
52
208
W19
ICD-10 Finland
Unspecified fall
1.4
8.7
370
2676
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.8
8.7
117
644
G04BD12
ATC
mirabegron; oral
1.4
8.7
466
3503
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.7
8.7
141
821
K05.18
ICD-10 Finland
Chronic gingivitis
1.5
8.7
296
2055
ZXY02
NOMESCO Finland
Neuropsychologist
3.7
8.7
27
74
EBA10
NOMESCO Finland
Operative extraction of tooth
1.3
8.7
513
3916
F05.9
ICD-10 Finland
Delirium, unspecified
2.1
8.7
77
367
F02
ICPC
Red eye
1.6
8.7
177
1097
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
8.7
619
4859
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.5
8.6
279
1918
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.5
8.6
50
198
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
4.4
8.6
21
48
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
2.0
8.6
92
470
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.8
8.6
129
735
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
8.6
172
1061
N28
ICPC
Limited function/disability (N)
2.2
8.6
70
323
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
8.6
577
4491
H54.3
ICD-10 Finland
Mild or no visual impairment, binocular
8.2
8.6
18
22
CKD20
NOMESCO Finland
Removal of vitreous body substitute
3.6
8.5
27
75
DFF59
NOMESCO Finland
Other assessment of balance
2.6
8.5
49
193
ACC51
NOMESCO Finland
Release of median nerve
1.5
8.5
295
2055
F80.1
ICD-10 Finland
Expressive language disorder
2.9
8.5
38
131
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.0
8.5
88
444
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.7
8.5
163
994
L07
ICPC
Jaw symptom/complaint
2.2
8.5
65
292
S12
ICPC
Insect bite/sting
1.4
8.5
347
2494
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
8.5
280
1933
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.6
8.5
215
1404
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
8.5
852
6987
R5110, ,
SPAT
1.4
8.5
339
2428
DHB50
NOMESCO Finland
Turbinoplasty
1.9
8.4
99
522
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
8.4
998
8337
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
8.4
186
1175
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
2.1
8.4
73
345
EC1VA, ,
NOMESCO Finland
1.6
8.4
193
1231
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.1
8.4
76
365
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.5
8.4
263
1796
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
1.7
8.4
153
921
F99
ICPC
Eye/adnexa disease other
3.1
8.4
34
111
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
2.0
8.4
83
413
H10
ICD-10 Finland
Conjunctivitis
1.5
8.4
291
2030
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
4.5
8.4
20
45
3689X
ICD-9 Finland
Visual disturbances, Unspecified visual disturbance
+∞
8.3
8
*
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
3.7
8.3
25
67
FPH96
NOMESCO Finland
Other removal of cardiac pacemaker or cardioverter-defibrillator
4.0
8.3
23
58
J42
ICD-10 Finland
Unspecified chronic bronchitis
2.6
8.3
47
184
I49.5
ICD-10 Finland
Sick sinus syndrome
1.8
8.3
129
743
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
1.6
8.3
170
1055
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.5
8.3
220
1451
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.4
8.3
415
3088
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
8.3
640
5076
NA1BG, ,
SPAT
2.1
8.3
78
381
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
8.3
414
3081
UJH02
NOMESCO Finland
Anoscopy
1.7
8.3
151
910
A07
ICPC
Coma
3.8
8.2
24
63
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
8.2
282
1962
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.4
8.2
341
2458
P02
ICPC
Acute stress reaction
1.6
8.2
211
1382
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.6
8.2
181
1144
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.4
8.2
439
3301
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
8.2
4128
39660
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.6
8.2
182
1152
S01EA03
ATC
apraclonidine; ophthalmic
2.9
8.2
38
134
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
8.2
1444
12569
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.4
8.2
307
2172
G63.2
ICD-10 Finland
Diabetic polyneuropathy
4.2
8.2
21
50
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
1.6
8.2
173
1083
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
3.7
8.2
25
68
D06BB10
ATC
imiquimod; topical
1.6
8.2
201
1304
H91.9
ICD-10 Finland
Hearing loss, unspecified
1.6
8.1
200
1297
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
8.1
143
853
H10.2
ICD-10 Finland
Other acute conjunctivitis
2.3
8.1
61
272
SPAT1325
SPAT
Vaccination
1.2
8.1
1296
11172
S70.0
ICD-10 Finland
Contusion of hip
1.7
8.1
146
877
S06
ICPC
Rash localized
1.5
8.1
216
1427
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.4
8.1
55
235
R10.0
ICD-10 Finland
Acute abdomen
1.7
8.1
129
749
XX3XW, ,
NOMESCO Finland
3.5
8.1
27
78
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
2.4
8.1
54
229
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
1.9
8.1
91
474
K22
ICPC
Risk factor cardiovascular disease
1.5
8.0
220
1462
K92.1
ICD-10 Finland
Melaena
1.6
8.0
183
1167
N06AB05
ATC
paroxetine; oral
1.5
8.0
220
1463
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
3.8
8.0
23
60
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.8
7.9
118
671
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
2.9
7.9
35
120
S02.51
ICD-10 Finland
Fracture of tooth, open
1.4
7.9
358
2618
WX725
NOMESCO Finland
Noninvasive ventilation
1.5
7.9
212
1401
I47.1
ICD-10 Finland
Supraventricular tachycardia
1.7
7.9
155
951
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
2.2
7.9
61
275
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.4
7.9
287
2018
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
3.2
7.9
30
94
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
7.9
278
1943
A01AB09
ATC
miconazole; local oral
1.4
7.9
309
2203
SPAT1216
SPAT
Assessment of functional ability
1.3
7.9
564
4424
M13.9
ICD-10 Finland
Arthritis, unspecified
1.5
7.9
283
1986
M02AA10
ATC
ketoprofen; topical
1.3
7.9
606
4801
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.9
7.9
102
556
N07AA02
ATC
pyridostigmine; systemic
3.7
7.9
24
65
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.2
7.9
66
308
R33
ICD-10 Finland
Retention of urine
1.5
7.9
251
1721
R06
ICPC
Nose bleed/epistaxis
1.9
7.9
91
478
H60.8
ICD-10 Finland
Other otitis externa
1.7
7.9
125
725
SPAT1050
SPAT
Extensive neurological examination
2.0
7.9
80
402
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
7.9
357
2614
SPAT1053
SPAT
Memory test
1.3
7.8
483
3710
N06AG02
ATC
moclobemide; oral
1.7
7.8
149
908
J01DC02
ATC
cefuroxime; systemic
1.5
7.8
201
1317
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
1.7
7.8
128
749
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
2.3
7.8
56
245
N29
ICPC
Neurological sympt/complt other
2.0
7.8
77
383
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.8
7.8
112
631
C03DA01
ATC
spironolactone; oral
1.3
7.8
443
3363
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.1
7.8
71
343
H52.5
ICD-10 Finland
Disorders of accommodation
9.4
7.8
15
16
EB1AA, ,
SPAT
1.5
7.8
247
1694
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.6
7.8
158
980
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
2.5
7.7
46
185
R03BC03
ATC
nedocromil; inhalant
1.5
7.7
247
1696
H3603, E108,
ICD-10 Finland
45.0
7.7
9
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
7.7
281
1979
F43
ICPC
Eye, Other diagnostic procedure
2.0
7.7
84
433
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
1.7
7.7
131
775
N76.4
ICD-10 Finland
Abscess of vulva
3.1
7.7
31
101
N06BA07
ATC
modafinil; oral
3.9
7.7
22
57
G04BD08
ATC
solifenacin; oral
1.5
7.7
238
1624
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.7
7.7
39
145
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
1.7
7.6
137
822
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
3.3
7.6
28
86
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.4
7.6
48
198
AA5PD
NOMESCO Finland
CT examination of brain pefusion
2.7
7.6
40
151
H13
ICPC
Plugged feeling ear
1.3
7.6
750
6130
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.2
7.6
61
280
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
4.0
7.6
21
53
R4180, ,
SPAT
2.3
7.6
52
223
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.7
7.6
133
793
H53.5
ICD-10 Finland
Colour vision deficiencies
18.4
7.6
11
6
R75
ICPC
Sinusitis acute/chronic
1.6
7.6
193
1262
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.6
7.6
174
1111
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
7.6
369
2734
XA420
NOMESCO Finland
Extensive sleep examination
2.6
7.6
43
169
280
Kela drug reimbursment
Clopidogrel
2.4
7.6
49
205
K03.80
ICD-10 Finland
Irradiated enamel
1.5
7.6
221
1490
L30.4
ICD-10 Finland
Erythema intertrigo
2.2
7.5
61
281
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
1.8
7.5
107
601
H26.8
ICD-10 Finland
Other specified cataract
2.6
7.5
40
152
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
1.7
7.5
127
750
L03AB07
ATC
interferon beta-1a; parenteral
3.2
7.5
28
87
WW200, ,
SPAT
1.2
7.5
1223
10549
R06AE09
ATC
levocetirizine; oral
1.3
7.5
551
4339
H93.2
ICD-10 Finland
Other abnormal auditory perceptions
2.6
7.5
42
164
XG466
NOMESCO Finland
Sleep oxymetry
1.8
7.5
107
602
M65.3
ICD-10 Finland
Trigger finger
1.6
7.5
183
1186
WX400
NOMESCO Finland
Inhalation anesthesy
1.6
7.5
149
919
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.7
7.5
119
691
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.6
7.5
151
935
F34.1
ICD-10 Finland
Dysthymia
1.7
7.5
138
835
H16.9
ICD-10 Finland
Keratitis, unspecified
2.1
7.5
69
335
N03AF01
ATC
carbamazepine; oral, rectal
1.6
7.5
164
1037
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
7.4
374
2785
JAH01
NOMESCO Finland
Laparoscopy
1.6
7.4
169
1077
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.6
7.4
165
1046
M19.8
ICD-10 Finland
Other specified arthrosis
1.6
7.4
159
999
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
2.2
7.4
61
283
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
1.8
7.4
107
604
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
1.5
7.4
206
1374
FP1B5, ,
SPAT
1.8
7.4
111
634
M50.3
ICD-10 Finland
Other cervical disc degeneration
1.9
7.4
90
482
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.9
7.4
86
454
-1, ,
ICPC
1.7
7.4
139
846
K83
ICPC
Heart valve disease NOS
2.6
7.3
41
160
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.7
7.3
137
832
D07AA02
ATC
hydrocortisone; topical
1.3
7.3
519
4067
H82
ICPC
Vertiginous syndrome
2.0
7.3
72
358
W29
ICPC
Pregnancy symptom/complaint other
1.9
7.3
83
434
A06AX04
ATC
linaclotide; oral
3.6
7.3
23
64
M70.7
ICD-10 Finland
Other bursitis of hip
1.8
7.3
103
578
X18
ICPC
Breast pain female
2.1
7.3
67
325
H26.02
ICD-10 Finland
Presenil cataract
1.8
7.3
98
542
OAB42, ,
SPAT
1.3
7.3
527
4143
H47.3
ICD-10 Finland
Other disorders of optic disc
3.8
7.2
21
55
F43.29
ICD-10 Finland
Adaptation disorder UNS
1.9
7.2
89
479
A85
ICPC
Adverse effect medical agent
2.4
7.2
48
204
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
2.3
7.2
52
229
L04AX03
ATC
methotrexate; systemic
1.4
7.2
370
2767
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
2.7
7.2
36
133
K43
ICPC
Cardiovascular, Other diagnostic procedure
2.5
7.2
41
162
A10
ICPC
Bleeding/haemorrhage NOS
2.5
7.2
41
162
M01AX17
ATC
nimesulide; oral
1.2
7.2
880
7371
H35.36
ICD-10 Finland
Macular cyst
2.8
7.1
34
122
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
7.1
393
2969
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
1.6
7.1
150
939
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.7
7.1
132
800
E03.89
ICD-10 Finland
Other specified hypothyroidism
1.6
7.1
159
1010
81
HP
Angiography of the heart and coronary arteries
1.6
7.1
176
1145
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
2.9
7.1
31
106
S15
ICPC
Foreign body in skin
1.5
7.1
247
1725
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.5
7.1
208
1404
D82
ICPC
Teeth/gum disease
1.2
7.1
1551
13736
L04AA31
ATC
[U] teriflunomide
4.1
7.1
19
47
W10
ICD-10 Finland
Fall on and from stairs and steps
1.5
7.1
201
1348
I20.01
ICD-10 Finland
Unstable angina
1.8
7.0
92
504
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
2.7
7.0
37
140
3007
Kela drug reimbursment
Erenumab and fremanezumab
2.3
7.0
52
231
OAA65, ,
SPAT
1.3
7.0
686
5597
PA2DG
NOMESCO Finland
Very extensive MRI examination of vessels in the head with high intensity magnet
8.8
7.0
14
16
J30.0
ICD-10 Finland
Vasomotor rhinitis
1.8
7.0
99
556
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.6
7.0
146
912
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
7.0
175
1141
FP1C5
NOMESCO Finland
Resting ECG, 15 leads
2.3
7.0
50
219
N02CC06
ATC
eletriptan; oral
1.7
7.0
129
781
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.0
7.0
68
337
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.9
7.0
79
413
ZXD35
NOMESCO Finland
Usual procedure
1.7
7.0
111
646
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
3.3
7.0
25
76
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
1.9
6.9
83
442
NH2AA
NOMESCO Finland
Heel X-ray examination
3.0
6.9
30
102
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.4
6.9
332
2454
G25.0
ICD-10 Finland
Essential tremor
1.8
6.9
96
536
A07AA02
ATC
nystatin; oral
1.5
6.9
208
1411
N06AX05
ATC
trazodone; oral
1.8
6.9
92
507
ZXD20
NOMESCO Finland
Day surgery
1.3
6.9
466
3626
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
3.0
6.9
29
97
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
1.9
6.9
84
450
H10.8
ICD-10 Finland
Other conjunctivitis
2.4
6.9
43
177
K90.0
ICD-10 Finland
Coeliac disease
1.7
6.9
108
625
T74.1
ICD-10 Finland
Physical abuse
2.0
6.9
67
332
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
2.1
6.9
58
272
R81
ICPC
Pneumonia
1.6
6.9
140
869
M19.9
ICD-10 Finland
Arthrosis, unspecified
1.6
6.9
161
1034
N03AX18
ATC
lacosamide; systemic
2.9
6.9
31
108
M77.9
ICD-10 Finland
Enthesopathy, unspecified
1.7
6.9
118
701
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.7
6.9
118
701
N20.9
ICD-10 Finland
Urinary calculus, unspecified
1.8
6.9
90
494
NA3AA, ,
SPAT
1.6
6.9
151
956
I50.9
ICD-10 Finland
Heart failure, unspecified
1.3
6.9
447
3462
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.3
6.8
397
3023
WX320
NOMESCO Finland
Spinalanesthesy
1.2
6.8
957
8121
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
1.8
6.8
91
502
R1250, ,
SPAT
1.7
6.8
121
725
IBA03
NOMESCO Finland
Psychotherapy evaluation
2.5
6.8
41
166
D07AB08
ATC
desonide; topical
1.3
6.8
396
3016
EMAK, ,
NOMESCO Finland
1.6
6.8
134
825
XF606
NOMESCO Finland
Ortostatic test
2.7
6.8
35
131
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.0
6.8
71
361
R5599
NOMESCO Finland
Other rehabilitation service
1.8
6.8
99
561
CKC20
NOMESCO Finland
Cryopexy of undetached retina
4.1
6.8
18
44
X57
ICD-10 Finland
Unspecified privation
1.9
6.8
85
460
S80.8
ICD-10 Finland
Other superficial injuries of lower leg
3.0
6.8
28
93
H54.1
ICD-10 Finland
Severe visual impairment, binocular
40.1
6.8
8
*
CG2T4
NOMESCO Finland
Topography assessment of cornea
2.5
6.7
39
155
I65.0
ICD-10 Finland
Occlusion and stenosis of vertebral artery
5.6
6.7
18
32
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
4.3
6.7
17
40
M77.1
ICD-10 Finland
Lateral epicondylitis
1.4
6.7
289
2097
N02CC04
ATC
rizatriptan; oral
1.5
6.7
204
1387
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
2.8
6.7
32
115
R01AD01
ATC
beclometasone; nasal
1.3
6.7
568
4554
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.3
6.7
46
198
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
1.8
6.7
86
469
G43.2
ICD-10 Finland
Status migrainosus
3.9
6.7
19
49
M01AX05
ATC
glucosamine; oral
1.2
6.7
716
5904
H81.4
ICD-10 Finland
Vertigo of central origin
2.7
6.7
33
121
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.4
6.7
252
1788
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
2.0
6.7
64
316
X19
ICPC
Breast lump/mass female
1.9
6.7
73
378
SPAT1211
SPAT
Application of soft bandage
1.4
6.6
316
2334
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
3.7
6.6
20
54
A02
ICPC
Chills
2.6
6.6
35
133
G44.0
ICD-10 Finland
Cluster headache syndrome
2.3
6.6
45
193
R49.08
ICD-10 Finland
Other specified dysphonia
1.8
6.6
86
471
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
4.0
6.6
18
45
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.4
6.6
44
187
S23.4
ICD-10 Finland
Sprain and strain of ribs and sternum
2.1
6.6
61
297
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.5
6.6
226
1575
U27
ICPC
Fear of urinary disease other
2.7
6.6
33
122
FN2AB
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon
2.0
6.6
63
311
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.6
6.6
131
810
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
6.6
481
3786
T83
ICPC
Overweight
1.8
6.6
88
487
L29.8
ICD-10 Finland
Other pruritus
2.1
6.6
55
258
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
8.7
6.5
13
15
H43.2
ICD-10 Finland
Crystalline deposits in vitreous body
4.2
6.5
17
41
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.6
6.5
141
889
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
6.5
328
2444
Y06
ICPC
Prostate symptom/complaint
1.8
6.5
92
517
H66
ICD-10 Finland
Suppurative and unspecified otitis media
1.8
6.5
92
517
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
1.7
6.5
117
704
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.7
6.5
33
123
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.6
6.5
162
1057
RS221, ,
NOMESCO Finland
2.2
6.5
51
233
RK110, ,
NOMESCO Finland
3.0
6.5
27
90
N05BE01
ATC
buspirone; oral
1.7
6.5
102
592
D68.8
ICD-10 Finland
Other specified coagulation defects
2.3
6.5
45
195
G04CA01
ATC
alfuzosin; oral
1.3
6.5
357
2699
C10AC01
ATC
colestyramine; oral
1.7
6.5
101
585
XF405
NOMESCO Finland
Symptom ECG
2.8
6.5
31
112
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.6
6.5
161
1050
U06
ICPC
Haematuria
1.8
6.4
92
519
XKC03
NOMESCO Finland
Water cystometry
1.7
6.4
106
623
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.6
6.4
154
995
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
6.4
343
2579
A60
ICPC
General and Unspecified, Result test/procedure
1.6
6.4
157
1019
F32.8
ICD-10 Finland
Other depressive episodes
2.0
6.4
67
341
EB1HA, ,
SPAT
1.7
6.4
101
586
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.2
6.4
51
234
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
1.8
6.4
90
505
B02AA02
ATC
tranexamic acid; systemic
1.3
6.4
556
4472
G56.8
ICD-10 Finland
Other mononeuropathies of upper limb
3.4
6.4
22
65
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
2.0
6.4
64
321
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.8
6.4
91
513
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
1.6
6.4
137
863
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.8
6.4
87
484
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
1.7
6.4
106
625
79199
ICD-8 Finland
Headache
2.2
6.4
49
222
D01BA02
ATC
terbinafine; oral
1.2
6.4
950
8109
A10AB05
ATC
insulin aspart; parenteral
1.4
6.4
265
1914
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
2.2
6.3
48
216
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
3.0
6.3
26
86
K77
ICPC
Heart failure
1.9
6.3
74
392
G54.0
ICD-10 Finland
Brachial plexus disorders
1.8
6.3
92
522
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
2.7
6.3
32
119
B01AE07
ATC
dabigatran etexilate; oral
1.6
6.3
132
826
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.3
6.3
424
3299
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.7
6.3
102
597
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
2.9
6.3
28
97
S01EE05
ATC
tafluprost; ophthalmic
1.6
6.3
127
788
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.1
6.3
56
269
CEC30
NOMESCO Finland
Resection of extraocular muscle
11.0
6.3
11
10
K86
ICPC
Hypertension uncomplicated
1.3
6.3
506
4032
K12.18
ICD-10 Finland
Other forms of stomatitis
2.6
6.3
34
131
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
6.3
244
1741
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
3.5
6.3
21
61
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.4
6.3
243
1733
M89.0
ICD-10 Finland
Algoneurodystrophy
2.6
6.3
35
137
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
3.3
6.3
22
66
F41.08
ICD-10 Finland
Mild or other specified panic syndrome
3.3
6.3
22
66
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.7
6.3
117
712
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.2
6.3
1169
10188
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
2.9
6.3
27
92
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
2.5
6.3
38
155
F43.8
ICD-10 Finland
Other reactions to severe stress
1.7
6.3
105
621
H02.3
ICD-10 Finland
Blepharochalasis
1.4
6.2
240
1709
SPAT1043
SPAT
Audiometry
1.3
6.2
360
2740
L53.9
ICD-10 Finland
Erythematous condition, unspecified
2.2
6.2
49
224
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
6.2
2876
26946
K96
ICPC
Haemorrhoids
1.7
6.2
111
667
Z04
ICD-10 Finland
Examination and observation for other reasons
2.0
6.2
62
311
M43.1
ICD-10 Finland
Spondylolisthesis
1.6
6.2
146
941
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
3.7
6.2
19
52
AXX01, ,
SPAT
1.6
6.2
147
949
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
1.9
6.2
69
360
K92.0
ICD-10 Finland
Haematemesis
1.8
6.2
79
431
C10AX13
ATC
evolocumab; parenteral
3.1
6.2
25
82
C10AA04
ATC
fluvastatin; oral
1.4
6.2
284
2087
WYA30, ,
SPAT
2.7
6.2
31
115
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.7
6.2
102
601
NG1EA, ,
SPAT
2.3
6.2
43
187
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
1.5
6.2
160
1054
S19
ICPC
Skin injury other
1.6
6.1
141
903
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
6.1
208
1447
M10
ICD-10 Finland
Gout
1.6
6.1
146
943
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
6.1
162
1071
P01BA02
ATC
hydroxychloroquine; oral
1.4
6.1
304
2261
R30.1
ICD-10 Finland
Vesical tenesmus
1.8
6.1
81
447
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.3
6.1
410
3189
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
1.9
6.1
75
404
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.5
6.1
179
1210
F43.01
ICD-10 Finland
Acute stress reaction moderate
2.0
6.1
64
327
S01EE04
ATC
travoprost; ophthalmic
1.9
6.1
70
369
L50
ICD-10 Finland
Urticaria
1.9
6.1
69
362
AA1BG, ,
SPAT
1.8
6.1
78
426
A10AE04
ATC
insulin glargine; parenteral
1.3
6.1
330
2489
S50.0
ICD-10 Finland
Contusion of elbow
1.7
6.1
113
687
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.2
6.1
48
220
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
1.5
6.1
170
1138
Z29
ICPC
Social problem NOS
1.8
6.1
81
448
T82
ICPC
Obesity
1.5
6.1
155
1018
A01AB04
ATC
amphotericin B; local oral
1.5
6.1
154
1010
H3603, E106,
ICD-10 Finland
8.6
6.0
12
14
K02.0
ICD-10 Finland
Caries limited to enamel
1.2
6.0
783
6588
3015
Kela drug reimbursment
Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia
2.9
6.0
27
94
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.9
6.0
76
413
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
3.1
6.0
24
78
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
1.9
6.0
75
406
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
2.2
6.0
46
208
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.4
6.0
242
1738
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
2.4
6.0
38
158
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.3
6.0
405
3152
SPAT1081
SPAT
Cardiorespiratory global assessment
1.5
6.0
178
1206
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.5
6.0
35
140
N04BC05
ATC
pramipexole; oral
1.4
6.0
273
2002
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
2.5
6.0
36
146
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
3.2
6.0
23
73
M47.81
ICD-10 Finland
Other spondylosis, occipito-atlanto-axial region
2.7
6.0
30
111
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
1.7
6.0
99
583
R03BB01
ATC
ipratropium bromide; inhalant
1.7
6.0
106
636

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Neurology
13 [38004458]
9.0e-01
1.1e+00
2.1e+00
7.5e+00
3.1e+00
1.9e+00
1.1e+00
cases:22.23%
controls:10.42%
cases:12.40%
controls:4.43%
cases:5.87%
controls:0.78%
cases:27.64%
controls:0.02%
cases:14.62%
controls:0.76%
cases:23.23%
controls:4.23%
cases:25.90%
controls:10.11%
1072
5025
3750
43182
598
2136
4224
46080
283
374
4539
47842
1333
10
3489
48206
703
364
4104
47634
1052
1921
3476
43476
876
3396
2506
30192
Visual field defects
H53.4 [45557469]
3.8e+00
3.8e+00
—
1.0e+50
—
4.8e+00
3.6e+00
cases:0.71%
controls:0.02%
cases:0.46%
controls:0.01%
—
—
cases:0.62%
controls:0.00%
—
—
cases:1.33%
controls:0.01%
cases:1.42%
controls:0.04%
34
8
4788
48199
22
5
4800
48211
—
30
0
4792
48216
—
60
5
4468
45392
48
13
3334
33575
Ophthalmology
18 [38004463]
5.9e-01
7.6e-01
1.6e+00
6.6e+00
3.6e+00
1.9e+00
8.8e-01
cases:27.83%
controls:17.59%
cases:15.39%
controls:7.81%
cases:6.62%
controls:1.47%
cases:29.32%
controls:0.06%
cases:35.26%
controls:1.48%
cases:35.87%
controls:7.72%
cases:36.58%
controls:19.27%
1342
8480
3480
39727
742
3767
4080
44449
319
711
4503
47505
1414
28
3408
48188
1695
710
3112
47288
1624
3503
2904
41894
1237
6471
2145
27117
Amaurosis fugax
G45.3 [45600791]
2.0e+00
2.8e+00
4.4e+00
1.0e+50
—
4.0e+00
2.1e+00
cases:0.91%
controls:0.13%
cases:0.73%
controls:0.04%
cases:0.81%
controls:0.01%
cases:1.89%
controls:0.00%
—
—
cases:1.35%
controls:0.02%
cases:1.18%
controls:0.15%
44
63
4778
48144
35
21
4787
48195
39
5
4783
48211
91
0
4731
48216
—
61
11
4467
45386
40
51
3342
33537
Visual disturbance other
F05 [2002000403]
1.1e+00
2.2e+00
4.5e+00
—
3.9e+00
1.9e+00
1.6e+00
cases:0.93%
controls:0.30%
cases:0.91%
controls:0.11%
cases:1.24%
controls:0.01%
—
—
cases:0.69%
controls:0.01%
cases:0.57%
controls:0.09%
cases:1.83%
controls:0.39%
45
146
4777
48061
44
51
4778
48165
60
7
4762
48209
—
33
7
4774
47991
26
40
4502
45357
62
130
3320
33458
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
6.3e-01
8.6e-01
1.9e+00
6.7e+00
2.9e+00
1.0e+00
7.3e-01
cases:14.83%
controls:8.51%
cases:7.69%
controls:3.40%
cases:2.63%
controls:0.39%
cases:11.63%
controls:0.02%
cases:5.76%
controls:0.34%
cases:8.13%
controls:3.15%
cases:19.72%
controls:10.55%
715
4102
4107
44105
371
1640
4451
46576
127
187
4695
48029
561
8
4261
48208
277
163
4530
47835
368
1430
4160
43967
667
3544
2715
30044
Diplopia
H53.2 [45576792]
2.7e+00
3.9e+00
—
1.0e+50
1.0e+50
4.8e+00
3.3e+00
cases:0.77%
controls:0.05%
cases:0.68%
controls:0.01%
—
—
cases:0.85%
controls:0.00%
cases:0.87%
controls:0.00%
cases:1.28%
controls:0.01%
cases:1.66%
controls:0.06%
37
26
4785
48181
33
7
4789
48209
—
41
0
4781
48216
42
0
4765
47998
58
5
4470
45392
56
20
3326
33568
Emergency Room Visit
ER [9203]
7.1e-01
7.5e-01
1.9e+00
7.2e+00
2.3e+00
9.3e-01
7.1e-01
cases:52.36%
controls:35.00%
cases:20.26%
controls:10.71%
cases:7.55%
controls:1.24%
cases:30.86%
controls:0.03%
cases:10.40%
controls:1.15%
cases:20.63%
controls:9.29%
cases:40.30%
controls:24.85%
2525
16871
2297
31336
977
5162
3845
43054
364
596
4458
47620
1488
16
3334
48200
500
552
4307
47446
934
4216
3594
41181
1363
8347
2019
25241
Emergency Medicine
93 [38004510]
5.1e-01
7.2e-01
1.6e+00
7.5e+00
1.6e+00
7.7e-01
6.9e-01
cases:31.63%
controls:21.82%
cases:20.32%
controls:11.05%
cases:7.03%
controls:1.46%
cases:42.60%
controls:0.04%
cases:6.66%
controls:1.48%
cases:21.86%
controls:11.49%
cases:46.81%
controls:30.70%
1525
10519
3297
37688
980
5328
3842
42888
339
703
4483
47513
2054
20
2768
48196
320
710
4487
47288
990
5218
3538
40179
1583
10313
1799
23275
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
1.1e+00
1.4e+00
3.6e+00
1.0e+50
3.4e+00
1.9e+00
1.3e+00
cases:2.90%
controls:0.99%
cases:1.45%
controls:0.35%
cases:1.45%
controls:0.04%
cases:3.28%
controls:0.00%
cases:1.29%
controls:0.04%
cases:2.14%
controls:0.32%
cases:4.14%
controls:1.13%
140
476
4682
47731
70
167
4752
48049
70
20
4752
48196
158
0
4664
48216
62
21
4745
47977
97
146
4431
45251
140
380
3242
33208
Perimetry
XCK00 [2001301380]
7.3e-01
1.3e+00
2.9e+00
1.0e+50
3.8e+00
2.8e+00
1.3e+00
cases:1.85%
controls:0.90%
cases:0.68%
controls:0.19%
cases:0.39%
controls:0.02%
cases:0.79%
controls:0.00%
cases:1.39%
controls:0.03%
cases:2.52%
controls:0.16%
cases:1.86%
controls:0.51%
89
434
4733
47773
33
94
4789
48122
19
11
4803
48205
38
0
4784
48216
67
15
4740
47983
114
74
4414
45323
63
170
3319
33418
Other disorders of vitreous body
H43.8 [45533329]
8.4e-01
1.2e+00
2.4e+00
—
4.9e+00
2.3e+00
1.1e+00
cases:2.78%
controls:1.21%
cases:1.14%
controls:0.36%
cases:0.56%
controls:0.05%
—
—
cases:6.10%
controls:0.05%
cases:3.49%
controls:0.36%
cases:3.93%
controls:1.33%
134
585
4688
47622
55
174
4767
48042
27
25
4795
48191
—
293
24
4514
47974
158
164
4370
45233
133
447
3249
33141
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
7.1e-01
8.7e-01
1.5e+00
5.6e+00
2.1e+00
1.0e+00
8.1e-01
cases:10.58%
controls:5.50%
cases:5.85%
controls:2.54%
cases:1.66%
controls:0.36%
cases:5.00%
controls:0.02%
cases:2.54%
controls:0.32%
cases:6.49%
controls:2.48%
cases:15.26%
controls:7.42%
510
2650
4312
45557
282
1223
4540
46993
80
175
4742
48041
241
9
4581
48207
122
154
4685
47844
294
1128
4234
44269
516
2492
2866
31096
Subjective visual disturbances
H53.1 [45557467]
2.5e+00
3.5e+00
—
1.0e+50
—
4.0e+00
2.5e+00
cases:3.86%
controls:0.32%
cases:3.03%
controls:0.10%
—
—
cases:4.02%
controls:0.00%
—
—
cases:4.77%
controls:0.09%
cases:5.44%
controls:0.45%
186
152
4636
48055
146
46
4676
48170
—
194
0
4628
48216
—
216
42
4312
45355
184
151
3198
33437
Ocular pain
H57.1 [45596140]
1.1e+00
1.3e+00
3.4e+00
1.0e+50
3.5e+00
1.6e+00
1.3e+00
cases:1.29%
controls:0.42%
cases:0.56%
controls:0.15%
cases:0.48%
controls:0.02%
cases:0.39%
controls:0.00%
cases:0.42%
controls:0.01%
cases:0.75%
controls:0.15%
cases:1.89%
controls:0.52%
62
201
4760
48006
27
74
4795
48142
23
8
4799
48208
19
0
4803
48216
20
6
4787
47992
34
66
4494
45331
64
176
3318
33412
Neck artery ultrasound examination with Doppler method
PA6DE [2001308705]
9.6e-01
1.6e+00
2.3e+00
1.0e+50
3.9e+00
2.3e+00
1.2e+00
cases:1.33%
controls:0.51%
cases:0.48%
controls:0.10%
cases:0.17%
controls:0.02%
cases:1.66%
controls:0.00%
cases:0.71%
controls:0.01%
cases:0.64%
controls:0.06%
cases:0.92%
controls:0.29%
64
247
4758
47960
23
47
4799
48169
8
8
4814
48208
80
0
4742
48216
34
7
4773
47991
29
29
4499
45368
31
96
3351
33492
Visual disturbance, unspecified
H53.9 [45557475]
1.5e+00
2.7e+00
—
1.0e+50
—
5.1e+00
2.9e+00
cases:0.83%
controls:0.18%
cases:1.04%
controls:0.07%
—
—
cases:78.97%
controls:0.00%
—
—
cases:11.02%
controls:0.08%
cases:5.26%
controls:0.31%
40
89
4782
48118
50
34
4772
48182
—
3808
0
1014
48216
—
499
35
4029
45362
178
105
3204
33483
Retinal breaks without detachment
H33.3 [45596066]
7.7e-01
1.5e+00
2.0e+00
1.0e+50
4.6e+00
2.3e+00
1.1e+00
cases:0.68%
controls:0.32%
cases:0.37%
controls:0.09%
cases:0.17%
controls:0.02%
cases:0.37%
controls:0.00%
cases:1.39%
controls:0.01%
cases:1.04%
controls:0.11%
cases:1.03%
controls:0.36%
33
153
4789
48054
18
42
4804
48174
8
11
4814
48205
18
0
4804
48216
67
7
4740
47991
47
48
4481
45349
35
122
3347
33466
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
5.4e-01
6.1e-01
1.5e+00
6.5e+00
1.8e+00
6.3e-01
5.1e-01
cases:18.79%
controls:11.85%
cases:9.12%
controls:5.18%
cases:2.90%
controls:0.68%
cases:10.20%
controls:0.02%
cases:3.97%
controls:0.68%
cases:9.14%
controls:5.08%
cases:22.24%
controls:14.59%
906
5714
3916
42493
440
2499
4382
45717
140
328
4682
47888
492
8
4330
48208
191
324
4616
47674
414
2304
4114
43093
752
4902
2630
28686
Sequelae of cerebral infarction
I69.3 [45533476]
6.4e-01
9.3e-01
1.4e+00
4.1e+00
2.3e+00
1.5e+00
1.2e+00
cases:1.89%
controls:1.00%
cases:1.35%
controls:0.54%
cases:0.46%
controls:0.11%
cases:0.75%
controls:0.01%
cases:1.10%
controls:0.12%
cases:2.85%
controls:0.66%
cases:4.49%
controls:1.47%
91
482
4731
47725
65
259
4757
47957
22
53
4800
48163
36
6
4786
48210
53
56
4754
47942
129
299
4399
45098
152
493
3230
33095
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
3.9e-01
6.6e-01
1.3e+00
5.3e+00
2.6e+00
9.2e-01
8.1e-01
cases:11.30%
controls:7.91%
cases:6.86%
controls:3.68%
cases:1.97%
controls:0.53%
cases:5.95%
controls:0.03%
cases:5.58%
controls:0.45%
cases:7.71%
controls:3.22%
cases:17.56%
controls:8.70%
545
3812
4277
44395
331
1775
4491
46441
95
257
4727
47959
287
15
4535
48201
268
216
4539
47782
349
1462
4179
43935
594
2921
2788
30667
Migraine with aura [classical migraine]
G43.1 [45562086]
1.0e+00
1.4e+00
2.7e+00
—
3.0e+00
2.1e+00
1.6e+00
cases:2.84%
controls:1.03%
cases:1.66%
controls:0.42%
cases:0.83%
controls:0.05%
—
—
cases:1.46%
controls:0.08%
cases:3.42%
controls:0.42%
cases:5.26%
controls:1.16%
137
496
4685
47711
80
201
4742
48015
40
26
4782
48190
—
70
37
4737
47961
155
192
4373
45205
178
389
3204
33199
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.2e-01
5.9e-01
1.5e+00
5.8e+00
1.8e+00
6.6e-01
5.8e-01
cases:27.27%
controls:19.84%
cases:15.35%
controls:9.12%
cases:4.98%
controls:1.18%
cases:15.55%
controls:0.05%
cases:7.16%
controls:1.21%
cases:15.48%
controls:8.68%
cases:36.19%
controls:24.08%
1315
9564
3507
38643
740
4397
4082
43819
240
570
4582
47646
750
26
4072
48190
344
580
4463
47418
701
3942
3827
41455
1224
8088
2158
25500
Office Visit
OMOP4822458 [581477]
3.8e-01
5.5e-01
1.4e+00
5.4e+00
2.3e+00
7.5e-01
6.0e-01
cases:11.95%
controls:8.48%
cases:3.61%
controls:2.12%
cases:1.04%
controls:0.26%
cases:2.61%
controls:0.01%
cases:2.64%
controls:0.27%
cases:3.53%
controls:1.71%
cases:7.84%
controls:4.44%
576
4089
4246
44118
174
1021
4648
47195
50
125
4772
48091
126
6
4696
48210
127
128
4680
47870
160
775
4368
44622
265
1491
3117
32097
Thorax X-ray examination
GD1AA [2001303617]
6.1e-01
6.2e-01
1.5e+00
5.7e+00
1.3e+00
7.7e-01
8.2e-01
cases:19.08%
controls:11.40%
cases:7.40%
controls:4.13%
cases:2.18%
controls:0.47%
cases:5.18%
controls:0.02%
cases:1.73%
controls:0.48%
cases:7.62%
controls:3.66%
cases:21.82%
controls:10.91%
920
5494
3902
42713
357
1991
4465
46225
105
227
4717
47989
250
9
4572
48207
83
232
4724
47766
345
1662
4183
43735
738
3666
2644
29922
Emergency Room and Inpatient Visit
ERIP [262]
4.6e-01
5.3e-01
1.3e+00
6.0e+00
1.8e+00
5.9e-01
5.5e-01
cases:12.17%
controls:8.07%
cases:7.09%
controls:4.29%
cases:2.07%
controls:0.59%
cases:5.41%
controls:0.01%
cases:3.35%
controls:0.58%
cases:8.26%
controls:4.76%
cases:23.54%
controls:15.14%
587
3891
4235
44316
342
2068
4480
46148
100
286
4722
47930
261
7
4561
48209
161
277
4646
47721
374
2159
4154
43238
796
5086
2586
28502
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
8.5e-01
1.3e+00
2.7e+00
1.0e+50
3.2e+00
2.0e+00
1.1e+00
cases:3.05%
controls:1.33%
cases:1.29%
controls:0.36%
cases:0.46%
controls:0.03%
cases:2.84%
controls:0.00%
cases:0.81%
controls:0.03%
cases:2.14%
controls:0.31%
cases:3.40%
controls:1.11%
147
642
4675
47565
62
174
4760
48042
22
15
4800
48201
137
0
4685
48216
39
16
4768
47982
97
140
4431
45257
115
374
3267
33214
Occlusion and stenosis of carotid artery
I65.2 [45552808]
1.1e+00
1.7e+00
—
1.0e+50
4.0e+00
2.7e+00
1.5e+00
cases:0.54%
controls:0.18%
cases:0.33%
controls:0.06%
—
—
cases:0.44%
controls:0.00%
cases:0.79%
controls:0.01%
cases:1.02%
controls:0.07%
cases:0.83%
controls:0.19%
26
86
4796
48121
16
30
4806
48186
—
21
0
4801
48216
38
7
4769
47991
46
31
4482
45366
28
64
3354
33524
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
9.8e-01
1.2e+00
2.2e+00
1.0e+50
3.3e+00
1.8e+00
1.3e+00
cases:2.84%
controls:1.09%
cases:1.16%
controls:0.36%
cases:0.33%
controls:0.04%
cases:1.80%
controls:0.00%
cases:1.12%
controls:0.04%
cases:1.90%
controls:0.33%
cases:3.37%
controls:0.92%
137
524
4685
47683
56
175
4766
48041
16
17
4806
48199
87
0
4735
48216
54
21
4753
47977
86
149
4442
45248
114
309
3268
33279
Headache
R51.80 [2000503603]
1.0e+00
1.4e+00
2.9e+00
—
2.6e+00
1.5e+00
1.2e+00
cases:6.20%
controls:2.34%
cases:2.90%
controls:0.70%
cases:1.22%
controls:0.07%
—
—
cases:1.25%
controls:0.09%
cases:2.89%
controls:0.63%
cases:7.63%
controls:2.38%
299
1127
4523
47080
140
339
4682
47877
59
34
4763
48182
—
60
43
4747
47955
131
288
4397
45109
258
798
3124
32790
Giant cell arteritis with polymyalgia rheumatica
M31.5 [45596562]
1.0e+00
1.3e+00
2.2e+00
1.0e+50
3.6e+00
1.9e+00
1.6e+00
cases:0.25%
controls:0.09%
cases:0.25%
controls:0.07%
cases:0.23%
controls:0.02%
cases:0.33%
controls:0.00%
cases:0.60%
controls:0.02%
cases:0.53%
controls:0.08%
cases:0.65%
controls:0.13%
12
43
4810
48164
12
33
4810
48183
11
12
4811
48204
16
0
4806
48216
29
8
4778
47990
24
35
4504
45362
22
43
3360
33545
Paraesthesia of skin
R20.2 [45568120]
1.1e+00
1.3e+00
2.7e+00
1.0e+50
2.5e+00
1.8e+00
1.3e+00
cases:2.63%
controls:0.89%
cases:0.97%
controls:0.27%
cases:0.27%
controls:0.02%
cases:0.91%
controls:0.00%
cases:0.40%
controls:0.03%
cases:1.57%
controls:0.26%
cases:3.16%
controls:0.87%
127
431
4695
47776
47
130
4775
48086
13
9
4809
48207
44
0
4778
48216
19
16
4788
47982
71
119
4457
45278
107
293
3275
33295
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.1e+00
1.6e+00
1.9e+00
1.0e+50
2.7e+00
2.0e+00
1.3e+00
cases:2.74%
controls:0.93%
cases:1.20%
controls:0.24%
cases:0.27%
controls:0.04%
cases:0.35%
controls:0.00%
cases:0.50%
controls:0.03%
cases:1.79%
controls:0.26%
cases:2.78%
controls:0.80%
132
450
4690
47757
58
117
4764
48099
13
19
4809
48197
17
0
4805
48216
24
16
4783
47982
81
116
4447
45281
94
268
3288
33320
Cerebral infarction due to thrombosis of cerebral arteries
I63.3 [45562366]
7.4e-01
1.3e+00
2.2e+00
—
3.5e+00
1.4e+00
1.2e+00
cases:0.81%
controls:0.39%
cases:0.35%
controls:0.10%
cases:0.15%
controls:0.02%
—
—
cases:0.42%
controls:0.01%
cases:0.55%
controls:0.13%
cases:1.06%
controls:0.34%
39
186
4783
48021
17
46
4805
48170
7
8
4815
48208
—
20
6
4787
47992
25
60
4503
45337
36
114
3346
33474
General Practice
1 [38004446]
5.3e-01
5.6e-01
1.3e+00
5.4e+00
1.1e+00
7.4e-01
5.8e-01
cases:23.35%
controls:15.16%
cases:9.60%
controls:5.70%
cases:2.74%
controls:0.76%
cases:8.67%
controls:0.04%
cases:2.62%
controls:0.88%
cases:11.70%
controls:5.97%
cases:25.64%
controls:16.15%
1126
7308
3696
40899
463
2747
4359
45469
132
366
4690
47850
418
20
4404
48196
126
423
4681
47575
530
2711
3998
42686
867
5426
2515
28162
Thrombin time
3243-3 [3036489]
6.6e-01
1.2e+00
3.0e+00
—
3.3e+00
1.1e+00
9.7e-01
cases:1.97%
controls:1.02%
cases:1.12%
controls:0.34%
cases:0.33%
controls:0.02%
—
—
cases:0.81%
controls:0.03%
cases:0.91%
controls:0.29%
cases:2.31%
controls:0.89%
95
494
4727
47713
54
165
4768
48051
16
8
4806
48208
—
39
15
4768
47983
41
133
4487
45264
78
298
3304
33290
Carotid artery syndrome (hemispheric)
G45.1 [45576586]
1.1e+00
9.3e-01
2.9e+00
1.0e+50
2.5e+00
1.4e+00
1.3e+00
cases:1.06%
controls:0.34%
cases:0.37%
controls:0.15%
cases:0.27%
controls:0.01%
cases:0.39%
controls:0.00%
cases:0.23%
controls:0.02%
cases:0.38%
controls:0.09%
cases:1.27%
controls:0.36%
51
163
4771
48044
18
71
4804
48145
13
7
4809
48209
19
0
4803
48216
11
9
4796
47989
17
43
4511
45354
43
121
3339
33467
Internal Medicine
11 [38004456]
5.3e-01
6.0e-01
1.2e+00
5.3e+00
1.2e+00
7.0e-01
6.3e-01
cases:30.61%
controls:20.57%
cases:12.57%
controls:7.31%
cases:3.73%
controls:1.17%
cases:7.26%
controls:0.04%
cases:3.60%
controls:1.13%
cases:13.25%
controls:7.03%
cases:27.38%
controls:16.77%
1476
9917
3346
38290
606
3526
4216
44690
180
562
4642
47654
350
19
4472
48197
173
540
4634
47458
600
3190
3928
42207
926
5632
2456
27956
Other investigative procedure of eye
XCW99 [2001301491]
8.5e-01
9.4e-01
1.6e+00
—
3.6e+00
2.1e+00
9.6e-01
cases:4.31%
controls:1.89%
cases:1.51%
controls:0.60%
cases:0.50%
controls:0.10%
—
—
cases:2.95%
controls:0.08%
cases:4.24%
controls:0.54%
cases:3.58%
controls:1.40%
208
909
4614
47298
73
289
4749
47927
24
47
4798
48169
—
142
38
4665
47960
192
247
4336
45150
121
471
3261
33117
Cerebral infarction due to embolism of cerebral arteries
I63.4 [45591475]
1.1e+00
1.1e+00
2.2e+00
—
3.2e+00
1.7e+00
8.0e-01
cases:0.75%
controls:0.24%
cases:0.35%
controls:0.12%
cases:0.17%
controls:0.02%
—
—
cases:0.54%
controls:0.02%
cases:0.68%
controls:0.13%
cases:0.77%
controls:0.35%
36
118
4786
48089
17
56
4805
48160
8
9
4814
48207
—
26
11
4781
47987
31
60
4497
45337
26
116
3356
33472
Inpatient Hospital
21 [8717]
3.8e-01
4.2e-01
1.2e+00
5.1e+00
1.7e+00
6.9e-01
5.2e-01
cases:36.27%
controls:28.08%
cases:11.57%
controls:7.92%
cases:3.36%
controls:1.04%
cases:6.18%
controls:0.04%
cases:5.24%
controls:1.00%
cases:12.32%
controls:6.60%
cases:23.71%
controls:15.60%
1749
13537
3073
34670
558
3820
4264
44396
162
503
4660
47713
298
20
4524
48196
252
478
4555
47520
558
2994
3970
42403
802
5240
2580
28348
Examination of eyes and vision
Z01.0 [45566391]
7.7e-01
7.5e-01
2.3e+00
—
3.5e+00
1.7e+00
8.7e-01
cases:6.12%
controls:2.93%
cases:2.38%
controls:1.14%
cases:1.31%
controls:0.13%
—
—
cases:4.74%
controls:0.15%
cases:6.52%
controls:1.21%
cases:8.49%
controls:3.75%
295
1411
4527
46796
115
552
4707
47664
63
65
4759
48151
—
228
71
4579
47927
295
549
4233
44848
287
1260
3095
32328
Outpatient Hospital
22 [8756]
3.6e-01
4.4e-01
1.1e+00
4.7e+00
1.9e+00
7.8e-01
5.9e-01
cases:30.09%
controls:23.07%
cases:8.27%
controls:5.51%
cases:2.20%
controls:0.71%
cases:3.09%
controls:0.03%
cases:3.91%
controls:0.62%
cases:8.90%
controls:4.29%
cases:17.86%
controls:10.76%
1451
11123
3371
37084
399
2655
4423
45561
106
342
4716
47874
149
14
4673
48202
188
298
4619
47700
403
1946
4125
43451
604
3614
2778
29974
Visual field testing with Octopus automated perimetry
CS444 [2001301477]
8.4e-01
8.5e-01
—
—
4.5e+00
2.4e+00
1.2e+00
cases:1.00%
controls:0.43%
cases:0.46%
controls:0.19%
—
—
—
—
cases:1.10%
controls:0.01%
cases:2.16%
controls:0.20%
cases:1.92%
controls:0.60%
48
208
4774
47999
22
94
4800
48122
—
—
53
6
4754
47992
98
93
4430
45304
65
203
3317
33385
Vitreous haemorrhage
H43.1 [45543053]
1.1e+00
8.2e-01
1.4e+00
1.0e+50
4.4e+00
2.7e+00
1.4e+00
cases:0.81%
controls:0.27%
cases:0.21%
controls:0.09%
cases:0.15%
controls:0.04%
cases:0.83%
controls:0.00%
cases:1.56%
controls:0.02%
cases:1.35%
controls:0.09%
cases:0.89%
controls:0.22%
39
132
4783
48075
10
44
4812
48172
7
17
4815
48199
40
0
4782
48216
75
9
4732
47989
61
40
4467
45357
30
73
3352
33515
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
5.9e-01
8.9e-01
2.1e+00
1.0e+50
3.6e+00
1.4e+00
9.3e-01
cases:2.94%
controls:1.65%
cases:1.06%
controls:0.44%
cases:0.35%
controls:0.04%
cases:0.46%
controls:0.00%
cases:1.14%
controls:0.03%
cases:1.66%
controls:0.40%
cases:3.84%
controls:1.55%
142
794
4680
47413
51
210
4771
48006
17
20
4805
48196
22
0
4800
48216
55
15
4752
47983
75
180
4453
45217
130
521
3252
33067
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
5.7e-01
7.6e-01
1.5e+00
3.7e+00
1.6e+00
7.7e-01
7.5e-01
cases:10.33%
controls:6.10%
cases:4.40%
controls:2.11%
cases:0.81%
controls:0.18%
cases:0.56%
controls:0.01%
cases:1.04%
controls:0.21%
cases:4.31%
controls:2.04%
cases:13.75%
controls:6.98%
498
2941
4324
45266
212
1018
4610
47198
39
87
4783
48129
27
7
4795
48209
50
103
4757
47895
195
928
4333
44469
465
2344
2917
31244
Other visual disturbances
H53.8 [45586516]
9.9e-01
2.3e+00
—
1.0e+50
1.0e+50
4.5e+00
2.8e+00
cases:0.23%
controls:0.09%
cases:0.31%
controls:0.03%
—
—
cases:20.18%
controls:0.00%
cases:2.87%
controls:0.00%
cases:2.52%
controls:0.03%
cases:1.48%
controls:0.09%
11
41
4811
48166
15
15
4807
48201
—
973
0
3849
48216
138
0
4669
47998
114
13
4414
45384
50
31
3332
33557
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
6.7e-01
8.3e-01
2.1e+00
1.0e+50
3.6e+00
1.4e+00
9.1e-01
cases:3.50%
controls:1.83%
cases:1.06%
controls:0.46%
cases:0.39%
controls:0.05%
cases:0.52%
controls:0.00%
cases:1.25%
controls:0.03%
cases:1.77%
controls:0.44%
cases:4.08%
controls:1.68%
169
883
4653
47324
51
224
4771
47992
19
23
4803
48193
25
0
4797
48216
60
16
4747
47982
80
198
4448
45199
138
564
3244
33024
Cerebral infarction, unspecified
I63.9 [45596216]
8.4e-01
1.2e+00
2.4e+00
—
2.7e+00
1.5e+00
8.9e-01
cases:2.76%
controls:1.22%
cases:1.41%
controls:0.43%
cases:0.83%
controls:0.07%
—
—
cases:1.14%
controls:0.08%
cases:2.23%
controls:0.50%
cases:3.31%
controls:1.39%
133
586
4689
47621
68
208
4754
48008
40
35
4782
48181
—
55
38
4752
47960
101
226
4427
45171
112
466
3270
33122
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
7.1e-01
1.1e+00
2.7e+00
—
3.1e+00
1.1e+00
9.2e-01
cases:7.61%
controls:3.91%
cases:4.25%
controls:1.48%
cases:1.62%
controls:0.11%
—
—
cases:2.81%
controls:0.14%
cases:3.62%
controls:1.22%
cases:9.91%
controls:4.22%
367
1884
4455
46323
205
714
4617
47502
78
55
4744
48161
—
135
65
4672
47933
164
555
4364
44842
335
1416
3047
32172
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
5.2e-01
1.2e+00
2.4e+00
—
3.2e+00
1.2e+00
8.9e-01
cases:1.37%
controls:0.82%
cases:0.89%
controls:0.26%
cases:0.21%
controls:0.02%
—
—
cases:0.69%
controls:0.03%
cases:0.84%
controls:0.25%
cases:1.63%
controls:0.68%
66
393
4756
47814
43
126
4779
48090
10
9
4812
48207
—
33
13
4774
47985
38
112
4490
45285
55
227
3327
33361
Multiple sclerosis
G35 [45571794]
9.1e-01
1.0e+00
1.7e+00
—
2.1e+00
1.9e+00
1.9e+00
cases:0.83%
controls:0.33%
cases:0.77%
controls:0.27%
cases:0.39%
controls:0.07%
—
—
cases:0.60%
controls:0.07%
cases:1.72%
controls:0.27%
cases:2.37%
controls:0.35%
40
161
4782
48046
37
132
4785
48084
19
36
4803
48180
—
29
35
4778
47963
78
123
4450
45274
80
119
3302
33469
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
7.7e-01
7.9e-01
1.3e+00
—
3.7e+00
1.9e+00
9.8e-01
cases:3.69%
controls:1.74%
cases:1.91%
controls:0.87%
cases:0.52%
controls:0.14%
—
—
cases:4.26%
controls:0.11%
cases:5.83%
controls:0.89%
cases:5.85%
controls:2.29%
178
837
4644
47370
92
421
4730
47795
25
67
4797
48149
—
205
52
4602
47946
264
405
4264
44992
198
769
3184
32819
Pure hypercholesterolaemia
E78.01 [2000501514]
3.7e-01
4.1e-01
1.1e+00
5.0e+00
1.6e+00
6.2e-01
2.8e-01
cases:6.43%
controls:4.54%
cases:3.80%
controls:2.55%
cases:1.49%
controls:0.48%
cases:2.86%
controls:0.02%
cases:2.12%
controls:0.43%
cases:4.79%
controls:2.64%
cases:9.96%
controls:7.71%
310
2190
4512
46017
183
1231
4639
46985
72
232
4750
47984
138
10
4684
48206
102
206
4705
47792
217
1200
4311
44197
337
2589
3045
30999
Vertebro-basilar artery syndrome
G45.0 [45538120]
1.2e+00
1.6e+00
—
1.0e+50
3.0e+00
2.1e+00
1.4e+00
cases:0.64%
controls:0.19%
cases:0.29%
controls:0.06%
—
—
cases:0.35%
controls:0.00%
cases:0.33%
controls:0.02%
cases:0.46%
controls:0.06%
cases:0.89%
controls:0.21%
31
93
4791
48114
14
29
4808
48187
—
17
0
4805
48216
16
8
4791
47990
21
25
4507
45372
30
71
3352
33517
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
9.2e-01
1.3e+00
2.9e+00
1.0e+50
2.1e+00
1.1e+00
1.0e+00
cases:0.56%
controls:0.22%
cases:0.48%
controls:0.13%
cases:0.19%
controls:0.01%
cases:0.21%
controls:0.00%
cases:0.23%
controls:0.03%
cases:0.40%
controls:0.13%
cases:0.74%
controls:0.27%
27
108
4795
48099
23
61
4799
48155
9
5
4813
48211
10
0
4812
48216
11
14
4796
47984
18
60
4510
45337
25
91
3357
33497
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.1e-01
4.8e-01
1.1e+00
4.8e+00
1.4e+00
6.0e-01
6.0e-01
cases:54.42%
controls:46.61%
cases:39.44%
controls:28.66%
cases:13.96%
controls:5.36%
cases:29.93%
controls:0.34%
cases:19.60%
controls:5.49%
cases:41.54%
controls:28.14%
cases:69.40%
controls:55.47%
2624
22468
2198
25739
1902
13818
2920
34398
673
2586
4149
45630
1443
165
3379
48051
942
2634
3865
45364
1881
12776
2647
32621
2347
18630
1035
14958
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
3.9e-01
6.8e-01
1.5e+00
4.6e+00
9.8e-01
6.6e-01
4.9e-01
cases:4.36%
controls:3.00%
cases:2.90%
controls:1.50%
cases:0.91%
controls:0.21%
cases:0.97%
controls:0.01%
cases:0.50%
controls:0.19%
cases:2.72%
controls:1.43%
cases:7.98%
controls:5.04%
210
1445
4612
46762
140
721
4682
47495
44
100
4778
48116
47
5
4775
48211
24
90
4783
47908
123
649
4405
44748
270
1694
3112
31894
Senile nuclear cataract
H25.1 [45581628]
1.9e-01
3.2e-01
1.0e+00
4.7e+00
2.0e+00
9.7e-01
4.3e-01
cases:5.21%
controls:4.36%
cases:2.36%
controls:1.72%
cases:0.75%
controls:0.27%
cases:1.10%
controls:0.01%
cases:1.79%
controls:0.26%
cases:4.55%
controls:1.78%
cases:7.84%
controls:5.23%
251
2101
4571
46106
114
831
4708
47385
36
130
4786
48086
53
5
4769
48211
86
124
4721
47874
206
808
4322
44589
265
1757
3117
31831
Other retinal artery occlusions
H34.2 [45605668]
1.9e+00
2.3e+00
—
1.0e+50
—
2.9e+00
1.9e+00
cases:0.19%
controls:0.03%
cases:0.15%
controls:0.01%
—
—
cases:0.23%
controls:0.00%
—
—
cases:0.51%
controls:0.03%
cases:0.41%
controls:0.06%
9
13
4813
48194
7
7
4815
48209
—
11
0
4811
48216
—
23
13
4505
45384
14
21
3368
33567
Retinal detachment with retinal break
H33.0 [45547857]
1.2e+00
9.0e-01
1.3e+00
1.0e+50
3.9e+00
2.8e+00
1.1e+00
cases:0.81%
controls:0.24%
cases:0.29%
controls:0.12%
cases:0.10%
controls:0.03%
cases:0.77%
controls:0.00%
cases:1.60%
controls:0.03%
cases:1.81%
controls:0.11%
cases:0.89%
controls:0.31%
39
118
4783
48089
14
57
4808
48159
5
14
4817
48202
37
0
4785
48216
77
16
4730
47982
82
50
4446
45347
30
103
3352
33485
ECG with 12 standard connections
XF400 [2001303368]
7.3e-01
9.8e-01
2.3e+00
—
2.6e+00
9.9e-01
1.3e+00
cases:4.11%
controls:2.02%
cases:1.58%
controls:0.60%
cases:0.54%
controls:0.05%
—
—
cases:0.60%
controls:0.04%
cases:1.39%
controls:0.52%
cases:4.41%
controls:1.26%
198
973
4624
47234
76
287
4746
47929
26
25
4796
48191
—
29
21
4778
47977
63
237
4465
45160
149
423
3233
33165
Photocoagulation of retina
CKC12 [2001301394]
8.6e-01
9.3e-01
—
—
3.7e+00
2.4e+00
1.0e+00
cases:1.49%
controls:0.64%
cases:0.46%
controls:0.18%
—
—
—
—
cases:1.23%
controls:0.03%
cases:1.70%
controls:0.15%
cases:1.57%
controls:0.57%
72
307
4750
47900
22
87
4800
48129
—
—
59
15
4748
47983
77
69
4451
45328
53
193
3329
33395
Extensive CT of neck arteries
PA6BD [2001308697]
1.0e+00
1.5e+00
2.7e+00
1.0e+50
—
2.7e+00
1.0e+00
cases:1.33%
controls:0.48%
cases:0.52%
controls:0.12%
cases:0.19%
controls:0.01%
cases:2.14%
controls:0.00%
—
—
cases:0.64%
controls:0.04%
cases:0.62%
controls:0.23%
64
233
4758
47974
25
56
4797
48160
9
6
4813
48210
103
0
4719
48216
—
29
20
4499
45377
21
77
3361
33511
Occupational therapy
R4120 [2001310234]
8.4e-01
9.4e-01
2.2e+00
1.0e+50
2.3e+00
1.3e+00
1.3e+00
cases:1.87%
controls:0.81%
cases:0.64%
controls:0.25%
cases:0.21%
controls:0.02%
cases:0.29%
controls:0.00%
cases:0.23%
controls:0.02%
cases:0.84%
controls:0.24%
cases:2.37%
controls:0.66%
90
392
4732
47815
31
122
4791
48094
10
11
4812
48205
14
0
4808
48216
11
11
4796
47987
38
107
4490
45290
80
221
3302
33367
Migraine, unspecified
G43.9 [45595943]
9.2e-01
1.1e+00
2.1e+00
—
2.2e+00
1.5e+00
1.0e+00
cases:2.09%
controls:0.85%
cases:1.00%
controls:0.33%
cases:0.33%
controls:0.04%
—
—
cases:0.46%
controls:0.05%
cases:1.26%
controls:0.29%
cases:2.66%
controls:0.98%
101
408
4721
47799
48
161
4774
48055
16
19
4806
48197
—
22
24
4785
47974
57
132
4471
45265
90
329
3292
33259
Other specified counselling
Z71.8 [45581061]
5.7e-01
5.9e-01
1.4e+00
3.7e+00
1.4e+00
7.4e-01
5.1e-01
cases:10.93%
controls:6.49%
cases:5.77%
controls:3.27%
cases:1.78%
controls:0.46%
cases:0.60%
controls:0.01%
cases:1.73%
controls:0.45%
cases:7.51%
controls:3.73%
cases:17.21%
controls:11.12%
527
3127
4295
45080
278
1578
4544
46638
86
222
4736
47994
29
7
4793
48209
83
217
4724
47781
340
1695
4188
43702
582
3734
2800
29854
Asthma, unspecified
J45.9 [45562456]
5.6e-01
6.9e-01
7.7e-01
4.4e+00
1.1e+00
6.3e-01
6.4e-01
cases:7.40%
controls:4.35%
cases:4.13%
controls:2.11%
cases:0.91%
controls:0.42%
cases:1.18%
controls:0.01%
cases:1.21%
controls:0.40%
cases:4.06%
controls:2.20%
cases:9.25%
controls:5.10%
357
2096
4465
46111
199
1019
4623
47197
44
204
4778
48012
57
7
4765
48209
58
193
4749
47805
184
1000
4344
44397
313
1714
3069
31874
Other healthcare associate professional
Z3229 [2001311561]
5.5e-01
1.1e+00
1.8e+00
—
2.5e+00
1.8e+00
1.1e+00
cases:1.78%
controls:1.04%
cases:0.58%
controls:0.20%
cases:0.19%
controls:0.03%
—
—
cases:0.40%
controls:0.03%
cases:1.08%
controls:0.18%
cases:1.54%
controls:0.50%
86
501
4736
47706
28
98
4794
48118
9
15
4813
48201
—
19
16
4788
47982
49
82
4479
45315
52
167
3330
33421
Other visual field testing
CS494 [2001301478]
8.9e-01
9.9e-01
—
—
3.5e+00
2.2e+00
1.2e+00
cases:0.75%
controls:0.31%
cases:0.48%
controls:0.18%
—
—
—
—
cases:0.48%
controls:0.01%
cases:1.41%
controls:0.16%
cases:1.30%
controls:0.38%
36
149
4786
48058
23
86
4799
48130
—
—
23
7
4784
47991
64
72
4464
45325
44
129
3338
33459
Headache
N01 [2002000720]
7.5e-01
1.3e+00
2.3e+00
1.0e+50
2.5e+00
9.7e-01
9.7e-01
cases:3.94%
controls:1.90%
cases:1.72%
controls:0.50%
cases:0.56%
controls:0.06%
cases:0.29%
controls:0.00%
cases:0.58%
controls:0.05%
cases:1.26%
controls:0.48%
cases:4.58%
controls:1.78%
190
918
4632
47289
83
240
4739
47976
27
27
4795
48189
14
0
4808
48216
28
23
4779
47975
57
218
4471
45179
155
598
3227
32990
Hemiplegia, unspecified
G81.9 [45562106]
1.6e+00
2.3e+00
—
1.0e+50
—
2.8e+00
2.0e+00
cases:0.29%
controls:0.06%
cases:0.21%
controls:0.02%
—
—
cases:0.10%
controls:0.00%
—
—
cases:0.18%
controls:0.01%
cases:0.30%
controls:0.04%
14
29
4808
48178
10
10
4812
48206
—
5
0
4817
48216
—
8
5
4520
45392
10
13
3372
33575
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
4.1e-01
1.2e+00
2.3e+00
—
3.1e+00
1.2e+00
8.5e-01
cases:1.18%
controls:0.79%
cases:0.81%
controls:0.25%
cases:0.19%
controls:0.02%
—
—
cases:0.67%
controls:0.03%
cases:0.75%
controls:0.23%
cases:1.51%
controls:0.65%
57
381
4765
47826
39
120
4783
48096
9
9
4813
48207
—
32
14
4775
47984
34
103
4494
45294
51
219
3331
33369
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
7.4e-01
7.8e-01
8.8e-01
2.2e+00
1.6e+00
1.2e+00
1.2e+00
cases:2.32%
controls:1.12%
cases:1.82%
controls:0.84%
cases:0.71%
controls:0.29%
cases:0.17%
controls:0.02%
cases:1.41%
controls:0.28%
cases:2.65%
controls:0.80%
cases:3.22%
controls:1.03%
112
542
4710
47665
88
406
4734
47810
34
141
4788
48075
8
9
4814
48207
68
134
4739
47864
120
361
4408
45036
109
345
3273
33243
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
7.4e-01
7.8e-01
8.8e-01
2.2e+00
1.6e+00
1.2e+00
1.2e+00
cases:2.32%
controls:1.13%
cases:1.82%
controls:0.84%
cases:0.71%
controls:0.29%
cases:0.17%
controls:0.02%
cases:1.41%
controls:0.28%
cases:2.65%
controls:0.80%
cases:3.22%
controls:1.03%
112
543
4710
47664
88
406
4734
47810
34
141
4788
48075
8
9
4814
48207
68
134
4739
47864
120
361
4408
45036
109
345
3273
33243
INR in Blood by Coagulation assay
34714-6 [3032080]
4.6e-01
5.0e-01
7.7e-01
4.7e+00
1.0e+00
5.8e-01
5.8e-01
cases:22.71%
controls:15.60%
cases:12.94%
controls:8.30%
cases:5.31%
controls:2.54%
cases:13.25%
controls:0.14%
cases:6.64%
controls:2.52%
cases:13.56%
controls:8.06%
cases:28.00%
controls:17.86%
1095
7518
3727
40689
624
4003
4198
44213
256
1223
4566
46993
639
67
4183
48149
319
1208
4488
46790
614
3659
3914
41738
947
5998
2435
27590
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.5e-01
5.0e-01
1.0e+00
3.7e+00
1.7e+00
5.9e-01
6.2e-01
cases:37.39%
controls:29.54%
cases:21.53%
controls:14.25%
cases:5.02%
controls:1.85%
cases:3.80%
controls:0.10%
cases:10.01%
controls:1.91%
cases:22.50%
controls:13.83%
cases:48.52%
controls:33.64%
1803
14242
3019
33965
1038
6870
3784
41346
242
892
4580
47324
183
46
4639
48170
481
915
4326
47083
1019
6279
3509
39118
1641
11298
1741
22290
clopidogrel; oral
B01AC04 [21600989]
6.7e-01
7.3e-01
9.3e-01
1.9e+00
1.9e+00
1.4e+00
1.1e+00
cases:6.43%
controls:3.40%
cases:4.69%
controls:2.31%
cases:1.78%
controls:0.71%
cases:0.19%
controls:0.03%
cases:4.33%
controls:0.64%
cases:8.35%
controls:2.30%
cases:10.20%
controls:3.79%
310
1640
4512
46567
226
1112
4596
47104
86
342
4736
47874
9
14
4813
48202
208
308
4599
47690
378
1045
4150
44352
345
1272
3037
32316
Neuro-ophthalmology Physician
207WX0109X [903241]
1.5e+00
1.9e+00
—
1.0e+50
—
4.1e+00
2.4e+00
cases:0.17%
controls:0.04%
cases:0.15%
controls:0.02%
—
—
cases:0.15%
controls:0.00%
—
—
cases:1.08%
controls:0.02%
cases:0.65%
controls:0.06%
8
17
4814
48190
7
10
4815
48206
—
7
0
4815
48216
—
49
8
4479
45389
22
20
3360
33568
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.5e-01
3.8e-01
8.5e-01
4.6e+00
1.3e+00
5.3e-01
4.9e-01
cases:57.49%
controls:51.18%
cases:47.59%
controls:38.21%
cases:15.45%
controls:7.21%
cases:29.20%
controls:0.41%
cases:21.34%
controls:7.08%
cases:50.93%
controls:38.02%
cases:74.51%
controls:64.11%
2772
24670
2050
23537
2295
18425
2527
29791
745
3477
4077
44739
1408
196
3414
48020
1026
3398
3781
44600
2306
17259
2222
28138
2520
21534
862
12054
Atherosclerotic heart disease
I25.1 [45596196]
4.4e-01
5.1e-01
1.1e+00
3.8e+00
1.4e+00
7.1e-01
5.2e-01
cases:7.47%
controls:4.95%
cases:4.40%
controls:2.70%
cases:1.51%
controls:0.52%
cases:1.41%
controls:0.03%
cases:1.81%
controls:0.48%
cases:5.54%
controls:2.79%
cases:9.88%
controls:6.09%
360
2384
4462
45823
212
1302
4610
46914
73
249
4749
47967
68
16
4754
48200
87
228
4720
47770
251
1267
4277
44130
334
2047
3048
31541
Eye symptom/complaint other
F29 [2002000412]
6.6e-01
8.9e-01
2.7e+00
—
2.4e+00
1.0e+00
7.6e-01
cases:2.92%
controls:1.53%
cases:1.29%
controls:0.53%
cases:0.85%
controls:0.06%
—
—
cases:0.60%
controls:0.06%
cases:1.57%
controls:0.57%
cases:4.46%
controls:2.15%
141
737
4681
47470
62
256
4760
47960
41
29
4781
48187
—
29
27
4778
47971
71
259
4457
45138
151
721
3231
32867
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.5e-01
3.8e-01
8.4e-01
4.6e+00
1.3e+00
5.2e-01
4.9e-01
cases:57.80%
controls:51.49%
cases:48.01%
controls:38.72%
cases:15.51%
controls:7.35%
cases:28.93%
controls:0.41%
cases:21.57%
controls:7.21%
cases:51.33%
controls:38.51%
cases:74.60%
controls:64.39%
2787
24823
2035
23384
2315
18671
2507
29545
748
3542
4074
44674
1395
200
3427
48016
1037
3462
3770
44536
2324
17484
2204
27913
2523
21628
859
11960
Parabulbar anesthesia
WX140 [2001310772]
6.9e-01
3.8e-01
1.8e+00
1.0e+50
4.4e+00
2.2e+00
1.1e+00
cases:1.12%
controls:0.56%
cases:0.25%
controls:0.17%
cases:0.10%
controls:0.02%
cases:0.17%
controls:0.00%
cases:1.46%
controls:0.02%
cases:1.33%
controls:0.15%
cases:1.60%
controls:0.56%
54
272
4768
47935
12
82
4810
48134
5
8
4817
48208
8
0
4814
48216
70
9
4737
47989
60
67
4468
45330
54
189
3328
33399
Puncture of vitreous body with injection of medication
CKD05 [2001301407]
5.0e-01
6.2e-01
5.1e-01
3.0e+00
1.8e+00
1.5e+00
8.2e-01
cases:1.43%
controls:0.87%
cases:1.04%
controls:0.56%
cases:0.44%
controls:0.26%
cases:0.29%
controls:0.01%
cases:1.60%
controls:0.26%
cases:2.61%
controls:0.60%
cases:2.51%
controls:1.13%
69
420
4753
47787
50
269
4772
47947
21
126
4801
48090
14
7
4808
48209
77
126
4730
47872
118
271
4410
45126
85
378
3297
33210
Dry eye syndrome
H04.10 [2000502254]
5.9e-01
8.4e-01
1.7e+00
—
2.9e+00
1.2e+00
8.6e-01
cases:3.24%
controls:1.81%
cases:1.82%
controls:0.80%
cases:0.62%
controls:0.11%
—
—
cases:1.87%
controls:0.10%
cases:2.78%
controls:0.83%
cases:6.00%
controls:2.63%
156
873
4666
47334
88
384
4734
47832
30
53
4792
48163
—
90
48
4717
47950
126
375
4402
45022
203
884
3179
32704
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.4e-01
4.7e-01
9.1e-01
4.2e+00
1.0e+00
5.3e-01
6.8e-01
cases:11.39%
controls:8.35%
cases:6.35%
controls:4.07%
cases:1.37%
controls:0.56%
cases:0.71%
controls:0.01%
cases:1.50%
controls:0.55%
cases:6.67%
controls:4.04%
cases:19.69%
controls:11.00%
549
4025
4273
44182
306
1961
4516
46255
66
268
4756
47948
34
5
4788
48211
72
264
4735
47734
302
1834
4226
43563
666
3696
2716
29892
Fibromyalgia
M79.7 [45553272]
8.5e-01
1.1e+00
2.0e+00
—
2.0e+00
1.2e+00
1.0e+00
cases:1.31%
controls:0.56%
cases:0.79%
controls:0.26%
cases:0.27%
controls:0.04%
—
—
cases:0.23%
controls:0.03%
cases:0.84%
controls:0.26%
cases:1.71%
controls:0.63%
63
270
4759
47937
38
123
4784
48093
13
18
4809
48198
—
11
15
4796
47983
38
116
4490
45281
58
213
3324
33375
Demyelinating disease of central nervous system, unspecified
G37.9 [45571797]
2.2e+00
—
—
1.0e+50
—
3.6e+00
2.3e+00
cases:0.23%
controls:0.02%
—
—
—
—
cases:0.10%
controls:0.00%
—
—
cases:0.42%
controls:0.01%
cases:0.24%
controls:0.02%
11
12
4811
48195
—
—
5
0
4817
48216
—
19
5
4509
45392
8
8
3374
33580
antibiotics in combination with other drugs
S01AA20 [21603571]
3.7e-01
4.7e-01
1.0e+00
2.6e+00
2.2e+00
9.7e-01
4.6e-01
cases:13.09%
controls:9.45%
cases:4.67%
controls:2.96%
cases:0.77%
controls:0.28%
cases:0.17%
controls:0.01%
cases:2.89%
controls:0.33%
cases:6.91%
controls:2.73%
cases:13.69%
controls:9.07%
631
4554
4191
43653
225
1427
4597
46789
37
133
4785
48083
8
6
4814
48210
139
159
4668
47839
313
1238
4215
44159
463
3047
2919
30541
Plain photography of ocular fundus
CK2S4 [2001301455]
6.8e-01
9.7e-01
1.0e+00
—
3.4e+00
2.0e+00
1.1e+00
cases:2.01%
controls:1.03%
cases:1.27%
controls:0.49%
cases:0.19%
controls:0.07%
—
—
cases:2.06%
controls:0.07%
cases:3.29%
controls:0.48%
cases:3.70%
controls:1.24%
97
496
4725
47711
61
234
4761
47982
9
33
4813
48183
—
99
35
4708
47963
149
216
4379
45181
125
416
3257
33172
CT angiography of head and neck vasculature
PA7AD [2001300233]
1.0e+00
1.5e+00
2.9e+00
1.0e+50
—
1.4e+00
1.1e+00
cases:0.85%
controls:0.31%
cases:0.64%
controls:0.14%
cases:0.35%
controls:0.02%
cases:3.34%
controls:0.00%
—
—
cases:0.68%
controls:0.17%
cases:1.98%
controls:0.66%
41
148
4781
48059
31
67
4791
48149
17
9
4805
48207
161
0
4661
48216
—
31
77
4497
45320
67
222
3315
33366
Dizziness and giddiness
R42 [45568132]
8.4e-01
1.1e+00
1.9e+00
—
2.1e+00
1.2e+00
9.1e-01
cases:8.48%
controls:3.85%
cases:3.73%
controls:1.32%
cases:1.04%
controls:0.16%
—
—
cases:1.12%
controls:0.15%
cases:4.28%
controls:1.30%
cases:10.64%
controls:4.59%
409
1858
4413
46349
180
636
4642
47580
50
77
4772
48139
—
54
70
4753
47928
194
591
4334
44806
360
1542
3022
32046
EKG study
11524-6 [3013512]
2.6e-01
4.0e-01
1.1e+00
4.3e+00
1.1e+00
3.5e-01
3.2e-01
cases:13.46%
controls:10.70%
cases:8.40%
controls:5.78%
cases:1.99%
controls:0.68%
cases:2.30%
controls:0.03%
cases:2.23%
controls:0.75%
cases:7.97%
controls:5.77%
cases:19.16%
controls:14.64%
649
5160
4173
43047
405
2788
4417
45428
96
329
4726
47887
111
15
4711
48201
107
361
4700
47637
361
2618
4167
42779
648
4917
2734
28671
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
9.9e-01
1.1e+00
2.3e+00
1.0e+50
—
2.1e+00
1.3e+00
cases:1.43%
controls:0.54%
cases:0.48%
controls:0.16%
cases:0.17%
controls:0.02%
cases:0.25%
controls:0.00%
—
—
cases:1.15%
controls:0.14%
cases:1.69%
controls:0.47%
69
258
4753
47949
23
77
4799
48139
8
8
4814
48208
12
0
4810
48216
—
52
62
4476
45335
57
157
3325
33431
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.0e-01
3.2e-01
7.8e-01
4.4e+00
1.2e+00
4.9e-01
4.2e-01
cases:60.56%
controls:55.72%
cases:52.26%
controls:44.24%
cases:18.06%
controls:9.15%
cases:29.30%
controls:0.49%
cases:23.97%
controls:8.94%
cases:56.45%
controls:44.24%
cases:77.85%
controls:69.78%
2920
26862
1902
21345
2520
21333
2302
26883
871
4411
3951
43805
1413
234
3409
47982
1152
4290
3655
43708
2556
20084
1972
25313
2633
23439
749
10149
chloramphenicol
S01AA01 [21603554]
3.8e-01
4.4e-01
1.2e+00
3.6e+00
1.3e+00
4.8e-01
4.5e-01
cases:16.16%
controls:11.67%
cases:5.99%
controls:3.93%
cases:1.37%
controls:0.40%
cases:0.52%
controls:0.01%
cases:1.44%
controls:0.41%
cases:6.32%
controls:4.01%
cases:18.48%
controls:12.63%
779
5627
4043
42580
289
1896
4533
46320
66
195
4756
48021
25
7
4797
48209
69
197
4738
47801
286
1822
4242
43575
625
4243
2757
29345
chloramphenicol
S03AA08 [21605197]
3.8e-01
4.4e-01
1.2e+00
3.6e+00
1.3e+00
4.8e-01
4.5e-01
cases:16.16%
controls:11.67%
cases:5.99%
controls:3.93%
cases:1.37%
controls:0.40%
cases:0.52%
controls:0.01%
cases:1.44%
controls:0.41%
cases:6.32%
controls:4.01%
cases:18.48%
controls:12.63%
779
5627
4043
42580
289
1896
4533
46320
66
195
4756
48021
25
7
4797
48209
69
197
4738
47801
286
1822
4242
43575
625
4243
2757
29345
Physiotherapist
Z3226 [2001311560]
6.4e-01
8.6e-01
1.6e+00
—
2.1e+00
1.5e+00
1.2e+00
cases:4.04%
controls:2.16%
cases:0.89%
controls:0.38%
cases:0.19%
controls:0.04%
—
—
cases:0.31%
controls:0.04%
cases:1.13%
controls:0.26%
cases:2.42%
controls:0.76%
195
1043
4627
47164
43
183
4779
48033
9
18
4813
48198
—
15
19
4792
47979
51
120
4477
45277
82
255
3300
33333
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
9.9e-01
1.2e+00
2.2e+00
1.0e+50
—
2.2e+00
1.3e+00
cases:1.43%
controls:0.54%
cases:0.50%
controls:0.16%
cases:0.15%
controls:0.02%
cases:0.25%
controls:0.00%
—
—
cases:1.17%
controls:0.14%
cases:1.69%
controls:0.47%
69
258
4753
47949
24
75
4798
48141
7
8
4815
48208
12
0
4810
48216
—
53
62
4475
45335
57
157
3325
33431
Medical doctor
Z2221 [2001311556]
6.6e-01
1.0e+00
1.7e+00
—
2.0e+00
1.3e+00
1.1e+00
cases:8.77%
controls:4.75%
cases:2.61%
controls:0.97%
cases:0.56%
controls:0.11%
—
—
cases:0.85%
controls:0.11%
cases:2.50%
controls:0.70%
cases:4.70%
controls:1.63%
423
2288
4399
45919
126
468
4696
47748
27
51
4795
48165
—
41
55
4766
47943
113
316
4415
45081
159
548
3223
33040
Inpatient Visit
IP [9201]
3.2e-01
3.0e-01
9.1e-01
3.5e+00
1.6e+00
6.4e-01
4.4e-01
cases:11.95%
controls:8.95%
cases:5.45%
controls:4.09%
cases:1.14%
controls:0.46%
cases:0.60%
controls:0.02%
cases:2.23%
controls:0.45%
cases:7.09%
controls:3.87%
cases:18.30%
controls:12.60%
576
4315
4246
43892
263
1973
4559
46243
55
222
4767
47994
29
9
4793
48207
107
217
4700
47781
321
1758
4207
43639
619
4231
2763
29357
Migraine without aura [common migraine]
G43.0 [45600784]
7.1e-01
7.8e-01
1.9e+00
—
2.0e+00
1.3e+00
1.1e+00
cases:1.58%
controls:0.78%
cases:0.83%
controls:0.38%
cases:0.35%
controls:0.05%
—
—
cases:0.44%
controls:0.06%
cases:1.17%
controls:0.34%
cases:2.48%
controls:0.88%
76
377
4746
47830
40
184
4782
48032
17
25
4805
48191
—
21
29
4786
47969
53
153
4475
45244
84
295
3298
33293
Central retinal artery occlusion
H34.1 [45600901]
2.4e+00
2.8e+00
—
1.0e+50
—
—
2.5e+00
cases:0.29%
controls:0.03%
cases:0.17%
controls:0.01%
—
—
cases:0.46%
controls:0.00%
—
—
—
—
cases:0.56%
controls:0.04%
14
13
4808
48194
8
5
4814
48211
—
22
0
4800
48216
—
—
19
15
3363
33573
Tension-type headache
G44.2 [45581495]
7.1e-01
1.1e+00
1.6e+00
—
2.4e+00
1.2e+00
6.8e-01
cases:4.23%
controls:2.13%
cases:1.62%
controls:0.53%
cases:0.27%
controls:0.06%
—
—
cases:0.44%
controls:0.04%
cases:1.74%
controls:0.51%
cases:4.02%
controls:2.07%
204
1028
4618
47179
78
256
4744
47960
13
27
4809
48189
—
21
20
4786
47978
79
231
4449
45166
136
696
3246
32892
Visual field testing with Goldmann perimetry
CS424 [2001301475]
1.7e+00
1.5e+00
—
1.0e+50
1.0e+50
4.1e+00
1.9e+00
cases:0.31%
controls:0.06%
cases:0.10%
controls:0.02%
—
—
cases:0.19%
controls:0.00%
cases:0.46%
controls:0.00%
cases:0.80%
controls:0.01%
cases:0.53%
controls:0.08%
15
28
4807
48179
5
11
4817
48205
—
9
0
4813
48216
22
0
4785
47998
36
6
4492
45391
18
27
3364
33561
CBC panel - Blood by Automated count
58410-2 [40761511]
2.2e-01
3.1e-01
7.7e-01
4.5e+00
1.1e+00
4.2e-01
3.1e-01
cases:56.49%
controls:51.11%
cases:39.53%
controls:32.48%
cases:11.76%
controls:5.82%
cases:20.12%
controls:0.27%
cases:15.27%
controls:5.59%
cases:40.46%
controls:30.93%
cases:65.29%
controls:57.88%
2724
24638
2098
23569
1906
15661
2916
32555
567
2805
4255
45411
970
131
3852
48085
734
2681
4073
45317
1832
14043
2696
31354
2208
19442
1174
14146
Cardiology
6 [38004451]
5.1e-01
6.9e-01
9.3e-01
3.0e+00
9.8e-01
8.6e-01
7.2e-01
cases:20.34%
controls:13.26%
cases:11.82%
controls:6.27%
cases:2.45%
controls:0.98%
cases:0.56%
controls:0.03%
cases:2.33%
controls:0.89%
cases:13.05%
controls:5.98%
cases:24.78%
controls:13.80%
981
6392
3841
41815
570
3024
4252
45192
118
471
4704
47745
27
14
4795
48202
112
428
4695
47570
591
2714
3937
42683
838
4635
2544
28953
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
3.8e-01
3.2e-01
9.1e-01
4.0e+00
9.3e-01
5.2e-01
6.4e-01
cases:8.88%
controls:6.26%
cases:3.73%
controls:2.73%
cases:0.95%
controls:0.39%
cases:0.54%
controls:0.01%
cases:0.89%
controls:0.36%
cases:4.39%
controls:2.65%
cases:12.06%
controls:6.74%
428
3020
4394
45187
180
1317
4642
46899
46
186
4776
48030
26
5
4796
48211
43
171
4764
47827
199
1203
4329
44194
408
2263
2974
31325
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
3.6e-01
4.3e-01
8.4e-01
3.9e+00
9.7e-01
5.1e-01
6.5e-01
cases:13.11%
controls:9.54%
cases:7.26%
controls:4.84%
cases:1.58%
controls:0.69%
cases:0.81%
controls:0.02%
cases:1.73%
controls:0.66%
cases:7.88%
controls:4.88%
cases:22.24%
controls:13.00%
632
4599
4190
43608
350
2334
4472
45882
76
331
4746
47885
39
8
4783
48208
83
319
4724
47679
357
2214
4171
43183
752
4366
2630
29222
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.1e-01
3.1e-01
8.1e-01
4.3e+00
1.1e+00
4.5e-01
3.9e-01
cases:44.32%
controls:39.22%
cases:37.91%
controls:30.89%
cases:14.00%
controls:6.73%
cases:22.36%
controls:0.38%
cases:18.10%
controls:6.62%
cases:41.10%
controls:30.75%
cases:61.27%
controls:51.78%
2137
18908
2685
29299
1828
14892
2994
33324
675
3244
4147
44972
1078
184
3744
48032
870
3176
3937
44822
1861
13961
2667
31436
2072
17393
1310
16195
Depressive episode, unspecified
F32.9 [45571760]
5.5e-01
6.5e-01
1.3e+00
2.5e+00
1.1e+00
8.6e-01
6.6e-01
cases:2.99%
controls:1.75%
cases:1.22%
controls:0.64%
cases:0.41%
controls:0.12%
cases:0.12%
controls:0.01%
cases:0.40%
controls:0.13%
cases:1.59%
controls:0.68%
cases:3.76%
controls:1.97%
144
843
4678
47364
59
309
4763
47907
20
56
4802
48160
6
5
4816
48211
19
61
4788
47937
72
307
4456
45090
127
662
3255
32926
Senile macular degeneration (atrophic)(exudative)
H35.31 [2000502315]
5.6e-01
4.6e-01
5.2e-01
3.8e+00
1.4e+00
1.0e+00
8.3e-01
cases:1.18%
controls:0.68%
cases:0.87%
controls:0.55%
cases:0.52%
controls:0.31%
cases:0.46%
controls:0.01%
cases:1.14%
controls:0.28%
cases:1.72%
controls:0.64%
cases:2.34%
controls:1.03%
57
327
4765
47880
42
267
4780
47949
25
149
4797
48067
22
5
4800
48211
55
134
4752
47864
78
290
4450
45107
79
346
3303
33242
Leukocytes [#/volume] in Urine
30405-5 [3018095]
3.4e-01
3.8e-01
8.2e-01
3.9e+00
1.1e+00
4.8e-01
6.0e-01
cases:14.81%
controls:10.99%
cases:8.30%
controls:5.83%
cases:1.93%
controls:0.86%
cases:1.02%
controls:0.02%
cases:2.37%
controls:0.84%
cases:9.39%
controls:6.02%
cases:25.72%
controls:15.93%
714
5300
4108
42907
400
2809
4422
45407
93
415
4729
47801
49
10
4773
48206
114
403
4693
47595
425
2731
4103
42666
870
5349
2512
28239
Bacteria [Presence] in Urine
87829-8 [36304419]
3.5e-01
4.2e-01
7.1e-01
3.8e+00
1.0e+00
5.2e-01
7.3e-01
cases:11.16%
controls:8.12%
cases:5.81%
controls:3.88%
cases:1.08%
controls:0.53%
cases:0.66%
controls:0.01%
cases:1.37%
controls:0.51%
cases:6.12%
controls:3.74%
cases:19.22%
controls:10.31%
538
3916
4284
44291
280
1872
4542
46344
52
256
4770
47960
32
7
4790
48209
66
245
4741
47753
277
1696
4251
43701
650
3464
2732
30124
Eye pressure measurement
XCH00 [2001301234]
7.5e-01
8.8e-01
1.3e+00
1.0e+50
3.4e+00
1.8e+00
7.3e-01
cases:1.49%
controls:0.71%
cases:0.83%
controls:0.35%
cases:0.21%
controls:0.06%
cases:0.79%
controls:0.00%
cases:1.35%
controls:0.05%
cases:2.08%
controls:0.35%
cases:2.16%
controls:1.05%
72
344
4750
47863
40
167
4782
48049
10
28
4812
48188
38
0
4784
48216
65
22
4742
47976
94
160
4434
45237
73
353
3309
33235
Atherosclerosis of arteries of extremities
I70.2 [45538421]
3.9e-01
4.9e-01
8.0e-01
3.5e+00
1.2e+00
6.1e-01
5.8e-01
cases:2.12%
controls:1.44%
cases:1.37%
controls:0.84%
cases:0.52%
controls:0.23%
cases:0.48%
controls:0.01%
cases:0.67%
controls:0.21%
cases:1.66%
controls:0.91%
cases:3.13%
controls:1.78%
102
693
4720
47514
66
407
4756
47809
25
113
4797
48103
23
7
4799
48209
32
99
4775
47899
75
411
4453
44986
106
599
3276
32989
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
4.5e-01
9.4e-01
2.2e+00
—
2.8e+00
9.5e-01
6.9e-01
cases:1.18%
controls:0.76%
cases:0.64%
controls:0.25%
cases:0.15%
controls:0.02%
—
—
cases:0.44%
controls:0.03%
cases:0.62%
controls:0.24%
cases:1.48%
controls:0.75%
57
365
4765
47842
31
122
4791
48094
7
8
4815
48208
—
21
13
4786
47985
28
109
4500
45288
50
251
3332
33337
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
1.1e+00
1.1e+00
1.9e+00
1.0e+50
—
2.1e+00
1.3e+00
cases:1.56%
controls:0.52%
cases:0.52%
controls:0.18%
cases:0.15%
controls:0.02%
cases:0.33%
controls:0.00%
—
—
cases:1.10%
controls:0.13%
cases:1.69%
controls:0.47%
75
251
4747
47956
25
86
4797
48130
7
10
4815
48206
16
0
4806
48216
—
50
61
4478
45336
57
158
3325
33430
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.4e-01
4.1e-01
7.3e-01
3.9e+00
1.0e+00
5.0e-01
6.8e-01
cases:15.35%
controls:11.41%
cases:7.80%
controls:5.31%
cases:1.58%
controls:0.77%
cases:0.87%
controls:0.02%
cases:1.91%
controls:0.70%
cases:8.22%
controls:5.14%
cases:23.86%
controls:13.74%
740
5501
4082
42706
376
2560
4446
45656
76
371
4746
47845
42
9
4780
48207
92
338
4715
47660
372
2333
4156
43064
807
4616
2575
28972
Complicated migraine
G43.3 [45576576]
1.0e+00
1.5e+00
1.4e+00
—
2.3e+00
1.6e+00
1.1e+00
cases:0.64%
controls:0.23%
cases:0.52%
controls:0.12%
cases:0.10%
controls:0.02%
—
—
cases:0.25%
controls:0.03%
cases:0.53%
controls:0.11%
cases:0.89%
controls:0.30%
31
110
4791
48097
25
58
4797
48158
5
12
4817
48204
—
12
12
4795
47986
24
48
4504
45349
30
101
3352
33487
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22118-4 [3011166]
1.2e+00
1.5e+00
—
1.0e+50
1.0e+50
3.3e+00
1.5e+00
cases:0.73%
controls:0.21%
cases:0.23%
controls:0.05%
—
—
cases:0.10%
controls:0.00%
cases:0.62%
controls:0.00%
cases:0.64%
controls:0.02%
cases:0.68%
controls:0.15%
35
103
4787
48104
11
25
4811
48191
—
5
0
4817
48216
30
0
4777
47998
29
11
4499
45386
23
51
3359
33537
F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
21668-9 [3015816]
5.9e-01
1.4e+00
—
—
3.6e+00
1.4e+00
1.0e+00
cases:0.68%
controls:0.38%
cases:0.41%
controls:0.10%
—
—
—
—
cases:0.40%
controls:0.01%
cases:0.40%
controls:0.10%
cases:0.80%
controls:0.29%
33
184
4789
48023
20
48
4802
48168
—
—
19
5
4788
47993
18
45
4510
45352
27
97
3355
33491
Outpatient Visit
OP [9202]
5.7e-01
4.0e-01
5.8e-01
3.6e+00
1.1e+00
7.3e-01
4.7e-01
cases:89.44%
controls:82.71%
cases:69.47%
controls:60.45%
cases:18.93%
controls:11.55%
cases:15.68%
controls:0.49%
cases:28.00%
controls:11.59%
cases:74.14%
controls:58.12%
cases:90.12%
controls:85.10%
4313
39874
509
8333
3350
29147
1472
19069
913
5567
3909
42649
756
234
4066
47982
1346
5563
3461
42435
3357
26383
1171
19014
3048
28585
334
5003
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.6e-01
2.9e-01
7.8e-01
4.3e+00
1.1e+00
4.1e-01
4.2e-01
cases:43.76%
controls:39.83%
cases:38.84%
controls:32.16%
cases:13.19%
controls:6.54%
cases:21.09%
controls:0.36%
cases:17.39%
controls:6.48%
cases:42.16%
controls:32.69%
cases:65.55%
controls:55.46%
2110
19200
2712
29007
1873
15508
2949
32708
636
3151
4186
45065
1017
175
3805
48041
836
3110
3971
44888
1909
14839
2619
30558
2217
18628
1165
14960
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
1.1e+00
1.1e+00
1.9e+00
—
—
2.2e+00
1.2e+00
cases:1.70%
controls:0.58%
cases:0.54%
controls:0.19%
cases:0.15%
controls:0.02%
—
—
—
—
cases:1.37%
controls:0.15%
cases:1.86%
controls:0.55%
82
279
4740
47928
26
91
4796
48125
7
11
4815
48205
—
—
62
69
4466
45328
63
184
3319
33404
Platelets [#/volume] in Blood
26515-7 [3007461]
1.3e-01
3.2e-01
7.6e-01
4.3e+00
1.1e+00
4.7e-01
3.4e-01
cases:63.60%
controls:60.61%
cases:57.05%
controls:49.06%
cases:20.39%
controls:10.71%
cases:30.57%
controls:0.57%
cases:25.77%
controls:10.51%
cases:60.49%
controls:48.98%
cases:80.57%
controls:74.68%
3067
29217
1755
18990
2751
23653
2071
24563
983
5165
3839
43051
1474
275
3348
47941
1239
5046
3568
42952
2739
22237
1789
23160
2725
25082
657
8506
Thoracic aortic aneurysm, without mention of rupture
I71.2 [45601082]
6.6e-01
1.2e+00
1.9e+00
1.0e+50
1.9e+00
1.1e+00
6.7e-01
cases:1.06%
controls:0.55%
cases:0.89%
controls:0.28%
cases:0.29%
controls:0.04%
cases:0.33%
controls:0.00%
cases:0.31%
controls:0.05%
cases:0.77%
controls:0.26%
cases:1.15%
controls:0.60%
51
266
4771
47941
43
135
4779
48081
14
20
4808
48196
16
0
4806
48216
15
22
4792
47976
35
120
4493
45277
39
200
3343
33388
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.3e-01
3.2e-01
7.6e-01
4.3e+00
1.1e+00
4.7e-01
3.3e-01
cases:63.77%
controls:60.80%
cases:57.01%
controls:49.13%
cases:20.36%
controls:10.73%
cases:30.57%
controls:0.57%
cases:25.77%
controls:10.51%
cases:60.51%
controls:49.03%
cases:80.54%
controls:74.79%
3075
29308
1747
18899
2749
23690
2073
24526
982
5172
3840
43044
1474
275
3348
47941
1239
5044
3568
42954
2740
22256
1788
23141
2724
25119
658
8469
MCH [Entitic mass]
28539-5 [3035941]
1.3e-01
3.2e-01
7.6e-01
4.3e+00
1.1e+00
4.7e-01
3.3e-01
cases:63.73%
controls:60.74%
cases:56.99%
controls:49.12%
cases:20.39%
controls:10.73%
cases:30.57%
controls:0.57%
cases:25.77%
controls:10.51%
cases:60.51%
controls:49.00%
cases:80.51%
controls:74.79%
3073
29283
1749
18924
2748
23682
2074
24534
983
5173
3839
43043
1474
275
3348
47941
1239
5046
3568
42952
2740
22244
1788
23153
2723
25122
659
8466
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.3e-01
3.2e-01
7.6e-01
4.3e+00
1.1e+00
4.7e-01
3.3e-01
cases:63.77%
controls:60.81%
cases:57.09%
controls:49.16%
cases:20.43%
controls:10.75%
cases:30.57%
controls:0.57%
cases:25.82%
controls:10.53%
cases:60.56%
controls:49.04%
cases:80.54%
controls:74.83%
3075
29315
1747
18892
2753
23704
2069
24512
985
5181
3837
43035
1474
276
3348
47940
1241
5052
3566
42946
2742
22261
1786
23136
2724
25134
658
8454
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.3e-01
3.2e-01
7.6e-01
4.3e+00
1.1e+00
4.6e-01
3.3e-01
cases:63.83%
controls:60.83%
cases:57.13%
controls:49.21%
cases:20.45%
controls:10.75%
cases:30.46%
controls:0.57%
cases:25.75%
controls:10.53%
cases:60.56%
controls:49.10%
cases:80.57%
controls:74.85%
3078
29325
1744
18882
2755
23725
2067
24491
986
5184
3836
43032
1469
274
3353
47942
1238
5056
3569
42942
2742
22290
1786
23107
2725
25142
657
8446
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.3e-01
3.2e-01
7.5e-01
4.3e+00
1.1e+00
4.7e-01
3.3e-01
cases:63.94%
controls:60.86%
cases:57.11%
controls:49.25%
cases:20.43%
controls:10.77%
cases:30.59%
controls:0.57%
cases:25.82%
controls:10.56%
cases:60.60%
controls:49.12%
cases:80.57%
controls:74.88%
3083
29338
1739
18869
2754
23748
2068
24468
985
5195
3837
43021
1475
275
3347
47941
1241
5069
3566
42929
2744
22298
1784
23099
2725
25152
657
8436
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.3e-01
3.2e-01
7.6e-01
4.3e+00
1.1e+00
4.7e-01
3.3e-01
cases:63.77%
controls:60.81%
cases:57.09%
controls:49.19%
cases:20.41%
controls:10.75%
cases:30.57%
controls:0.57%
cases:25.77%
controls:10.53%
cases:60.58%
controls:49.08%
cases:80.51%
controls:74.82%
3075
29313
1747
18894
2753
23716
2069
24500
984
5181
3838
43035
1474
275
3348
47941
1239
5052
3568
42946
2743
22283
1785
23114
2723
25132
659
8456
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.0e-01
4.5e-01
8.9e-01
3.3e+00
1.1e+00
6.5e-01
5.9e-01
cases:22.34%
controls:16.16%
cases:12.90%
controls:8.59%
cases:3.34%
controls:1.39%
cases:1.76%
controls:0.07%
cases:4.22%
controls:1.43%
cases:15.30%
controls:8.62%
cases:33.21%
controls:21.55%
1077
7790
3745
40417
622
4142
4200
44074
161
672
4661
47544
85
32
4737
48184
203
688
4604
47310
693
3912
3835
41485
1123
7238
2259
26350
Neuropsychological investigation
XA800 [2001300412]
7.8e-01
1.3e+00
—
—
2.0e+00
2.0e+00
1.3e+00
cases:0.95%
controls:0.44%
cases:0.54%
controls:0.15%
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.73%
controls:0.10%
cases:1.42%
controls:0.38%
46
211
4776
47996
26
72
4796
48144
—
—
6
8
4801
47990
33
47
4495
45350
48
126
3334
33462
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
4.3e-01
4.8e-01
1.0e+00
3.5e+00
9.5e-01
5.0e-01
4.6e-01
cases:11.88%
controls:8.07%
cases:6.74%
controls:4.26%
cases:1.53%
controls:0.56%
cases:0.41%
controls:0.01%
cases:1.39%
controls:0.54%
cases:6.93%
controls:4.34%
cases:18.54%
controls:12.54%
573
3889
4249
44318
325
2056
4497
46160
74
271
4748
47945
20
6
4802
48210
67
261
4740
47737
314
1972
4214
43425
627
4213
2755
29375
Unspecified visual loss
H54.7 [45586517]
1.3e+00
2.6e+00
—
1.0e+50
—
2.5e+00
2.2e+00
cases:0.10%
controls:0.03%
cases:0.15%
controls:0.01%
—
—
cases:0.15%
controls:0.00%
—
—
cases:0.15%
controls:0.01%
cases:0.38%
controls:0.04%
5
13
4817
48194
7
5
4815
48211
—
7
0
4815
48216
—
7
6
4521
45391
13
14
3369
33574
Essential (primary) hypertension
I10 [45591453]
2.2e-01
3.5e-01
8.1e-01
4.0e+00
1.1e+00
4.8e-01
2.9e-01
cases:27.42%
controls:23.27%
cases:16.32%
controls:12.06%
cases:4.58%
controls:2.09%
cases:5.89%
controls:0.11%
cases:6.32%
controls:2.15%
cases:18.66%
controls:12.48%
cases:33.94%
controls:27.74%
1322
11216
3500
36991
787
5813
4035
42403
221
1010
4601
47206
284
54
4538
48162
304
1032
4503
46966
845
5667
3683
39730
1148
9317
2234
24271
Other and unspecified speech disturbances
R47.8 [45592422]
1.6e+00
2.3e+00
—
1.0e+50
—
2.1e+00
1.3e+00
cases:0.31%
controls:0.06%
cases:0.12%
controls:0.01%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.15%
controls:0.02%
cases:0.38%
controls:0.11%
15
29
4807
48178
6
6
4816
48210
—
6
0
4816
48216
—
7
9
4521
45388
13
36
3369
33552
Observation for suspected nervous system disorder
Z03.3 [45609903]
8.5e-01
1.1e+00
—
1.0e+50
3.1e+00
1.3e+00
9.2e-01
cases:1.41%
controls:0.61%
cases:0.56%
controls:0.19%
—
—
cases:0.15%
controls:0.00%
cases:0.46%
controls:0.02%
cases:0.60%
controls:0.16%
cases:1.51%
controls:0.61%
68
292
4754
47915
27
94
4795
48122
—
7
0
4815
48216
22
10
4785
47988
27
74
4501
45323
51
204
3331
33384
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
3.8e-01
4.8e-01
9.9e-01
3.0e+00
1.1e+00
6.4e-01
6.2e-01
cases:19.99%
controls:14.63%
cases:11.45%
controls:7.44%
cases:3.03%
controls:1.15%
cases:1.20%
controls:0.06%
cases:3.64%
controls:1.22%
cases:13.07%
controls:7.36%
cases:29.30%
controls:18.29%
964
7052
3858
41155
552
3586
4270
44630
146
554
4676
47662
58
29
4764
48187
175
584
4632
47414
592
3341
3936
42056
991
6142
2391
27446
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.2e-01
2.6e-01
7.5e-01
4.3e+00
1.1e+00
4.0e-01
2.6e-01
cases:48.09%
controls:45.15%
cases:39.20%
controls:33.23%
cases:13.73%
controls:7.02%
cases:21.80%
controls:0.38%
cases:18.37%
controls:6.84%
cases:42.23%
controls:32.78%
cases:60.94%
controls:54.52%
2319
21765
2503
26442
1890
16020
2932
32196
662
3384
4160
44832
1051
183
3771
48033
883
3285
3924
44713
1912
14882
2616
30515
2061
18312
1321
15276
Separation of retinal layers
H35.7 [45543037]
2.5e-01
9.2e-01
—
—
3.3e+00
2.4e+00
1.4e+00
cases:0.10%
controls:0.08%
cases:0.12%
controls:0.05%
—
—
—
—
cases:0.35%
controls:0.01%
cases:0.57%
controls:0.05%
cases:0.38%
controls:0.10%
5
39
4817
48168
6
24
4816
48192
—
—
17
6
4790
47992
26
23
4502
45374
13
33
3369
33555
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.5e-01
4.5e-01
6.9e-01
3.6e+00
1.1e+00
4.8e-01
5.2e-01
cases:34.32%
controls:26.86%
cases:18.73%
controls:12.80%
cases:3.53%
controls:1.80%
cases:1.99%
controls:0.06%
cases:5.06%
controls:1.78%
cases:18.82%
controls:12.49%
cases:42.22%
controls:30.29%
1655
12950
3167
35257
903
6173
3919
42043
170
867
4652
47349
96
28
4726
48188
243
852
4564
47146
852
5670
3676
39727
1428
10174
1954
23414
Supplier / Service Provider
OMOP5117446 [33004]
-2.9e-01
-3.0e-01
-8.2e-02
—
2.7e+00
2.2e+00
2.8e+00
cases:23.23%
controls:28.75%
cases:6.84%
controls:8.99%
cases:0.79%
controls:0.85%
—
—
cases:1.14%
controls:0.08%
cases:6.63%
controls:0.78%
cases:20.28%
controls:1.57%
1120
13860
3702
34347
330
4337
4492
43879
38
412
4784
47804
—
55
37
4752
47961
300
354
4228
45043
686
527
2696
33061
pH of Serum or Plasma
2753-2 [3018418]
3.8e-01
4.8e-01
7.9e-01
2.9e+00
1.3e+00
6.6e-01
6.2e-01
cases:12.98%
controls:9.25%
cases:7.55%
controls:4.80%
cases:1.70%
controls:0.78%
cases:0.71%
controls:0.04%
cases:2.73%
controls:0.79%
cases:8.94%
controls:4.82%
cases:20.79%
controls:12.34%
626
4459
4196
43748
364
2312
4458
45904
82
375
4740
47841
34
19
4788
48197
131
381
4676
47617
405
2187
4123
43210
703
4146
2679
29442
Short blood count panel - Blood
55429-5 [40758558]
3.1e-01
4.2e-01
9.0e-01
3.2e+00
9.8e-01
5.8e-01
6.0e-01
cases:11.30%
controls:8.57%
cases:6.55%
controls:4.41%
cases:2.20%
controls:0.91%
cases:1.27%
controls:0.05%
cases:2.52%
controls:0.96%
cases:7.40%
controls:4.27%
cases:17.00%
controls:10.09%
545
4129
4277
44078
316
2125
4506
46091
106
437
4716
47779
61
24
4761
48192
121
462
4686
47536
335
1938
4193
43459
575
3388
2807
30200
Thrombophilia screening test
314089003 [4195642]
6.9e-01
1.5e+00
2.3e+00
—
—
1.5e+00
1.0e+00
cases:0.79%
controls:0.40%
cases:0.41%
controls:0.09%
cases:0.12%
controls:0.01%
—
—
—
—
cases:0.49%
controls:0.11%
cases:0.71%
controls:0.26%
38
191
4784
48016
20
44
4802
48172
6
6
4816
48210
—
—
22
49
4506
45348
24
88
3358
33500
Case Management Agency
251B00000X [38004193]
2.0e-01
3.1e-01
7.3e-01
4.1e+00
9.5e-01
4.7e-01
2.4e-01
cases:86.00%
controls:83.36%
cases:81.96%
controls:76.90%
cases:51.20%
controls:33.62%
cases:57.98%
controls:2.23%
cases:56.71%
controls:33.73%
cases:84.89%
controls:77.86%
cases:92.19%
controls:90.26%
4147
40187
675
8020
3952
37078
870
11138
2469
16211
2353
32005
2796
1076
2026
47140
2726
16191
2081
31807
3844
35348
684
10049
3118
30316
264
3272
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
2.9e-01
3.6e-01
6.9e-01
3.8e+00
9.9e-01
4.4e-01
4.2e-01
cases:9.44%
controls:7.26%
cases:5.54%
controls:3.92%
cases:1.16%
controls:0.58%
cases:0.56%
controls:0.01%
cases:1.56%
controls:0.59%
cases:6.45%
controls:4.23%
cases:18.72%
controls:13.15%
455
3500
4367
44707
267
1890
4555
46326
56
282
4766
47934
27
6
4795
48210
75
282
4732
47716
292
1922
4236
43475
633
4417
2749
29171
Other retinal vascular occlusions
H34.8 [45547863]
6.5e-01
1.0e+00
9.4e-01
—
2.7e+00
2.0e+00
1.2e+00
cases:0.52%
controls:0.27%
cases:0.50%
controls:0.18%
cases:0.21%
controls:0.08%
—
—
cases:1.19%
controls:0.08%
cases:1.61%
controls:0.21%
cases:1.27%
controls:0.38%
25
131
4797
48076
24
88
4798
48128
10
39
4812
48177
—
57
38
4750
47960
73
97
4455
45300
43
128
3339
33460
Hypothyroidism, unspecified
E03.9 [45537945]
2.9e-01
5.3e-01
9.1e-01
3.7e+00
9.5e-01
5.9e-01
2.0e-01
cases:3.94%
controls:2.98%
cases:2.41%
controls:1.43%
cases:0.64%
controls:0.26%
cases:0.83%
controls:0.02%
cases:0.77%
controls:0.30%
cases:2.56%
controls:1.43%
cases:4.88%
controls:4.02%
190
1436
4632
46771
116
691
4706
47525
31
125
4791
48091
40
10
4782
48206
37
144
4770
47854
116
649
4412
44748
165
1349
3217
32239
Ptosis of eyelid
H02.4 [45605583]
8.8e-01
1.0e+00
2.3e+00
1.0e+50
1.8e+00
5.5e-01
9.6e-01
cases:0.73%
controls:0.30%
cases:0.37%
controls:0.13%
cases:0.15%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.15%
controls:0.03%
cases:0.20%
controls:0.11%
cases:0.86%
controls:0.33%
35
146
4787
48061
18
64
4804
48152
7
7
4815
48209
7
0
4815
48216
7
12
4800
47986
9
52
4519
45345
29
111
3353
33477
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
5.3e-01
6.1e-01
8.7e-01
2.2e+00
1.2e+00
8.2e-01
7.5e-01
cases:5.29%
controls:3.18%
cases:2.18%
controls:1.20%
cases:0.44%
controls:0.18%
cases:0.15%
controls:0.02%
cases:0.52%
controls:0.16%
cases:2.54%
controls:1.14%
cases:7.24%
controls:3.54%
255
1533
4567
46674
105
578
4717
47638
21
88
4801
48128
7
8
4815
48208
25
78
4782
47920
115
517
4413
44880
245
1190
3137
32398
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
5.9e-01
6.8e-01
8.9e-01
2.8e+00
1.3e+00
7.6e-01
8.2e-01
cases:4.54%
controls:2.58%
cases:2.01%
controls:1.03%
cases:0.31%
controls:0.13%
cases:0.17%
controls:0.01%
cases:0.44%
controls:0.12%
cases:2.19%
controls:1.04%
cases:7.10%
controls:3.24%
219
1244
4603
46963
97
496
4725
47720
15
62
4807
48154
8
5
4814
48211
21
58
4786
47940
99
470
4429
44927
240
1088
3142
32500
Atrial fibrillation and flutter
I48 [45596206]
4.2e-01
4.5e-01
9.1e-01
3.2e+00
8.9e-01
6.1e-01
3.7e-01
cases:9.56%
controls:6.51%
cases:5.31%
controls:3.46%
cases:1.64%
controls:0.67%
cases:1.04%
controls:0.04%
cases:1.71%
controls:0.70%
cases:5.90%
controls:3.31%
cases:9.67%
controls:6.89%
461
3137
4361
45070
256
1666
4566
46550
79
322
4743
47894
50
20
4772
48196
82
338
4725
47660
267
1501
4261
43896
327
2313
3055
31275
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.0e-01
3.4e-01
7.4e-01
3.1e+00
1.7e+00
3.9e-01
3.7e-01
cases:28.14%
controls:24.24%
cases:13.96%
controls:10.32%
cases:2.57%
controls:1.24%
cases:0.93%
controls:0.04%
cases:6.45%
controls:1.24%
cases:14.31%
controls:10.12%
cases:35.98%
controls:28.03%
1357
11683
3465
36524
673
4978
4149
43238
124
600
4698
47616
45
20
4777
48196
310
597
4497
47401
648
4596
3880
40801
1217
9415
2165
24173
Trigeminal neuralgia
G50.0 [45581502]
8.4e-01
1.3e+00
1.5e+00
—
2.0e+00
1.3e+00
1.3e+00
cases:0.46%
controls:0.20%
cases:0.31%
controls:0.08%
cases:0.12%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.31%
controls:0.08%
cases:0.74%
controls:0.20%
22
95
4800
48112
15
39
4807
48177
6
13
4816
48203
—
9
12
4798
47986
14
38
4514
45359
25
66
3357
33522
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
1.1e+00
1.3e+00
—
1.0e+50
1.0e+50
2.9e+00
1.5e+00
cases:0.77%
controls:0.26%
cases:0.23%
controls:0.06%
—
—
cases:0.15%
controls:0.00%
cases:0.62%
controls:0.00%
cases:0.68%
controls:0.04%
cases:0.71%
controls:0.15%
37
123
4785
48084
11
29
4811
48187
—
7
0
4815
48216
30
0
4777
47998
31
18
4497
45379
24
51
3358
33537
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.6e-01
4.7e-01
6.1e-01
3.4e+00
8.9e-01
4.9e-01
6.2e-01
cases:32.89%
controls:25.40%
cases:17.77%
controls:11.90%
cases:3.32%
controls:1.82%
cases:1.93%
controls:0.07%
cases:4.01%
controls:1.69%
cases:17.71%
controls:11.61%
cases:42.31%
controls:28.32%
1586
12246
3236
35961
857
5737
3965
42479
160
879
4662
47337
93
32
4729
48184
193
809
4614
47189
802
5271
3726
40126
1431
9513
1951
24075
Acetylcholine receptor Ab [Moles/volume] in Serum
20427-1 [3006257]
1.7e+00
2.1e+00
—
—
1.0e+50
1.7e+00
1.3e+00
cases:0.58%
controls:0.11%
cases:0.21%
controls:0.02%
—
—
—
—
cases:0.37%
controls:0.00%
cases:0.22%
controls:0.04%
cases:0.41%
controls:0.11%
28
54
4794
48153
10
12
4812
48204
—
—
18
0
4789
47998
10
18
4518
45379
14
37
3368
33551
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
6.0e-01
1.2e+00
—
—
2.0e+00
1.3e+00
1.6e+00
cases:0.77%
controls:0.42%
cases:0.46%
controls:0.14%
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.40%
controls:0.11%
cases:0.92%
controls:0.18%
37
203
4785
48004
22
68
4800
48148
—
—
10
13
4797
47985
18
48
4510
45349
31
60
3351
33528
Concussion
S06.0 [45582805]
6.9e-01
8.9e-01
2.1e+00
—
1.5e+00
8.0e-01
7.7e-01
cases:2.45%
controls:1.24%
cases:0.87%
controls:0.36%
cases:0.31%
controls:0.04%
—
—
cases:0.27%
controls:0.06%
cases:0.86%
controls:0.39%
cases:3.10%
controls:1.46%
118
600
4704
47607
42
174
4780
48042
15
18
4807
48198
—
13
29
4794
47969
39
176
4489
45221
105
492
3277
33096
Otolaryngology
4 [38004449]
5.6e-01
6.4e-01
1.1e+00
2.2e+00
1.0e+00
7.0e-01
5.4e-01
cases:19.97%
controls:12.49%
cases:8.05%
controls:4.42%
cases:1.87%
controls:0.65%
cases:0.31%
controls:0.03%
cases:2.04%
controls:0.74%
cases:8.41%
controls:4.38%
cases:19.22%
controls:12.14%
963
6023
3859
42184
388
2130
4434
46086
90
315
4732
47901
15
16
4807
48200
98
354
4709
47644
381
1988
4147
43409
650
4079
2732
29509
Glaucoma secondary to other eye disorders
H40.5 [45571978]
5.5e-01
1.2e+00
—
—
2.0e+00
1.7e+00
1.7e+00
cases:0.19%
controls:0.11%
cases:0.25%
controls:0.07%
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.49%
controls:0.09%
cases:0.80%
controls:0.15%
9
52
4813
48155
12
36
4810
48180
—
—
10
13
4797
47985
22
39
4506
45358
27
49
3355
33539
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
4.9e-01
3.9e-01
1.2e+00
3.3e+00
6.3e-01
7.2e-01
5.8e-01
cases:5.39%
controls:3.36%
cases:2.43%
controls:1.65%
cases:0.58%
controls:0.18%
cases:0.29%
controls:0.01%
cases:0.35%
controls:0.19%
cases:3.29%
controls:1.64%
cases:10.08%
controls:5.93%
260
1620
4562
46587
117
795
4705
47421
28
88
4794
48128
14
5
4808
48211
17
91
4790
47907
149
743
4379
44654
341
1993
3041
31595
Neurosurgery
14 [38004459]
5.6e-01
7.7e-01
1.4e+00
—
1.7e+00
1.3e+00
9.2e-01
cases:5.02%
controls:2.94%
cases:2.49%
controls:1.17%
cases:0.73%
controls:0.19%
—
—
cases:1.04%
controls:0.19%
cases:3.91%
controls:1.06%
cases:6.15%
controls:2.54%
242
1418
4580
46789
120
564
4702
47652
35
91
4787
48125
—
50
91
4757
47907
177
479
4351
44918
208
853
3174
32735
Cardiac arrhythmia, unspecified
I49.9 [45581778]
8.4e-01
1.0e+00
1.5e+00
—
1.5e+00
9.0e-01
8.3e-01
cases:4.42%
controls:1.95%
cases:1.60%
controls:0.59%
cases:0.25%
controls:0.06%
—
—
cases:0.25%
controls:0.05%
cases:1.50%
controls:0.61%
cases:4.55%
controls:2.04%
213
942
4609
47265
77
283
4745
47933
12
27
4810
48189
—
12
26
4795
47972
68
279
4460
45118
154
685
3228
32903
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
2.6e-01
3.6e-01
6.0e-01
3.6e+00
9.2e-01
3.8e-01
4.7e-01
cases:9.37%
controls:7.36%
cases:5.79%
controls:4.11%
cases:1.10%
controls:0.61%
cases:0.52%
controls:0.01%
cases:1.52%
controls:0.61%
cases:6.29%
controls:4.37%
cases:17.86%
controls:11.92%
452
3547
4370
44660
279
1980
4543
46236
53
292
4769
47924
25
7
4797
48209
73
292
4734
47706
285
1985
4243
43412
604
4005
2778
29583
X-ray examination of the lungs in one projection
GD1PA [2001303645]
6.3e-01
7.7e-01
1.6e+00
1.0e+50
2.0e+00
9.6e-01
6.9e-01
cases:2.12%
controls:1.14%
cases:0.95%
controls:0.44%
cases:0.23%
controls:0.05%
cases:0.35%
controls:0.00%
cases:0.27%
controls:0.04%
cases:1.10%
controls:0.43%
cases:3.31%
controls:1.70%
102
550
4720
47657
46
214
4776
48002
11
23
4811
48193
17
0
4805
48216
13
18
4794
47980
50
194
4478
45203
112
570
3270
33018
Chronic maxillary sinusitis
J32.0 [45586667]
7.1e-01
1.3e+00
1.5e+00
—
1.5e+00
8.8e-01
7.4e-01
cases:1.85%
controls:0.91%
cases:0.93%
controls:0.27%
cases:0.19%
controls:0.04%
—
—
cases:0.21%
controls:0.05%
cases:0.77%
controls:0.32%
cases:1.71%
controls:0.82%
89
441
4733
47766
45
128
4777
48088
9
20
4813
48196
—
10
23
4797
47975
35
146
4493
45251
58
277
3324
33311
Presence of intraocular lens
Z96.1 [45585885]
6.0e-01
6.9e-01
8.9e-01
—
2.3e+00
1.4e+00
7.4e-01
cases:3.67%
controls:2.06%
cases:1.93%
controls:0.98%
cases:0.50%
controls:0.21%
—
—
cases:1.62%
controls:0.17%
cases:3.78%
controls:0.99%
cases:6.09%
controls:2.99%
177
992
4645
47215
93
473
4729
47743
24
99
4798
48117
—
78
80
4729
47918
171
449
4357
44948
206
1005
3176
32583
Exophoria
H50.52 [2000502357]
1.9e+00
1.3e+00
—
—
—
3.0e+00
1.6e+00
cases:0.35%
controls:0.05%
cases:0.12%
controls:0.03%
—
—
—
—
—
—
cases:0.44%
controls:0.02%
cases:0.44%
controls:0.09%
17
25
4805
48182
6
16
4816
48200
—
—
—
20
10
4508
45387
15
29
3367
33559
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12480-0 [3009991]
1.3e+00
1.4e+00
—
—
1.0e+50
3.2e+00
2.0e+00
cases:0.44%
controls:0.12%
cases:0.15%
controls:0.04%
—
—
—
—
cases:0.42%
controls:0.00%
cases:0.53%
controls:0.02%
cases:0.50%
controls:0.07%
21
56
4801
48151
7
18
4815
48198
—
—
20
0
4787
47998
24
10
4504
45387
17
22
3365
33566
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 [40759883]
1.5e+00
1.3e+00
—
—
1.0e+50
3.4e+00
1.7e+00
cases:0.64%
controls:0.15%
cases:0.15%
controls:0.04%
—
—
—
—
cases:0.62%
controls:0.00%
cases:0.88%
controls:0.03%
cases:0.59%
controls:0.11%
31
71
4791
48136
7
19
4815
48197
—
—
30
0
4777
47998
40
14
4488
45383
20
37
3362
33551
Chest pain, unspecified
R07.4 [45558450]
7.9e-01
8.5e-01
1.5e+00
—
1.4e+00
1.0e+00
9.5e-01
cases:11.16%
controls:5.38%
cases:3.98%
controls:1.75%
cases:0.81%
controls:0.18%
—
—
cases:0.79%
controls:0.19%
cases:4.42%
controls:1.64%
cases:12.86%
controls:5.39%
538
2592
4284
45615
192
842
4630
47374
39
89
4783
48127
—
38
92
4769
47906
200
744
4328
44653
435
1812
2947
31776
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
5.9e-01
8.1e-01
1.6e+00
1.0e+50
2.0e+00
8.5e-01
7.1e-01
cases:4.23%
controls:2.39%
cases:1.82%
controls:0.82%
cases:0.46%
controls:0.10%
cases:0.85%
controls:0.00%
cases:0.52%
controls:0.07%
cases:1.61%
controls:0.70%
cases:4.29%
controls:2.15%
204
1153
4618
47054
88
394
4734
47822
22
46
4800
48170
41
0
4781
48216
25
35
4782
47963
73
317
4455
45080
145
722
3237
32866
Obesity due to excess calories
E66.01 [2000501501]
4.2e-01
5.3e-01
1.0e+00
3.3e+00
7.5e-01
6.4e-01
5.9e-01
cases:2.32%
controls:1.54%
cases:1.37%
controls:0.81%
cases:0.35%
controls:0.12%
cases:0.27%
controls:0.01%
cases:0.37%
controls:0.18%
cases:1.55%
controls:0.82%
cases:3.76%
controls:2.11%
112
740
4710
47467
66
392
4756
47824
17
60
4805
48156
13
5
4809
48211
18
85
4789
47913
70
372
4458
45025
127
710
3255
32878
Benign neoplasm: Pituitary gland
D35.2 [45581304]
7.7e-01
1.1e+00
-1.0e+50
—
2.3e+00
1.6e+00
1.5e+00
cases:0.29%
controls:0.13%
cases:0.29%
controls:0.10%
cases:0.00%
controls:0.02%
—
—
cases:0.21%
controls:0.02%
cases:0.51%
controls:0.10%
cases:0.74%
controls:0.17%
14
65
4808
48142
14
47
4808
48169
0
8
4822
48208
—
10
10
4797
47988
23
47
4505
45350
25
56
3357
33532
Proliferative diabetic retinopathy
H36.03 [2000502323]
1.3e+00
1.0e+00
—
—
2.5e+00
1.5e+00
1.2e+00
cases:0.41%
controls:0.11%
cases:0.23%
controls:0.08%
—
—
—
—
cases:0.25%
controls:0.02%
cases:0.40%
controls:0.09%
cases:0.56%
controls:0.16%
20
55
4802
48152
11
39
4811
48177
—
—
12
10
4795
47988
18
42
4510
45355
19
55
3363
33533
Glaucoma, unspecified
H40.9 [45547899]
5.5e-01
1.5e+00
2.1e+00
1.0e+50
2.1e+00
1.8e+00
1.1e+00
cases:0.25%
controls:0.14%
cases:0.27%
controls:0.06%
cases:0.10%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.15%
controls:0.02%
cases:0.44%
controls:0.07%
cases:0.65%
controls:0.22%
12
69
4810
48138
13
28
4809
48188
5
6
4817
48210
7
0
4815
48216
7
9
4800
47989
20
34
4508
45363
22
74
3360
33514
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.8e-01
2.2e-01
6.4e-01
3.7e+00
9.0e-01
3.8e-01
4.3e-01
cases:17.48%
controls:15.02%
cases:14.02%
controls:11.54%
cases:4.62%
controls:2.48%
cases:4.62%
controls:0.12%
cases:5.89%
controls:2.48%
cases:16.48%
controls:11.85%
cases:29.89%
controls:21.74%
843
7243
3979
40964
676
5565
4146
42651
223
1197
4599
47019
223
59
4599
48157
283
1189
4524
46809
746
5378
3782
40019
1011
7303
2371
26285
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
6.7e-01
9.1e-01
1.5e+00
—
1.7e+00
9.4e-01
7.1e-01
cases:6.66%
controls:3.51%
cases:2.80%
controls:1.14%
cases:0.71%
controls:0.16%
—
—
cases:0.71%
controls:0.13%
cases:2.92%
controls:1.16%
cases:7.13%
controls:3.64%
321
1692
4501
46515
135
551
4687
47665
34
75
4788
48141
—
34
64
4773
47934
132
527
4396
44870
241
1221
3141
32367
Remote contact by phone
ZYC01 [2001311579]
7.8e-01
7.3e-01
1.5e+00
1.0e+50
1.7e+00
9.8e-01
7.1e-01
cases:1.64%
controls:0.76%
cases:0.83%
controls:0.40%
cases:0.31%
controls:0.07%
cases:0.12%
controls:0.00%
cases:0.31%
controls:0.06%
cases:1.28%
controls:0.48%
cases:2.60%
controls:1.29%
79
367
4743
47840
40
194
4782
48022
15
33
4807
48183
6
0
4816
48216
15
28
4792
47970
58
219
4470
45178
88
434
3294
33154
Ambulatory ECG
XF404 [2001303370]
6.3e-01
9.3e-01
2.4e+00
—
1.5e+00
1.3e+00
1.1e+00
cases:2.59%
controls:1.40%
cases:0.75%
controls:0.30%
cases:0.19%
controls:0.02%
—
—
cases:0.12%
controls:0.03%
cases:0.97%
controls:0.26%
cases:2.22%
controls:0.77%
125
675
4697
47532
36
143
4786
48073
9
8
4813
48208
—
6
14
4801
47984
44
117
4484
45280
75
259
3307
33329
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
2.1e-01
9.1e-01
2.0e+00
—
1.6e+00
8.9e-01
9.1e-01
cases:0.85%
controls:0.69%
cases:0.60%
controls:0.24%
cases:0.19%
controls:0.02%
—
—
cases:0.23%
controls:0.05%
cases:0.53%
controls:0.22%
cases:1.80%
controls:0.74%
41
332
4781
47875
29
117
4793
48099
9
12
4813
48204
—
11
22
4796
47976
24
99
4504
45298
61
247
3321
33341
Cerebrospinal fluid IgG ratio and IgG index
1324000 [4027681]
1.4e+00
—
—
—
1.0e+50
3.3e+00
1.7e+00
cases:0.54%
controls:0.13%
—
—
—
—
—
—
cases:0.50%
controls:0.00%
cases:0.68%
controls:0.03%
cases:0.38%
controls:0.07%
26
65
4796
48142
—
—
—
24
0
4783
47998
31
12
4497
45385
13
24
3369
33564
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
6.8e-01
1.0e+00
2.0e+00
1.0e+50
2.4e+00
1.3e+00
9.7e-01
cases:1.80%
controls:0.92%
cases:0.73%
controls:0.27%
cases:0.10%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.21%
controls:0.02%
cases:0.51%
controls:0.15%
cases:1.60%
controls:0.61%
87
443
4735
47764
35
129
4787
48087
5
7
4817
48209
7
0
4815
48216
10
9
4797
47989
23
66
4505
45331
54
205
3328
33383
Optic atrophy
H47.2 [45543066]
1.6e+00
—
—
—
—
3.4e+00
2.9e+00
cases:0.10%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.01%
cases:0.53%
controls:0.03%
5
10
4817
48197
—
—
—
—
18
6
4510
45391
18
10
3364
33578
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
2.8e-01
3.7e-01
7.6e-01
2.6e+00
1.4e+00
4.3e-01
4.6e-01
cases:49.05%
controls:42.23%
cases:32.37%
controls:24.81%
cases:6.45%
controls:3.12%
cases:1.12%
controls:0.09%
cases:11.77%
controls:3.17%
cases:33.57%
controls:24.77%
cases:63.90%
controls:52.66%
2365
20356
2457
27851
1561
11964
3261
36252
311
1504
4511
46712
54
41
4768
48175
566
1521
4241
46477
1520
11246
3008
34151
2161
17689
1221
15899
Scheduled procedure
ZXD10 [2001311387]
5.7e-01
6.3e-01
1.2e+00
—
1.5e+00
1.3e+00
1.1e+00
cases:10.35%
controls:6.14%
cases:2.36%
controls:1.28%
cases:0.39%
controls:0.11%
—
—
cases:0.46%
controls:0.11%
cases:2.94%
controls:0.81%
cases:5.91%
controls:2.10%
499
2959
4323
45248
114
616
4708
47600
19
55
4803
48161
—
22
51
4785
47947
133
367
4395
45030
200
705
3182
32883
Appearance of Cerebral spinal fluid
10333-3 [3023410]
1.1e+00
1.5e+00
—
—
—
2.1e+00
1.6e+00
cases:0.71%
controls:0.23%
cases:0.31%
controls:0.07%
—
—
—
—
—
—
cases:0.55%
controls:0.07%
cases:0.86%
controls:0.17%
34
113
4788
48094
15
34
4807
48182
—
—
—
25
32
4503
45365
29
57
3353
33531
Laboratory Visit
OMOP4822461 [32036]
8.4e-02
2.7e-01
6.4e-01
3.8e+00
9.8e-01
4.0e-01
1.9e-01
cases:68.33%
controls:66.48%
cases:67.05%
controls:60.82%
cases:30.30%
controls:18.72%
cases:32.39%
controls:1.06%
cases:37.65%
controls:18.49%
cases:70.45%
controls:61.50%
cases:82.97%
controls:80.09%
3295
32048
1527
16159
3233
29327
1589
18889
1461
9024
3361
39192
1562
510
3260
47706
1810
8874
2997
39124
3190
27917
1338
17480
2806
26902
576
6686
Examination and observation for other specified reasons
Z04.8 [45552063]
7.9e-01
9.3e-01
1.4e+00
—
1.3e+00
9.9e-01
9.2e-01
cases:4.27%
controls:1.99%
cases:1.51%
controls:0.60%
cases:0.25%
controls:0.06%
—
—
cases:0.27%
controls:0.08%
cases:1.48%
controls:0.56%
cases:4.97%
controls:2.04%
206
959
4616
47248
73
291
4749
47925
12
30
4810
48186
—
13
37
4794
47961
67
252
4461
45145
168
685
3214
32903
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 [3024474]
1.5e+00
1.1e+00
—
1.0e+50
1.0e+50
3.3e+00
1.5e+00
cases:0.71%
controls:0.17%
cases:0.12%
controls:0.04%
—
—
cases:0.12%
controls:0.00%
cases:0.62%
controls:0.00%
cases:0.86%
controls:0.03%
cases:0.47%
controls:0.11%
34
80
4788
48127
6
21
4816
48195
—
6
0
4816
48216
30
0
4777
47998
39
14
4489
45383
16
37
3366
33551
pH of Urine
2756-5 [3015736]
2.1e-01
3.0e-01
6.1e-01
3.5e+00
9.0e-01
3.9e-01
3.8e-01
cases:15.76%
controls:13.21%
cases:8.69%
controls:6.57%
cases:1.74%
controls:0.96%
cases:0.85%
controls:0.03%
cases:2.35%
controls:0.97%
cases:9.50%
controls:6.64%
cases:25.61%
controls:19.05%
760
6366
4062
41841
419
3169
4403
45047
84
461
4738
47755
41
13
4781
48203
113
467
4694
47531
430
3015
4098
42382
866
6397
2516
27191
CT of neck arteries
PA6AD [2001308692]
1.5e+00
1.7e+00
—
1.0e+50
—
1.7e+00
1.4e+00
cases:0.91%
controls:0.21%
cases:0.71%
controls:0.13%
—
—
cases:3.17%
controls:0.00%
—
—
cases:0.66%
controls:0.13%
cases:2.31%
controls:0.56%
44
102
4778
48105
34
63
4788
48153
—
153
0
4669
48216
—
30
58
4498
45339
78
189
3304
33399
Sedation and analgesia
WX002 [2001310758]
4.8e-01
4.7e-01
1.2e+00
—
2.3e+00
1.0e+00
7.9e-01
cases:6.01%
controls:3.80%
cases:1.37%
controls:0.86%
cases:0.27%
controls:0.09%
—
—
cases:0.64%
controls:0.06%
cases:1.94%
controls:0.70%
cases:4.88%
controls:2.27%
290
1831
4532
46376
66
416
4756
47800
13
41
4809
48175
—
31
31
4776
47967
88
318
4440
45079
165
763
3217
32825
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 [3007368]
1.4e+00
1.2e+00
—
1.0e+50
1.0e+50
3.3e+00
1.6e+00
cases:0.71%
controls:0.17%
cases:0.15%
controls:0.05%
—
—
cases:0.12%
controls:0.00%
cases:0.64%
controls:0.00%
cases:0.91%
controls:0.04%
cases:0.53%
controls:0.11%
34
82
4788
48125
7
22
4815
48194
—
6
0
4816
48216
31
0
4776
47998
41
16
4487
45381
18
38
3364
33550
Sleep apnoea
G47.3 [45562094]
3.7e-01
4.5e-01
5.3e-01
3.1e+00
7.0e-01
5.0e-01
5.6e-01
cases:8.63%
controls:6.11%
cases:6.06%
controls:3.95%
cases:1.35%
controls:0.80%
cases:1.16%
controls:0.05%
cases:1.64%
controls:0.82%
cases:6.25%
controls:3.90%
cases:12.18%
controls:7.34%
416
2945
4406
45262
292
1905
4530
46311
65
384
4757
47832
56
26
4766
48190
79
394
4728
47604
283
1769
4245
43628
412
2467
2970
31121
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
2.9e-01
4.3e-01
8.0e-01
2.4e+00
1.1e+00
5.7e-01
5.4e-01
cases:18.21%
controls:14.27%
cases:10.99%
controls:7.44%
cases:2.47%
controls:1.13%
cases:0.56%
controls:0.05%
cases:3.47%
controls:1.15%
cases:12.17%
controls:7.26%
cases:27.26%
controls:17.90%
878
6881
3944
41326
530
3586
4292
44630
119
543
4703
47673
27
24
4795
48192
167
553
4640
47445
551
3295
3977
42102
922
6012
2460
27576
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
157 [2001600155]
1.1e+00
—
—
—
—
4.0e+00
2.2e+00
cases:0.15%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.01%
cases:0.21%
controls:0.02%
7
23
4815
48184
—
—
—
—
33
6
4495
45391
7
8
3375
33580
Other chronic pain
R52.2 [45568139]
9.5e-01
1.1e+00
1.9e+00
—
1.0e+00
1.2e+00
9.6e-01
cases:0.97%
controls:0.38%
cases:0.41%
controls:0.14%
cases:0.15%
controls:0.02%
—
—
cases:0.10%
controls:0.04%
cases:0.49%
controls:0.15%
cases:1.24%
controls:0.48%
47
183
4775
48024
20
66
4802
48150
7
10
4815
48206
—
5
18
4802
47980
22
66
4506
45331
42
161
3340
33427
Other psychiatric treatment contact
IGY99 [2001304323]
8.6e-01
9.6e-01
—
—
1.8e+00
1.4e+00
1.1e+00
cases:0.62%
controls:0.26%
cases:0.35%
controls:0.13%
—
—
—
—
cases:0.15%
controls:0.03%
cases:0.44%
controls:0.11%
cases:1.01%
controls:0.32%
30
127
4792
48080
17
65
4805
48151
—
—
7
12
4800
47986
20
50
4508
45347
34
108
3348
33480
12 lead EKG panel
34534-8 [3044889]
2.7e-01
2.2e-01
7.6e-01
2.7e+00
1.3e+00
3.7e-01
4.7e-01
cases:34.40%
controls:28.61%
cases:16.94%
controls:14.08%
cases:3.55%
controls:1.68%
cases:0.85%
controls:0.06%
cases:5.49%
controls:1.55%
cases:18.18%
controls:13.28%
cases:43.73%
controls:32.77%
1659
13790
3163
34417
817
6790
4005
41426
171
812
4651
47404
41
27
4781
48189
264
745
4543
47253
823
6028
3705
39369
1479
11007
1903
22581
Bacteria identified in Urine by Culture
630-4 [3026008]
3.1e-01
3.7e-01
6.4e-01
3.2e+00
7.7e-01
3.4e-01
4.8e-01
cases:12.30%
controls:9.35%
cases:6.26%
controls:4.40%
cases:1.20%
controls:0.64%
cases:0.50%
controls:0.02%
cases:1.21%
controls:0.56%
cases:6.38%
controls:4.61%
cases:19.31%
controls:12.86%
593
4508
4229
43699
302
2123
4520
46093
58
308
4764
47908
24
10
4798
48206
58
271
4749
47727
289
2094
4239
43303
653
4318
2729
29270
Spinal stenosis
M48.0 [45557888]
4.9e-01
5.6e-01
5.2e-01
3.3e+00
8.2e-01
4.7e-01
4.6e-01
cases:3.80%
controls:2.36%
cases:1.93%
controls:1.11%
cases:0.37%
controls:0.22%
cases:0.33%
controls:0.01%
cases:0.48%
controls:0.21%
cases:1.86%
controls:1.17%
cases:4.26%
controls:2.73%
183
1136
4639
47071
93
537
4729
47679
18
107
4804
48109
16
6
4806
48210
23
101
4784
47897
84
532
4444
44865
144
917
3238
32671
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
2.2e-01
7.0e-01
1.0e+00
2.5e+00
9.0e-01
5.3e-01
4.4e-01
cases:2.99%
controls:2.42%
cases:2.45%
controls:1.23%
cases:0.83%
controls:0.30%
cases:0.27%
controls:0.02%
cases:0.75%
controls:0.31%
cases:2.23%
controls:1.32%
cases:4.35%
controls:2.84%
144
1165
4678
47042
118
592
4704
47624
40
143
4782
48073
13
11
4809
48205
36
147
4771
47851
101
601
4427
44796
147
954
3235
32634
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
4.8e-01
6.0e-01
6.9e-01
—
2.6e+00
1.5e+00
9.1e-01
cases:1.95%
controls:1.22%
cases:0.87%
controls:0.48%
cases:0.15%
controls:0.07%
—
—
cases:0.87%
controls:0.07%
cases:1.61%
controls:0.37%
cases:2.81%
controls:1.15%
94
588
4728
47619
42
232
4780
47984
7
35
4815
48181
—
42
32
4765
47966
73
169
4455
45228
95
386
3287
33202
Acute and subacute iridocyclitis
H20.0 [45542994]
9.0e-01
7.0e-01
1.1e+00
1.0e+50
2.6e+00
1.5e+00
1.1e+00
cases:1.24%
controls:0.51%
cases:0.39%
controls:0.20%
cases:0.10%
controls:0.04%
cases:0.27%
controls:0.00%
cases:0.48%
controls:0.04%
cases:0.80%
controls:0.18%
cases:1.33%
controls:0.45%
60
245
4762
47962
19
95
4803
48121
5
17
4817
48199
13
0
4809
48216
23
18
4784
47980
36
82
4492
45315
45
150
3337
33438
MRI examination of neck vasculature with high intensity magnet
PA6BG [2001308699]
1.5e+00
—
—
—
—
2.8e+00
1.8e+00
cases:0.21%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.18%
controls:0.01%
cases:0.21%
controls:0.04%
10
23
4812
48184
—
—
—
—
8
5
4520
45392
7
12
3375
33576
Other migraine
G43.8 [45595941]
6.5e-01
—
—
1.0e+50
3.1e+00
1.7e+00
1.2e+00
cases:0.29%
controls:0.15%
—
—
—
—
cases:0.15%
controls:0.00%
cases:0.23%
controls:0.01%
cases:0.42%
controls:0.08%
cases:0.68%
controls:0.20%
14
73
4808
48134
—
—
7
0
4815
48216
11
5
4796
47993
19
35
4509
45362
23
68
3359
33520
Bilateral
ZXA10 [2001311348]
3.6e-01
8.3e-01
1.2e+00
—
2.5e+00
1.6e+00
7.4e-01
cases:4.11%
controls:2.90%
cases:1.58%
controls:0.69%
cases:0.21%
controls:0.06%
—
—
cases:0.67%
controls:0.06%
cases:2.72%
controls:0.56%
cases:3.37%
controls:1.64%
198
1400
4624
46807
76
335
4746
47881
10
30
4812
48186
—
32
27
4775
47971
123
254
4405
45143
114
551
3268
33037
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
2.5e-01
3.2e-01
5.5e-01
3.3e+00
7.8e-01
3.9e-01
3.8e-01
cases:19.97%
controls:16.32%
cases:11.74%
controls:8.84%
cases:2.20%
controls:1.28%
cases:1.08%
controls:0.04%
cases:2.93%
controls:1.37%
cases:13.18%
controls:9.34%
cases:32.94%
controls:25.21%
963
7868
3859
40339
566
4260
4256
43956
106
619
4716
47597
52
19
4770
48197
141
659
4666
47339
597
4242
3931
41155
1114
8467
2268
25121
Cerebral aneurysm, nonruptured
I67.1 [45538401]
1.6e-01
1.0e+00
—
—
2.3e+00
1.7e+00
9.2e-01
cases:0.33%
controls:0.28%
cases:0.39%
controls:0.14%
—
—
—
—
cases:0.29%
controls:0.03%
cases:0.80%
controls:0.14%
cases:0.71%
controls:0.28%
16
137
4806
48070
19
69
4803
48147
—
—
14
14
4793
47984
36
65
4492
45332
24
95
3358
33493
Atypical facial pain
G50.1 [45542894]
1.2e+00
1.5e+00
—
—
—
2.0e+00
1.3e+00
cases:0.68%
controls:0.21%
cases:0.21%
controls:0.05%
—
—
—
—
—
—
cases:0.29%
controls:0.04%
cases:0.59%
controls:0.17%
33
99
4789
48108
10
22
4812
48194
—
—
—
13
18
4515
45379
20
57
3362
33531
Other bipolar affective disorders
F31.8 [45586237]
7.1e-01
1.0e+00
1.7e+00
—
1.6e+00
8.8e-01
9.8e-01
cases:0.60%
controls:0.30%
cases:0.41%
controls:0.15%
cases:0.25%
controls:0.05%
—
—
cases:0.25%
controls:0.05%
cases:0.35%
controls:0.15%
cases:0.65%
controls:0.24%
29
143
4793
48064
20
72
4802
48144
12
23
4810
48193
—
12
25
4795
47973
16
67
4512
45330
22
82
3360
33506
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
2.5e-01
3.0e-01
5.2e-01
3.3e+00
7.7e-01
3.8e-01
3.8e-01
cases:20.59%
controls:16.87%
cases:11.95%
controls:9.11%
cases:2.18%
controls:1.30%
cases:1.10%
controls:0.04%
cases:2.97%
controls:1.40%
cases:13.34%
controls:9.50%
cases:33.29%
controls:25.52%
993
8133
3829
40074
576
4391
4246
43825
105
627
4717
47589
53
19
4769
48197
143
672
4664
47326
604
4313
3924
41084
1126
8570
2256
25018
Pharmacy visit
OMOP4822462 [581458]
9.1e-01
7.5e-01
4.5e-01
8.1e-01
7.3e-01
1.0e+00
1.2e+00
cases:98.76%
controls:96.95%
cases:94.98%
controls:89.92%
cases:64.64%
controls:53.79%
cases:6.01%
controls:2.76%
cases:70.42%
controls:53.53%
cases:96.18%
controls:89.86%
cases:99.14%
controls:97.13%
4762
46738
60
1469
4580
43358
242
4858
3117
25933
1705
22283
290
1329
4532
46887
3385
25695
1422
22303
4355
40793
173
4604
3353
32624
29
964
Disorders of optic nerve, not elsewhere classified
H47.0 [45586485]
2.7e+00
2.1e+00
—
1.0e+50
—
—
3.2e+00
cases:0.25%
controls:0.02%
cases:0.10%
controls:0.01%
—
—
cases:0.10%
controls:0.00%
—
—
—
—
cases:0.44%
controls:0.02%
12
8
4810
48199
5
6
4817
48210
—
5
0
4817
48216
—
—
15
6
3367
33582
Post-traumatic stress disorder
F43.1 [45595909]
7.6e-01
1.2e+00
1.5e+00
—
1.3e+00
1.3e+00
1.2e+00
cases:0.62%
controls:0.29%
cases:0.46%
controls:0.14%
cases:0.25%
controls:0.06%
—
—
cases:0.17%
controls:0.05%
cases:0.64%
controls:0.17%
cases:1.18%
controls:0.37%
30
141
4792
48066
22
69
4800
48147
12
27
4810
48189
—
8
22
4799
47976
29
77
4499
45320
40
124
3342
33464
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
9.2e-01
1.3e+00
—
1.0e+50
—
2.3e+00
1.4e+00
cases:0.64%
controls:0.26%
cases:0.25%
controls:0.07%
—
—
cases:0.15%
controls:0.00%
—
—
cases:0.75%
controls:0.08%
cases:1.01%
controls:0.24%
31
124
4791
48083
12
33
4810
48183
—
7
0
4815
48216
—
34
36
4494
45361
34
80
3348
33508
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2.4e-01
3.0e-01
5.3e-01
3.3e+00
7.7e-01
3.8e-01
3.7e-01
cases:20.28%
controls:16.64%
cases:11.76%
controls:9.00%
cases:2.20%
controls:1.30%
cases:1.08%
controls:0.04%
cases:2.95%
controls:1.40%
cases:13.27%
controls:9.47%
cases:33.03%
controls:25.49%
978
8022
3844
40185
567
4341
4255
43875
106
628
4716
47588
52
19
4770
48197
142
670
4665
47328
601
4299
3927
41098
1117
8563
2265
25025
Visual field testing with Humphrey automated perimetry
CS434 [2001301476]
5.7e-01
8.1e-01
—
1.0e+50
3.2e+00
1.9e+00
8.0e-01
cases:0.54%
controls:0.31%
cases:0.44%
controls:0.19%
—
—
cases:0.35%
controls:0.00%
cases:0.64%
controls:0.03%
cases:1.33%
controls:0.20%
cases:1.15%
controls:0.52%
26
148
4796
48059
21
94
4801
48122
—
17
0
4805
48216
31
13
4776
47985
60
90
4468
45307
39
175
3343
33413
Respiratory and circulatory monitoring
WX700 [2001310817]
6.2e-01
6.7e-01
1.3e+00
1.0e+50
1.4e+00
1.1e+00
8.0e-01
cases:5.18%
controls:2.85%
cases:1.58%
controls:0.81%
cases:0.33%
controls:0.09%
cases:0.19%
controls:0.00%
cases:0.35%
controls:0.09%
cases:2.12%
controls:0.71%
cases:4.70%
controls:2.17%
250
1374
4572
46833
76
391
4746
47825
16
44
4806
48172
9
0
4813
48216
17
43
4790
47955
96
323
4432
45074
159
730
3223
32858
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
7.5e-01
9.7e-01
1.3e+00
—
2.0e+00
1.1e+00
9.8e-01
cases:0.89%
controls:0.43%
cases:0.52%
controls:0.20%
cases:0.12%
controls:0.04%
—
—
cases:0.27%
controls:0.04%
cases:0.66%
controls:0.23%
cases:1.71%
controls:0.65%
43
205
4779
48002
25
95
4797
48121
6
17
4816
48199
—
13
17
4794
47981
30
105
4498
45292
58
219
3324
33369
General Surgery
2 [38004447]
3.9e-01
3.9e-01
4.9e-01
3.0e+00
8.3e-01
6.5e-01
5.2e-01
cases:18.91%
controls:13.60%
cases:5.47%
controls:3.79%
cases:0.81%
controls:0.50%
cases:0.37%
controls:0.02%
cases:1.04%
controls:0.46%
cases:5.96%
controls:3.20%
cases:15.32%
controls:9.75%
912
6556
3910
41651
264
1827
4558
46389
39
240
4783
47976
18
9
4804
48207
50
219
4757
47779
270
1452
4258
43945
518
3275
2864
30313
Cervicobrachial syndrome
M53.1 [45567577]
5.9e-01
5.8e-01
1.7e+00
—
1.4e+00
9.2e-01
6.2e-01
cases:3.30%
controls:1.86%
cases:0.95%
controls:0.54%
cases:0.25%
controls:0.05%
—
—
cases:0.23%
controls:0.06%
cases:1.26%
controls:0.50%
cases:3.70%
controls:2.02%
159
897
4663
47310
46
258
4776
47958
12
23
4810
48193
—
11
27
4796
47971
57
229
4471
45168
125
677
3257
32911
Benign paroxysmal vertigo
H81.1 [45572061]
6.2e-01
8.1e-01
1.6e+00
1.0e+50
1.4e+00
7.7e-01
5.6e-01
cases:2.80%
controls:1.52%
cases:1.10%
controls:0.49%
cases:0.31%
controls:0.06%
cases:0.35%
controls:0.00%
cases:0.21%
controls:0.05%
cases:1.06%
controls:0.50%
cases:3.25%
controls:1.88%
135
733
4687
47474
53
238
4769
47978
15
31
4807
48185
17
0
4805
48216
10
24
4797
47974
48
225
4480
45172
110
630
3272
32958
Sixth [abducent] nerve palsy
H49.2 [45557451]
1.5e+00
—
—
—
—
3.0e+00
2.8e+00
cases:0.15%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.27%
controls:0.01%
cases:0.33%
controls:0.02%
7
16
4815
48191
—
—
—
—
12
6
4516
45391
11
7
3371
33581
Specialised imaging for glaucoma
CS5Z4 [2001301479]
1.5e-01
5.4e-01
—
1.0e+50
3.1e+00
1.8e+00
8.6e-01
cases:0.35%
controls:0.30%
cases:0.33%
controls:0.19%
—
—
cases:0.48%
controls:0.00%
cases:0.46%
controls:0.02%
cases:1.08%
controls:0.18%
cases:1.09%
controls:0.47%
17
146
4805
48061
16
93
4806
48123
—
23
0
4799
48216
22
10
4785
47988
49
82
4479
45315
37
157
3345
33431
Hospital outpatient
ZY010 [2001311599]
6.0e-01
8.7e-01
1.1e+00
—
1.2e+00
1.0e+00
9.0e-01
cases:1.56%
controls:0.86%
cases:0.75%
controls:0.32%
cases:0.29%
controls:0.10%
—
—
cases:0.35%
controls:0.10%
cases:0.82%
controls:0.29%
cases:1.33%
controls:0.55%
75
414
4747
47793
36
152
4786
48064
14
47
4808
48169
—
17
49
4790
47949
37
133
4491
45264
45
184
3337
33404
Fluorescein angiography (FAG) of choroid and retina
CK9F4 [2001301459]
1.2e+00
—
—
1.0e+50
—
2.6e+00
1.9e+00
cases:0.25%
controls:0.07%
—
—
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.18%
controls:0.01%
cases:0.30%
controls:0.04%
12
35
4810
48172
—
—
6
0
4816
48216
—
8
6
4520
45391
10
15
3372
33573
Lumbar puncture
TAB00 [2001300538]
9.9e-01
1.2e+00
1.7e+00
1.0e+50
—
2.7e+00
8.4e-01
cases:1.35%
controls:0.51%
cases:0.37%
controls:0.11%
cases:0.10%
controls:0.02%
cases:0.35%
controls:0.00%
—
—
cases:1.06%
controls:0.07%
cases:0.71%
controls:0.31%
65
244
4757
47963
18
53
4804
48163
5
9
4817
48207
17
0
4805
48216
—
48
34
4480
45363
24
103
3358
33485
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]
1.3e+00
2.1e+00
—
1.0e+50
1.0e+50
—
2.3e+00
cases:0.46%
controls:0.13%
cases:0.12%
controls:0.01%
—
—
cases:0.12%
controls:0.00%
cases:0.10%
controls:0.00%
—
—
cases:0.21%
controls:0.02%
22
63
4800
48144
6
7
4816
48209
—
6
0
4816
48216
5
0
4802
47998
—
7
7
3375
33581
acetylsalicylic acid; oral
B01AC06 [21600991]
4.9e-01
4.8e-01
4.5e-01
1.9e+00
1.3e+00
8.5e-01
6.7e-01
cases:5.39%
controls:3.39%
cases:3.44%
controls:2.17%
cases:1.24%
controls:0.79%
cases:0.21%
controls:0.03%
cases:2.58%
controls:0.74%
cases:4.97%
controls:2.19%
cases:7.75%
controls:4.13%
260
1632
4562
46575
166
1044
4656
47172
60
383
4762
47833
10
15
4812
48201
124
356
4683
47642
225
993
4303
44404
262
1386
3120
32202
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
1.9e-01
3.1e-01
7.0e-01
2.6e+00
7.2e-01
5.9e-01
5.5e-01
cases:11.90%
controls:10.08%
cases:5.12%
controls:3.80%
cases:0.87%
controls:0.43%
cases:0.37%
controls:0.03%
cases:0.89%
controls:0.44%
cases:5.61%
controls:3.17%
cases:15.85%
controls:9.82%
574
4858
4248
43349
247
1834
4575
46382
42
209
4780
48007
18
14
4804
48202
43
211
4764
47787
254
1441
4274
43956
536
3298
2846
30290
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
1.3e-01
2.4e-01
5.4e-01
2.6e+00
1.6e+00
3.1e-01
1.9e-01
cases:46.31%
controls:43.01%
cases:26.01%
controls:21.64%
cases:4.27%
controls:2.54%
cases:0.93%
controls:0.07%
cases:10.26%
controls:2.26%
cases:26.39%
controls:20.82%
cases:52.63%
controls:47.84%
2233
20736
2589
27471
1254
10434
3568
37782
206
1223
4616
46993
45
34
4777
48182
493
1084
4314
46914
1195
9452
3333
35945
1780
16067
1602
17521
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
2.3e-01
2.8e-01
6.1e-01
3.0e+00
5.7e-01
4.5e-01
4.3e-01
cases:18.13%
controls:14.93%
cases:7.57%
controls:5.85%
cases:1.29%
controls:0.71%
cases:0.66%
controls:0.03%
cases:1.12%
controls:0.64%
cases:7.44%
controls:4.89%
cases:22.00%
controls:15.50%
874
7199
3948
41008
365
2822
4457
45394
62
340
4760
47876
32
16
4790
48200
54
306
4753
47692
337
2218
4191
43179
744
5206
2638
28382
Anxiety disorder, unspecified
F41.9 [45542849]
5.2e-01
8.1e-01
1.2e+00
—
1.4e+00
9.2e-01
6.5e-01
cases:2.65%
controls:1.60%
cases:1.51%
controls:0.68%
cases:0.50%
controls:0.15%
—
—
cases:0.50%
controls:0.12%
cases:1.63%
controls:0.66%
cases:4.02%
controls:2.14%
128
771
4694
47436
73
327
4749
47889
24
70
4798
48146
—
24
58
4783
47940
74
300
4454
45097
136
719
3246
32869
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.7e-01
2.7e-01
5.7e-01
2.6e+00
1.1e+00
4.2e-01
3.8e-01
cases:57.36%
controls:53.19%
cases:45.62%
controls:38.94%
cases:11.49%
controls:6.85%
cases:3.84%
controls:0.29%
cases:17.60%
controls:6.88%
cases:49.34%
controls:38.98%
cases:75.25%
controls:67.47%
2766
25643
2056
22564
2200
18774
2622
29442
554
3303
4268
44913
185
138
4637
48078
846
3300
3961
44698
2234
17695
2294
27702
2545
22661
837
10927
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
9.5e-01
1.1e+00
1.6e+00
—
—
2.2e+00
1.2e+00
cases:1.27%
controls:0.49%
cases:0.44%
controls:0.15%
cases:0.12%
controls:0.02%
—
—
—
—
cases:1.13%
controls:0.12%
cases:1.66%
controls:0.48%
61
237
4761
47970
21
71
4801
48145
6
12
4816
48204
—
—
51
56
4477
45341
56
162
3326
33426
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2.3e-01
2.7e-01
6.5e-01
2.9e+00
7.0e-01
3.0e-01
5.0e-01
cases:12.51%
controls:10.24%
cases:6.03%
controls:4.65%
cases:1.35%
controls:0.71%
cases:0.39%
controls:0.02%
cases:1.44%
controls:0.72%
cases:6.10%
controls:4.58%
cases:18.81%
controls:12.31%
603
4938
4219
43269
291
2243
4531
45973
65
342
4757
47874
19
11
4803
48205
69
344
4738
47654
276
2081
4252
43316
636
4135
2746
29453
Physiotherapy
R4110 [2001310233]
3.6e-01
6.2e-01
1.2e+00
—
1.6e+00
8.8e-01
7.8e-01
cases:8.73%
controls:6.27%
cases:3.80%
controls:2.07%
cases:0.87%
controls:0.26%
—
—
cases:1.06%
controls:0.21%
cases:4.00%
controls:1.70%
cases:10.50%
controls:5.09%
421
3024
4401
45183
183
999
4639
47217
42
123
4780
48093
—
51
103
4756
47895
181
774
4347
44623
355
1709
3027
31879
Accelerated psychiatric treatment contact
IGY01 [2001304321]
9.0e-01
8.3e-01
1.8e+00
—
1.3e+00
1.1e+00
8.9e-01
cases:0.75%
controls:0.30%
cases:0.46%
controls:0.20%
cases:0.21%
controls:0.04%
—
—
cases:0.12%
controls:0.04%
cases:0.57%
controls:0.20%
cases:1.18%
controls:0.49%
36
147
4786
48060
22
96
4800
48120
10
17
4812
48199
—
6
17
4801
47981
26
90
4502
45307
40
164
3342
33424
Aortic (valve) stenosis
I35.0 [45576869]
5.4e-01
7.9e-01
1.7e+00
—
1.1e+00
7.1e-01
6.7e-01
cases:1.85%
controls:1.08%
cases:1.47%
controls:0.68%
cases:0.50%
controls:0.09%
—
—
cases:0.33%
controls:0.12%
cases:1.37%
controls:0.68%
cases:2.69%
controls:1.40%
89
522
4733
47685
71
326
4751
47890
24
44
4798
48172
—
16
56
4791
47942
62
307
4466
45090
91
469
3291
33119
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
5.7e-01
7.3e-01
1.6e+00
—
1.2e+00
8.0e-01
5.8e-01
cases:3.24%
controls:1.85%
cases:1.78%
controls:0.86%
cases:0.41%
controls:0.08%
—
—
cases:0.27%
controls:0.09%
cases:1.86%
controls:0.84%
cases:5.32%
controls:3.06%
156
893
4666
47314
86
417
4736
47799
20
40
4802
48176
—
13
41
4794
47957
84
381
4444
45016
180
1029
3202
32559
Headache
R51 [45558474]
9.2e-01
1.3e+00
2.2e+00
—
1.7e+00
5.3e-01
9.6e-01
cases:1.47%
controls:0.59%
cases:0.64%
controls:0.17%
cases:0.27%
controls:0.03%
—
—
cases:0.10%
controls:0.02%
cases:0.40%
controls:0.23%
cases:1.80%
controls:0.70%
71
286
4751
47921
31
83
4791
48133
13
14
4809
48202
—
5
9
4802
47989
18
106
4510
45291
61
235
3321
33353
Other cerebral infarction
I63.8 [45605810]
1.2e+00
2.1e+00
—
—
—
1.8e+00
1.6e+00
cases:0.17%
controls:0.05%
cases:0.15%
controls:0.02%
—
—
—
—
—
—
cases:0.18%
controls:0.03%
cases:0.27%
controls:0.06%
8
24
4814
48183
7
9
4815
48207
—
—
—
8
13
4520
45384
9
19
3373
33569
Other specified special examinations
Z01.8 [45581003]
5.2e-01
7.2e-01
1.2e+00
—
1.5e+00
8.8e-01
5.4e-01
cases:6.01%
controls:3.67%
cases:2.07%
controls:1.02%
cases:0.39%
controls:0.11%
—
—
cases:0.54%
controls:0.12%
cases:2.43%
controls:1.03%
cases:6.30%
controls:3.76%
290
1771
4532
46436
100
493
4722
47723
19
55
4803
48161
—
26
57
4781
47941
110
466
4418
44931
213
1262
3169
32326
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
3.7e-01
7.3e-01
1.0e+00
—
1.8e+00
8.3e-01
6.5e-01
cases:5.60%
controls:3.94%
cases:2.57%
controls:1.25%
cases:0.33%
controls:0.12%
—
—
cases:0.77%
controls:0.13%
cases:2.54%
controls:1.13%
cases:7.63%
controls:4.12%
270
1898
4552
46309
124
603
4698
47613
16
59
4806
48157
—
37
61
4770
47937
115
511
4413
44886
258
1385
3124
32203
Telehealth
OMOP5556618 [722455]
2.6e-01
3.2e-01
7.6e-01
2.6e+00
6.7e-01
4.3e-01
3.9e-01
cases:41.35%
controls:35.28%
cases:15.93%
controls:12.11%
cases:4.27%
controls:2.04%
cases:1.24%
controls:0.10%
cases:3.85%
controls:2.00%
cases:15.28%
controls:10.50%
cases:28.12%
controls:20.91%
1994
17007
2828
31200
768
5840
4054
42376
206
984
4616
47232
60
47
4762
48169
185
961
4622
47037
692
4765
3836
40632
951
7023
2431
26565
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
2.3e-01
2.8e-01
5.4e-01
3.1e+00
6.9e-01
3.3e-01
2.4e-01
cases:16.80%
controls:13.83%
cases:8.69%
controls:6.73%
cases:1.62%
controls:0.95%
cases:0.77%
controls:0.04%
cases:2.02%
controls:1.02%
cases:9.10%
controls:6.73%
cases:22.06%
controls:18.24%
810
6666
4012
41541
419
3243
4403
44973
78
458
4744
47758
37
17
4785
48199
97
491
4710
47507
412
3055
4116
42342
746
6125
2636
27463
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
5.8e-01
5.8e-01
2.0e+00
—
1.7e+00
5.8e-01
2.4e-01
cases:2.41%
controls:1.36%
cases:1.31%
controls:0.73%
cases:0.48%
controls:0.07%
—
—
cases:0.50%
controls:0.10%
cases:1.39%
controls:0.78%
cases:3.61%
controls:2.86%
116
656
4706
47551
63
353
4759
47863
23
32
4799
48184
—
24
46
4783
47952
63
355
4465
45042
122
959
3260
32629
lamotrigine; oral
N03AX09 [21604431]
7.1e-01
7.1e-01
1.1e+00
—
1.2e+00
7.4e-01
8.9e-01
cases:1.56%
controls:0.77%
cases:0.85%
controls:0.42%
cases:0.37%
controls:0.12%
—
—
cases:0.42%
controls:0.13%
cases:0.88%
controls:0.42%
cases:1.95%
controls:0.81%
75
371
4747
47836
41
203
4781
48013
18
58
4804
48158
—
20
61
4787
47937
40
192
4488
45205
66
271
3316
33317
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 [3014973]
1.1e+00
1.2e+00
—
1.0e+50
1.0e+50
2.7e+00
1.5e+00
cases:0.77%
controls:0.25%
cases:0.21%
controls:0.06%
—
—
cases:0.15%
controls:0.00%
cases:0.60%
controls:0.00%
cases:0.68%
controls:0.04%
cases:0.71%
controls:0.16%
37
122
4785
48085
10
30
4812
48186
—
7
0
4815
48216
29
0
4778
47998
31
20
4497
45377
24
53
3358
33535
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
6.6e-01
6.0e-01
1.2e+00
1.9e+00
9.3e-01
7.0e-01
8.4e-01
cases:1.47%
controls:0.76%
cases:0.66%
controls:0.37%
cases:0.37%
controls:0.11%
cases:0.15%
controls:0.02%
cases:0.29%
controls:0.11%
cases:0.75%
controls:0.37%
cases:1.86%
controls:0.82%
71
368
4751
47839
32
177
4790
48039
18
53
4804
48163
7
10
4815
48206
14
55
4793
47943
34
170
4494
45227
63
274
3319
33314
Psychiatric treatment plan, standard
ICB01 [2001304098]
6.4e-01
1.0e+00
1.6e+00
—
2.1e+00
8.7e-01
8.1e-01
cases:0.81%
controls:0.43%
cases:0.54%
controls:0.20%
cases:0.10%
controls:0.02%
—
—
cases:0.15%
controls:0.02%
cases:0.53%
controls:0.22%
cases:1.42%
controls:0.64%
39
207
4783
48000
26
96
4796
48120
5
10
4817
48206
—
7
9
4800
47989
24
101
4504
45296
48
214
3334
33374
Bacteria identified in Blood by Culture
600-7 [3023368]
3.7e-01
2.9e-01
7.5e-01
3.0e+00
4.6e-01
4.5e-01
5.0e-01
cases:9.50%
controls:6.77%
cases:4.00%
controls:3.02%
cases:0.85%
controls:0.40%
cases:0.29%
controls:0.01%
cases:0.67%
controls:0.42%
cases:4.66%
controls:3.01%
cases:14.49%
controls:9.34%
458
3262
4364
44945
193
1455
4629
46761
41
194
4781
48022
14
7
4808
48209
32
202
4775
47796
211
1367
4317
44030
490
3138
2892
30450
Sensorineural hearing loss, bilateral
H90.3 [45576850]
2.6e-01
4.2e-01
5.7e-01
3.3e+00
9.8e-01
4.5e-01
1.2e-01
cases:4.71%
controls:3.68%
cases:2.26%
controls:1.49%
cases:0.37%
controls:0.21%
cases:0.27%
controls:0.01%
cases:0.56%
controls:0.21%
cases:2.63%
controls:1.70%
cases:4.97%
controls:4.44%
227
1774
4595
46433
109
720
4713
47496
18
102
4804
48114
13
5
4809
48211
27
102
4780
47896
119
771
4409
44626
168
1490
3214
32098
methylprednisolone; oral, parenteral
H02AB04 [21602732]
5.6e-01
9.0e-01
1.4e+00
—
1.1e+00
8.0e-01
6.1e-01
cases:2.61%
controls:1.51%
cases:1.33%
controls:0.54%
cases:0.31%
controls:0.08%
—
—
cases:0.33%
controls:0.11%
cases:1.17%
controls:0.53%
cases:2.10%
controls:1.16%
126
729
4696
47478
64
261
4758
47955
15
38
4807
48178
—
16
53
4791
47945
53
241
4475
45156
71
388
3311
33200
Assessment of vision
XCW10 [2001301503]
7.1e-01
2.4e-01
—
1.0e+50
2.9e+00
1.7e+00
7.1e-01
cases:0.21%
controls:0.10%
cases:0.15%
controls:0.11%
—
—
cases:0.15%
controls:0.00%
cases:0.33%
controls:0.02%
cases:0.73%
controls:0.13%
cases:0.80%
controls:0.39%
10
49
4812
48158
7
55
4815
48161
—
7
0
4815
48216
16
9
4791
47989
33
60
4495
45337
27
132
3355
33456
apraclonidine
S01EA03 [21603675]
8.9e-01
—
—
—
2.6e+00
2.7e+00
1.2e+00
cases:0.17%
controls:0.07%
—
—
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.22%
controls:0.02%
cases:0.24%
controls:0.07%
8
33
4814
48174
—
—
—
7
5
4800
47993
10
7
4518
45390
8
23
3374
33565
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.3e-01
4.4e-01
5.8e-01
1.6e+00
1.1e+00
6.4e-01
6.5e-01
cases:14.68%
controls:10.97%
cases:9.50%
controls:6.30%
cases:2.16%
controls:1.22%
cases:0.21%
controls:0.04%
cases:3.52%
controls:1.21%
cases:11.29%
controls:6.28%
cases:22.29%
controls:13.06%
708
5286
4114
42921
458
3039
4364
45177
104
589
4718
47627
10
21
4812
48195
169
583
4638
47415
511
2853
4017
42544
754
4388
2628
29200
After-cataract
H26.4 [45600893]
4.7e-01
6.4e-01
1.1e+00
—
2.3e+00
1.3e+00
6.2e-01
cases:2.07%
controls:1.31%
cases:0.95%
controls:0.51%
cases:0.21%
controls:0.07%
—
—
cases:0.79%
controls:0.08%
cases:1.79%
controls:0.50%
cases:3.43%
controls:1.88%
100
630
4722
47577
46
244
4776
47972
10
33
4812
48183
—
38
40
4769
47958
81
229
4447
45168
116
631
3266
32957
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.1e-01
4.2e-01
6.2e-01
2.2e+00
7.3e-01
4.7e-01
5.3e-01
cases:37.76%
controls:30.75%
cases:24.82%
controls:17.83%
cases:5.99%
controls:3.31%
cases:1.58%
controls:0.18%
cases:6.72%
controls:3.37%
cases:25.62%
controls:17.66%
cases:49.73%
controls:36.82%
1821
14824
3001
33383
1197
8597
3625
39619
289
1598
4533
46618
76
88
4746
48128
323
1618
4484
46380
1160
8018
3368
37379
1682
12367
1700
21221
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
1.3e-01
2.0e-01
4.7e-01
2.4e+00
1.5e+00
3.1e-01
1.9e-01
cases:48.40%
controls:45.14%
cases:30.09%
controls:26.09%
cases:5.06%
controls:3.22%
cases:1.00%
controls:0.09%
cases:12.17%
controls:2.92%
cases:32.42%
controls:26.00%
cases:61.62%
controls:57.08%
2334
21763
2488
26444
1451
12580
3371
35636
244
1552
4578
46664
48
43
4774
48173
585
1402
4222
46596
1468
11803
3060
33594
2084
19173
1298
14415
Polymyalgia rheumatica
M35.3 [45533830]
5.8e-01
7.7e-01
1.7e+00
—
1.2e+00
9.4e-01
4.2e-01
cases:1.27%
controls:0.71%
cases:0.81%
controls:0.38%
cases:0.33%
controls:0.06%
—
—
cases:0.29%
controls:0.09%
cases:0.86%
controls:0.34%
cases:1.30%
controls:0.85%
61
343
4761
47864
39
182
4783
48034
16
28
4806
48188
—
14
42
4793
47956
39
154
4489
45243
44
287
3338
33301
Cathetrisation of vein
TPH04 [2001309597]
6.2e-01
6.2e-01
8.6e-01
—
1.6e+00
8.9e-01
6.7e-01
cases:6.99%
controls:3.88%
cases:2.61%
controls:1.42%
cases:0.44%
controls:0.18%
—
—
cases:0.75%
controls:0.16%
cases:3.16%
controls:1.32%
cases:7.72%
controls:4.09%
337
1871
4485
46336
126
683
4696
47533
21
89
4801
48127
—
36
76
4771
47922
143
601
4385
44796
261
1374
3121
32214
Pain, unspecified
R52.9 [45544151]
9.2e-01
9.3e-01
1.4e+00
—
8.2e-01
1.1e+00
7.9e-01
cases:3.28%
controls:1.33%
cases:1.22%
controls:0.49%
cases:0.21%
controls:0.05%
—
—
cases:0.10%
controls:0.05%
cases:1.55%
controls:0.50%
cases:4.52%
controls:2.11%
158
641
4664
47566
59
235
4763
47981
10
24
4812
48192
—
5
22
4802
47976
70
227
4458
45170
153
709
3229
32879
Presence of prosthetic heart valve
Z95.2 [45542495]
6.7e-01
1.1e+00
1.3e+00
—
1.7e+00
9.3e-01
8.1e-01
cases:0.68%
controls:0.35%
cases:0.60%
controls:0.21%
cases:0.15%
controls:0.04%
—
—
cases:0.19%
controls:0.03%
cases:0.57%
controls:0.23%
cases:1.06%
controls:0.48%
33
170
4789
48037
29
100
4793
48116
7
20
4815
48196
—
9
16
4798
47982
26
103
4502
45294
36
160
3346
33428
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
6.5e-01
6.4e-01
—
—
2.1e+00
8.6e-01
1.0e+00
cases:3.11%
controls:1.65%
cases:0.87%
controls:0.46%
—
—
—
—
cases:0.15%
controls:0.02%
cases:0.86%
controls:0.37%
cases:3.49%
controls:1.31%
150
794
4672
47413
42
222
4780
47994
—
—
7
9
4800
47989
39
167
4489
45230
118
439
3264
33149
Social worker
Z2446 [2001311559]
5.2e-01
8.3e-01
1.7e+00
—
1.9e+00
1.4e+00
1.3e+00
cases:1.06%
controls:0.63%
cases:0.33%
controls:0.15%
cases:0.10%
controls:0.02%
—
—
cases:0.15%
controls:0.02%
cases:0.44%
controls:0.11%
cases:1.06%
controls:0.29%
51
304
4771
47903
16
70
4806
48146
5
9
4817
48207
—
7
10
4800
47988
20
48
4508
45349
36
98
3346
33490
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
5.6e-01
5.1e-01
1.5e+00
—
1.8e+00
9.8e-01
4.1e-01
cases:1.49%
controls:0.85%
cases:0.68%
controls:0.41%
cases:0.23%
controls:0.05%
—
—
cases:0.23%
controls:0.04%
cases:1.19%
controls:0.45%
cases:2.63%
controls:1.76%
72
412
4750
47795
33
199
4789
48017
11
25
4811
48191
—
11
19
4796
47979
54
204
4474
45193
89
591
3293
32997
CT angiography of neck and brain
PA7BD [2001300235]
1.1e+00
1.9e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:0.48%
controls:0.15%
cases:0.23%
controls:0.04%
—
—
cases:0.48%
controls:0.00%
—
—
cases:0.18%
controls:0.02%
cases:0.21%
controls:0.06%
23
74
4799
48133
11
17
4811
48199
—
23
0
4799
48216
—
8
9
4520
45388
7
19
3375
33569
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.2e-01
1.9e-01
4.7e-01
2.4e+00
1.5e+00
3.1e-01
2.0e-01
cases:49.03%
controls:46.01%
cases:31.00%
controls:27.03%
cases:5.21%
controls:3.33%
cases:0.97%
controls:0.09%
cases:12.27%
controls:3.04%
cases:33.66%
controls:27.07%
cases:62.95%
controls:58.29%
2364
22182
2458
26025
1495
13031
3327
35185
251
1605
4571
46611
47
43
4775
48173
590
1458
4217
46540
1524
12287
3004
33110
2129
19579
1253
14009
Electrophysiological examination of eye
XCD10 [2001300413]
1.1e+00
1.4e+00
—
1.0e+50
1.0e+50
2.6e+00
1.4e+00
cases:0.58%
controls:0.19%
cases:0.19%
controls:0.05%
—
—
cases:0.10%
controls:0.00%
cases:0.33%
controls:0.00%
cases:0.75%
controls:0.06%
cases:0.68%
controls:0.16%
28
92
4794
48115
9
23
4813
48193
—
5
0
4817
48216
16
0
4791
47998
34
25
4494
45372
23
55
3359
33533
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
4.9e-01
6.3e-01
—
—
2.3e+00
1.5e+00
9.0e-01
cases:1.27%
controls:0.78%
cases:0.58%
controls:0.31%
—
—
—
—
cases:0.40%
controls:0.04%
cases:0.91%
controls:0.21%
cases:1.66%
controls:0.68%
61
377
4761
47830
28
150
4794
48066
—
—
19
19
4788
47979
41
95
4487
45302
56
228
3326
33360
Cluster headache syndrome
G44.0 [45533141]
9.7e-01
1.3e+00
—
—
2.3e+00
1.7e+00
1.1e+00
cases:0.29%
controls:0.11%
cases:0.17%
controls:0.04%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.29%
controls:0.05%
cases:0.38%
controls:0.13%
14
53
4808
48154
8
21
4814
48195
—
—
6
6
4801
47992
13
23
4515
45374
13
43
3369
33545
oxcarbazepine; oral
N03AF02 [21604418]
9.1e-01
8.4e-01
7.7e-01
—
1.5e+00
9.6e-01
9.2e-01
cases:1.10%
controls:0.45%
cases:0.77%
controls:0.33%
cases:0.23%
controls:0.11%
—
—
cases:0.46%
controls:0.10%
cases:0.88%
controls:0.34%
cases:1.15%
controls:0.46%
53
215
4769
47992
37
161
4785
48055
11
51
4811
48165
—
22
49
4785
47949
40
154
4488
45243
39
156
3343
33432
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
2.4e-01
2.3e-01
5.5e-01
3.1e+00
6.8e-01
3.4e-01
1.4e-01
cases:11.22%
controls:9.07%
cases:5.31%
controls:4.27%
cases:1.00%
controls:0.57%
cases:0.50%
controls:0.02%
cases:1.25%
controls:0.64%
cases:5.85%
controls:4.24%
cases:13.78%
controls:12.19%
541
4373
4281
43834
256
2059
4566
46157
48
277
4774
47939
24
11
4798
48205
60
306
4747
47692
265
1923
4263
43474
466
4093
2916
29495
Vascular Surgery
77 [38004496]
5.1e-01
5.2e-01
1.0e+00
—
1.7e+00
8.3e-01
5.6e-01
cases:5.81%
controls:3.57%
cases:2.20%
controls:1.32%
cases:0.52%
controls:0.18%
—
—
cases:1.12%
controls:0.22%
cases:2.87%
controls:1.27%
cases:6.00%
controls:3.51%
280
1719
4542
46488
106
638
4716
47578
25
89
4797
48127
—
54
104
4753
47894
130
576
4398
44821
203
1180
3179
32408
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
5.2e-01
6.4e-01
1.6e+00
—
1.4e+00
5.8e-01
4.0e-01
cases:2.94%
controls:1.77%
cases:1.82%
controls:0.97%
cases:0.60%
controls:0.12%
—
—
cases:0.56%
controls:0.14%
cases:1.88%
controls:1.06%
cases:5.26%
controls:3.58%
142
851
4680
47356
88
469
4734
47747
29
59
4793
48157
—
27
69
4780
47929
85
481
4443
44916
178
1201
3204
32387
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
3.4e-01
5.0e-01
5.8e-01
1.7e+00
7.7e-01
6.1e-01
5.7e-01
cases:22.48%
controls:17.10%
cases:13.50%
controls:8.68%
cases:3.09%
controls:1.75%
cases:0.54%
controls:0.10%
cases:3.54%
controls:1.66%
cases:14.69%
controls:8.53%
cases:31.99%
controls:20.99%
1084
8242
3738
39965
651
4185
4171
44031
149
843
4673
47373
26
47
4796
48169
170
799
4637
47199
665
3871
3863
41526
1082
7049
2300
26539
Papilloedema, unspecified
H47.1 [45562260]
1.3e+00
—
—
1.0e+50
—
3.1e+00
2.0e+00
cases:0.19%
controls:0.05%
—
—
—
—
cases:0.10%
controls:0.00%
—
—
cases:0.29%
controls:0.01%
cases:0.24%
controls:0.03%
9
25
4813
48182
—
—
5
0
4817
48216
—
13
6
4515
45391
8
11
3374
33577
Other and unspecified abdominal pain
R10.4 [45568113]
6.6e-01
8.2e-01
1.0e+00
—
8.2e-01
9.2e-01
8.0e-01
cases:12.28%
controls:6.73%
cases:4.73%
controls:2.13%
cases:0.56%
controls:0.20%
—
—
cases:0.50%
controls:0.22%
cases:4.77%
controls:1.96%
cases:14.19%
controls:6.92%
592
3242
4230
44965
228
1027
4594
47189
27
96
4795
48120
—
24
106
4783
47892
216
892
4312
44505
480
2324
2902
31264
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
1.2e-01
2.0e-01
4.6e-01
2.4e+00
1.4e+00
2.9e-01
2.0e-01
cases:51.08%
controls:48.17%
cases:34.94%
controls:30.62%
cases:5.91%
controls:3.80%
cases:1.02%
controls:0.10%
cases:12.92%
controls:3.49%
cases:37.61%
controls:31.01%
cases:66.71%
controls:62.03%
2463
23221
2359
24986
1685
14766
3137
33450
285
1833
4537
46383
49
46
4773
48170
621
1677
4186
46321
1703
14077
2825
31320
2256
20836
1126
12752
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29775-4 [3014326]
2.4e-01
6.2e-02
—
—
2.3e+00
1.7e+00
1.0e+00
cases:0.25%
controls:0.19%
cases:0.10%
controls:0.10%
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.44%
controls:0.08%
cases:0.65%
controls:0.23%
12
94
4810
48113
5
47
4817
48169
—
—
7
7
4800
47991
20
36
4508
45361
22
78
3360
33510
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
6.3e-01
8.3e-01
1.5e+00
—
1.9e+00
1.1e+00
6.2e-01
cases:2.16%
controls:1.16%
cases:0.77%
controls:0.34%
cases:0.12%
controls:0.03%
—
—
cases:0.25%
controls:0.04%
cases:0.73%
controls:0.25%
cases:1.95%
controls:1.06%
104
558
4718
47649
37
162
4785
48054
6
13
4816
48203
—
12
18
4795
47980
33
115
4495
45282
66
355
3316
33233
Physical Medicine And Rehabilitation
25 [38004468]
5.0e-01
6.8e-01
1.2e+00
1.8e+00
1.1e+00
7.8e-01
6.9e-01
cases:12.42%
controls:7.95%
cases:5.18%
controls:2.69%
cases:1.31%
controls:0.38%
cases:0.10%
controls:0.02%
cases:1.27%
controls:0.41%
cases:5.19%
controls:2.44%
cases:13.54%
controls:7.26%
599
3834
4223
44373
250
1296
4572
46920
63
185
4759
48031
5
8
4817
48208
61
196
4746
47802
235
1106
4293
44291
458
2439
2924
31149
Monocytes [#/volume] in Blood
26484-6 [3001604]
3.2e-01
3.9e-01
6.4e-01
1.5e+00
9.5e-01
6.3e-01
6.1e-01
cases:22.13%
controls:17.07%
cases:14.06%
controls:9.99%
cases:3.50%
controls:1.88%
cases:0.39%
controls:0.09%
cases:4.81%
controls:1.92%
cases:16.98%
controls:9.83%
cases:33.35%
controls:21.40%
1067
8231
3755
39976
678
4819
4144
43397
169
905
4653
47311
19
43
4803
48173
231
922
4576
47076
769
4463
3759
40934
1128
7187
2254
26401
Monocytes/Leukocytes in Blood
26485-3 [3019069]
3.3e-01
3.9e-01
5.6e-01
1.6e+00
9.6e-01
6.0e-01
6.0e-01
cases:21.13%
controls:16.10%
cases:13.02%
controls:9.23%
cases:3.05%
controls:1.76%
cases:0.41%
controls:0.09%
cases:4.51%
controls:1.78%
cases:15.26%
controls:9.01%
cases:30.31%
controls:19.34%
1019
7761
3803
40446
628
4450
4194
43766
147
848
4675
47368
20
41
4802
48175
217
854
4590
47144
691
4092
3837
41305
1025
6497
2357
27091
Optic neuritis
H46 [45571994]
2.2e+00
2.8e+00
—
1.0e+50
—
—
—
cases:0.29%
controls:0.03%
cases:0.17%
controls:0.01%
—
—
cases:0.52%
controls:0.00%
—
—
—
—
—
—
14
15
4808
48192
8
5
4814
48211
—
25
0
4797
48216
—
—
—
Intensive care
WX872 [2001310844]
3.4e-01
9.4e-01
2.3e+00
—
—
9.7e-01
8.0e-01
cases:0.95%
controls:0.68%
cases:0.52%
controls:0.20%
cases:0.15%
controls:0.01%
—
—
—
—
cases:0.35%
controls:0.13%
cases:0.95%
controls:0.43%
46
329
4776
47878
25
98
4797
48118
7
7
4815
48209
—
—
16
61
4512
45336
32
144
3350
33444
Basophils [#/volume] in Blood
26444-0 [3006315]
3.2e-01
3.9e-01
6.4e-01
1.5e+00
9.4e-01
6.3e-01
6.1e-01
cases:22.25%
controls:17.14%
cases:14.08%
controls:10.03%
cases:3.53%
controls:1.88%
cases:0.39%
controls:0.09%
cases:4.81%
controls:1.94%
cases:17.03%
controls:9.86%
cases:33.50%
controls:21.45%
1073
8264
3749
39943
679
4837
4143
43379
170
908
4652
47308
19
44
4803
48172
231
929
4576
47069
771
4475
3757
40922
1133
7203
2249
26385
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.4e-01
3.9e-01
5.6e-01
1.6e+00
9.7e-01
6.0e-01
5.9e-01
cases:21.11%
controls:16.07%
cases:12.98%
controls:9.21%
cases:3.05%
controls:1.76%
cases:0.41%
controls:0.09%
cases:4.54%
controls:1.77%
cases:15.24%
controls:9.00%
cases:30.16%
controls:19.36%
1018
7745
3804
40462
626
4440
4196
43776
147
848
4675
47368
20
42
4802
48174
218
851
4589
47147
690
4086
3838
41311
1020
6503
2362
27085
Neuropsychological rehabilitation
R4150 [2001310239]
1.3e+00
—
—
—
—
2.8e+00
2.2e+00
cases:0.21%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.18%
controls:0.01%
cases:0.33%
controls:0.04%
10
26
4812
48181
—
—
—
—
8
5
4520
45392
11
12
3371
33576
Migraine
N89 [2002000789]
6.6e-01
9.5e-01
—
—
2.3e+00
5.7e-01
1.1e+00
cases:0.93%
controls:0.49%
cases:0.46%
controls:0.18%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.27%
controls:0.15%
cases:1.45%
controls:0.50%
45
234
4777
47973
22
85
4800
48131
—
—
6
6
4801
47992
12
68
4516
45329
49
169
3333
33419

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2546
13122
2.99
300.54
2.7
2.1
146.50
212.47
u/l
4.74
2465
12387
1548
6333
3.12
271.97
2.5
2.1
29.27
29.60
s
1.21
1518
6148
3646
25402
2.77
202.90
6.3
5.0
6.46
6.67
mmol/l
7.99
3522
23962
2924
19524
2.26
159.41
16.7
14.2
1.23
1.24
inr
0.33
2523
16247
1572
8231
2.35
153.62
5.5
3.8
766.13
375.57
ng/l
1.01
1166
6290
2441
15998
2.06
128.90
5.1
3.7
29.92
85.64
ng/l
1.19
1681
10920
3056
21975
2.06
122.14
8.3
7.2
1.22
1.21
mmol/l
0.87
2752
18939
3995
32028
2.43
118.64
5.7
4.4
11.18
12.10
mm/h
4.39
3827
30005
1792
10992
2.00
108.61
4.8
4.1
91.60
90.75
%
0.75
1742
10743
2759
19679
1.94
106.09
7.9
6.5
1.21
1.21
mmol/l
0.22
2603
18192
3007
22398
1.91
97.64
7.7
6.4
0.04
0.04
e9/l
0.69
2599
19222
1599
9736
1.96
96.49
2.3
1.8
1.08
1.23
mg/l
0.65
1255
7515
2996
22348
1.90
96.16
7.7
6.4
0.57
0.58
e9/l
1.32
2597
19181
354
1081
3.45
95.03
1.2
1.3
451.65
547.97
mg/l
3.49
337
1032
3066
23086
1.90
95.03
7.9
6.6
0.19
0.19
e9/l
0.41
2703
20143
3265
25135
1.92
93.98
10.6
9.8
4.12
4.09
e9/l
0.33
2844
21816
3029
22862
1.87
91.48
7.7
6.4
1.86
1.93
e9/l
2.35
2693
20121
167
293
5.87
90.98
1.2
1.1
36.40
39.66
mg/l
0.39
147
238
3984
33061
2.17
90.11
9.8
8.3
76.41
78.77
u/l
3.31
3833
31420
305
879
3.64
89.37
1.3
1.4
—
—
—
0
0
321
962
3.50
88.62
1.2
1.3
3.71
3.79
mmol/l
0.63
296
918
4043
33879
2.18
86.97
5.6
4.5
14.76
14.76
pmol/l
0.01
3802
31232
3011
22902
1.83
86.20
6.9
6.6
10.70
11.24
umol/l
2.83
2889
21836
1989
13361
1.83
86.03
4.8
4.2
7.40
7.40
ph
0.54
1459
9573
3575
28716
1.94
86.01
6.6
4.7
86.56
1953.90
e6/l
5.87
34
378
316
958
3.46
85.65
1.3
1.5
694.15
1394.71
e6/l
0.69
239
747
160
287
5.73
85.14
1.1
1.1
205.92
256.02
mg/l
3.12
146
245
4497
39573
2.96
85.13
7.2
5.5
1.83
1.90
mu/l
3.77
4286
36788
312
943
3.47
84.95
1.3
1.4
54.96
32.48
e6/l
0.23
221
682
2769
20603
1.81
84.54
7.7
6.7
8.69
8.79
%
1.11
2629
19326
2761
20550
1.80
83.95
7.6
6.6
2.79
2.83
%
0.39
2622
19264
2775
20708
1.80
83.40
7.6
6.5
57.25
57.22
%
0.05
2676
19787
2660
19635
1.79
82.63
5.4
5.1
36.46
35.72
g/l
11.06
2506
18429
2753
20539
1.79
82.35
7.7
6.7
0.68
0.68
%
0.21
2612
19239
2303
16413
1.77
79.65
5.3
4.0
39.14
95.11
e6/l
9.47
1720
11351
2799
21101
1.78
79.59
7.7
6.6
27.94
27.95
%
0.01
2687
20010
2053
14204
1.77
78.24
4.4
3.4
26.01
72.13
e6/l
5.41
1639
10759
646
2994
2.34
78.06
2.6
2.4
22.62
21.18
au/ml
0.15
68
330
2020
13965
1.77
76.75
3.2
2.7
59.62
66.14
u/l
0.54
1890
12956
4643
41973
3.70
76.32
24.1
15.7
20.45
23.71
mg/l
11.23
4040
34540
1841
12509
1.76
73.40
3.5
3.1
1195.15
1306.64
ng/l
0.60
1603
10760
4675
42624
3.96
72.02
27.0
18.2
139.69
139.67
mmol/l
0.27
4647
41801
4679
42722
3.99
71.11
27.3
18.4
3.95
3.96
mmol/l
1.59
4645
41817
595
2776
2.30
70.40
1.4
1.3
41.98
51.97
au/ml
0.49
29
185
1800
12292
1.74
69.53
4.2
3.2
0.25
0.43
e6/l
5.21
1386
8954
2574
19382
1.70
69.34
2.4
2.1
95.92
96.54
pmol/l
0.27
1409
10110
1246
7678
1.84
68.06
3.7
2.9
1.09
1.15
e6/l
0.08
725
4015
1730
11757
1.73
67.49
4.1
3.2
0.29
336.20
estimate
—
8
46
123
221
5.68
65.32
1.2
1.3
0.62
0.58
ratio
0.34
71
126
2970
23575
1.67
62.51
4.9
3.9
10.15
4.18
estimate
0.60
551
5063
2984
23720
1.67
62.41
4.9
4.0
1.93
0.07
estimate
0.47
520
4760
1480
9796
1.74
62.39
3.4
2.7
5.34
6.18
e6/l
1.76
1378
8934
2944
23324
1.67
62.34
4.9
3.9
0.00
0.00
estimate
0.80
540
4931
2633
20357
1.64
60.58
2.9
2.4
77.38
77.65
nmol/l
0.18
2406
18537
1800
12721
1.66
58.52
3.5
3.0
0.07
0.05
0.12
29
295
3541
29677
1.72
58.47
4.9
4.0
0.20
7630.57
—
5
54
3482
29092
1.70
57.67
3.8
3.3
43.88
46.58
u/l
1.01
3322
27361
1122
6991
1.79
57.65
3.8
3.1
3.44
2.76
e6/l
1.12
600
3326
1772
12513
1.66
57.55
1.9
1.7
20.18
20.41
nmol/l
0.27
1527
10632
1289
8431
1.72
55.52
1.4
1.3
48.29
30.78
iu/ml
0.44
391
2581
1856
13351
1.63
55.45
7.6
6.5
—
—
—
0
0
176
482
3.75
55.40
1.3
1.4
—
—
—
0
0
379
1604
2.48
55.38
2.4
2.1
21.32
21.10
s
0.17
331
1410
163
430
3.89
54.13
1.4
1.6
—
—
—
0
0
1564
10828
1.66
54.08
4.7
3.8
0.13
0.15
—
8
116
1896
13788
1.62
53.71
3.9
3.2
—
—
—
0
0
1022
6337
1.78
52.78
1.5
1.4
584.24
553.58
titre
0.17
203
1377
2425
18772
1.59
52.31
4.3
3.5
6.27
6.24
ph
0.70
1364
10512
4372
39465
2.13
52.28
7.3
6.2
39.27
39.03
mmol/mol
0.98
4150
37057
62
70
8.96
50.17
1.1
1.1
—
—
—
0
0
1133
7328
1.71
50.03
3.4
3.4
0.82
0.82
mmol/l
1.07
1075
6908
743
4287
1.87
48.20
3.2
2.5
31.80
51.92
u/l
1.11
633
3615
1984
14870
1.57
47.76
3.6
3.3
28.57
34.13
u/l
4.51
1880
14025
2665
21372
1.55
47.10
3.9
3.2
106.52
114.65
ug/l
1.03
2503
20013
100
202
5.03
46.68
1.2
1.1
6.39
11.60
nmol/l
0.48
17
41
947
5938
1.74
46.32
2.5
2.4
118.22
135.59
ug/g
0.85
739
4729
1332
9156
1.63
45.86
1.5
1.5
2.19
2.39
g/l
4.07
776
5685
847
5157
1.78
45.86
2.7
2.8
6.18
7.79
umol/l
2.57
754
4514
2030
15393
1.55
45.80
3.3
3.6
2.35
2.36
mmol/l
0.46
1849
14023
4726
44531
3.77
45.76
29.6
20.2
76.91
75.74
umol/l
1.46
4708
44024
610
3353
1.94
45.76
2.7
2.3
7.68
6.92
ug/l
0.27
536
2957
1225
8294
1.64
44.62
3.5
2.9
521.00
525.32
mosm/kgh2o
0.29
1106
7290
943
5963
1.72
44.55
8.0
7.0
104.55
104.31
mmol/l
0.84
943
5958
4704
44259
3.35
44.49
15.9
12.1
25.36
25.75
u/l
0.97
4620
43032
2583
20721
1.53
44.46
3.0
2.8
—
—
estimate
—
0
0
1613
11680
1.57
44.28
2.8
2.3
2.49
2.79
mg/l
7.42
1420
10118
4414
40409
2.07
44.11
5.9
5.1
5.89
5.90
mmol/l
0.12
4136
37296
1496
10658
1.58
44.00
1.4
1.3
2.94
1.64
u/ml
1.34
347
2857
739
4403
1.80
42.80
5.2
3.8
7.38
7.38
ph
0.06
413
2518
733
4358
1.80
42.75
5.1
3.8
5.87
5.82
kpa
0.75
718
4249
1161
7828
1.64
42.70
1.4
1.3
9.91
11.99
u/ml
0.42
398
3072
713
4240
1.80
41.46
5.5
3.8
1.93
1.82
mmol/l
0.39
651
3713
1608
11770
1.55
41.42
4.7
4.4
—
—
—
0
0
669
3911
1.82
41.14
8.1
7.5
1.23
1.33
mmol/l
2.37
657
3845
711
4243
1.79
40.81
2.6
2.3
379.77
382.74
nmol/l
0.16
666
3933
2436
19546
1.50
40.17
12.9
11.5
0.00
0.00
e9/l
2.09
1939
15934
4479
41459
2.10
39.69
6.0
5.0
4.52
4.67
mmol/l
19.01
4260
38918
947
6164
1.67
39.63
1.3
1.2
—
—
—
0
0
4526
42064
2.20
39.60
6.9
5.7
2.61
2.73
mmol/l
15.82
4294
39323
4299
39267
1.86
39.38
4.9
4.2
1.30
1.28
mmol/l
0.78
4038
36282
591
3384
1.85
38.73
3.2
2.9
10.25
10.55
g/l
0.79
536
3122
3961
35432
1.65
38.27
28.3
19.3
13.59
13.60
%
0.35
3940
34965
623
3650
1.81
37.84
4.7
3.2
4.61
4.56
kpa
0.20
607
3548
4453
41234
2.02
37.81
5.8
4.9
1.45
1.48
mmol/l
5.57
4217
38461
1248
8799
1.56
37.21
2.8
3.0
2.44
2.45
mmol/l
1.87
1119
7888
2222
17785
1.46
35.34
2.3
2.1
—
—
—
0
0
781
4966
1.68
35.33
7.4
7.7
0.86
0.94
mmol/l
0.24
635
4085
784
4992
1.68
35.28
7.6
7.8
7.42
7.42
ph
0.09
426
2718
595
3512
1.79
35.10
2.8
2.5
0.33
0.42
e6/l
0.51
559
3351
115
325
3.60
34.61
1.1
1.2
1.83
2.20
mmol/l
3.59
104
305
678
4174
1.73
34.50
8.0
8.5
120.93
121.18
g/l
0.12
653
4074
1411
10366
1.51
34.30
4.9
4.1
1.02
1.31
kg/l
0.81
994
6912
710
4447
1.70
33.87
7.7
8.0
96.16
95.74
%
1.12
680
4294
1475
10959
1.50
33.86
2.6
2.4
—
—
—
0
0
4769
45736
4.23
33.84
35.5
24.0
6.74
6.73
e9/l
0.12
4719
44717
4768
45722
4.18
33.80
35.5
24.0
251.38
253.87
e9/l
1.91
4727
44845
4767
45725
4.11
33.39
35.3
23.8
30.27
30.29
pg
0.32
4752
45260
4767
45727
4.11
33.34
35.3
23.9
91.03
91.04
fl
0.09
4752
45263
4767
45730
4.11
33.28
36.1
24.3
40.34
40.49
%
0.38
4751
45241
4767
45731
4.10
33.25
35.4
23.9
4.48
4.47
e12/l
0.41
4720
44719
177
661
2.74
33.24
1.3
1.3
3.84
4.09
u/ml
0.10
89
288
777
5012
1.66
33.08
7.5
7.7
5.03
5.10
kpa
1.19
741
4821
4767
45742
4.09
33.01
35.7
24.1
134.58
134.55
g/l
0.05
4752
45290
776
5011
1.65
32.88
7.5
7.7
13.06
12.45
kpa
2.19
740
4820
1505
11289
1.48
32.71
2.7
2.7
329.68
337.87
umol/l
2.45
1324
10004
288
1355
2.20
32.67
2.7
2.3
95.00
93.62
%
0.50
275
1308
1016
7040
1.56
31.99
3.0
2.6
2.34
2.34
g/l
0.10
933
6515
1073
7529
1.55
31.93
3.0
2.6
12.69
13.09
umol/l
1.18
1005
7038
1846
14464
1.45
31.76
2.7
2.4
—
—
—
0
0
614
3760
1.73
31.68
9.8
8.8
—
—
—
0
0
138
471
2.99
30.61
2.5
2.3
—
—
—
0
0
350
1823
1.99
30.27
1.5
1.5
6.86
16.10
iu/ml
—
8
44
3913
35451
1.55
29.84
30.5
20.1
332.05
332.03
g/l
0.05
3900
35265
1857
14722
1.42
29.26
4.3
3.6
0.20
0.71
—
5
38
466
2699
1.80
29.05
4.8
3.2
133.28
129.29
g/l
4.05
458
2621
927
6454
1.54
28.13
3.0
2.6
21.89
22.56
%
0.89
856
5997
160
627
2.60
27.36
1.2
1.2
—
—
—
0
0
2149
17623
1.40
27.21
4.8
3.9
1.15
0.18
estimate
0.40
443
4028
161
637
2.58
27.00
1.1
1.1
120.28
116.52
%
0.79
148
572
531
3258
1.71
26.98
3.2
3.0
166.96
185.88
ng/l
0.57
482
2978
2194
18145
1.38
25.96
2.0
1.9
1.35
1.35
mmol/l
0.00
1896
15314
754
5116
1.56
25.45
2.0
1.8
—
—
—
0
0
349
1925
1.88
25.39
2.2
1.8
12.23
6.36
iu/ml
0.95
78
468
750
5087
1.56
25.35
1.4
1.4
—
—
—
0
0
423
2476
1.78
25.35
8.7
10.0
16.07
15.99
%
0.25
399
2381
388
2223
1.81
24.98
2.5
2.4
—
—
—
0
0
332
1822
1.88
24.52
1.3
1.3
0.37
1.47
u/ml
2.11
34
148
477
2919
1.70
24.38
1.5
1.3
260.06
218.71
u/ml
0.24
442
2708
827
5779
1.52
24.30
6.0
6.0
1.04
1.04
mmol/l
0.26
783
5364
234
1144
2.10
24.04
2.0
2.0
10.99
11.80
mg/l
0.81
218
1065
265
1360
2.00
23.86
1.4
1.4
288.10
280.07
ug/g
0.25
146
781
293
1557
1.94
23.85
1.3
1.3
—
—
—
0
0
565
3645
1.62
23.50
2.5
2.7
66.43
66.39
g/l
0.05
525
3364
646
4306
1.58
23.43
2.4
2.1
0.03
0.01
estimate
0.40
119
913
264
1363
1.99
23.37
2.0
1.7
0.24
0.23
g/l
0.11
258
1296
557
3592
1.62
23.19
3.0
2.7
6.07
6.10
ph
0.33
405
2445
767
5329
1.52
23.05
1.6
1.5
—
—
—
0
0
268
1415
1.95
22.23
2.0
1.7
1.23
1.19
g/l
1.55
262
1348
189
884
2.18
21.77
1.5
1.3
—
—
—
0
0
564
3711
1.59
21.53
1.2
1.2
—
—
—
0
0
456
2852
1.66
21.38
9.6
9.5
94.27
94.05
%
0.36
456
2842
419
2568
1.69
21.21
9.2
9.5
24.21
24.26
mmol/l
0.15
411
2526
210
1049
2.05
20.39
1.2
1.2
33.08
41.31
u/ml
0.38
27
107
271
1480
1.88
20.30
2.3
2.2
449.82
678.22
ug/l
0.54
255
1398
455
2901
1.63
19.72
3.5
3.4
4.51
4.49
pmol/l
0.17
421
2591
222
1145
1.98
19.72
2.9
3.2
2.21
2.04
index
0.14
118
580
420
2641
1.65
19.23
6.4
6.8
24.36
24.49
mmol/l
0.33
394
2521
1821
15108
1.33
19.11
3.6
3.4
7.35
7.40
mmol/l
0.20
1566
12825
851
6253
1.44
18.95
2.2
2.0
—
—
—
0
0
1111
8557
1.39
18.88
2.1
2.0
—
—
—
0
0
491
3223
1.58
18.83
1.3
1.2
122.72
148.23
u/ml
1.00
202
1172
273
1531
1.83
18.81
2.5
2.4
10.17
10.17
g/l
0.01
253
1374
255
1404
1.86
18.63
1.3
1.3
19.87
44.72
u/ml
1.28
17
76
238
1283
1.90
18.57
4.3
6.3
1.21
1.32
mmol/l
1.04
210
1122
571
3893
1.53
18.48
7.3
7.4
8.71
9.67
mmol/l
3.02
536
3746
326
1940
1.73
18.35
4.3
5.2
1.69
1.61
%
0.61
300
1832
306
1789
1.76
18.33
4.5
5.4
0.87
0.88
%
0.08
281
1688
372
2302
1.67
18.11
1.2
1.1
56.68
1.18
u/ml
—
5
25
514
3443
1.55
18.01
3.9
3.8
91.25
88.11
ng/l
0.28
459
2947
560
3832
1.52
17.79
2.4
2.7
69.12
70.00
e9/l
0.24
406
2794
100
386
2.62
17.74
1.2
1.2
—
—
—
0
0
691
4943
1.46
17.63
2.7
2.6
1.73
1.80
%
1.05
617
4419
473
3134
1.56
17.38
1.3
1.3
—
—
—
0
0
301
1787
1.73
17.08
2.4
2.3
3.67
3.70
g/l
0.20
279
1646
358
2229
1.65
17.01
3.9
3.3
1.02
1.02
ratio
0.80
334
2002
301
1790
1.73
16.98
2.4
2.3
7.35
7.42
g/l
0.29
281
1645
1690
14043
1.31
16.98
3.6
3.5
40.43
46.75
mg/l
0.64
1064
8856
93
355
2.65
16.89
1.2
1.1
—
—
—
0
0
300
1789
1.72
16.76
2.4
2.3
4.23
4.23
g/l
0.02
280
1646
285
1677
1.74
16.70
2.4
2.4
2.93
2.92
g/l
0.02
265
1535
379
2406
1.62
16.67
1.4
1.2
—
—
—
0
0
223
1220
1.87
16.64
1.3
1.2
—
—
—
0
0
214
1160
1.88
16.44
1.2
1.1
4.18
4.36
0.08
16
150
342
2129
1.65
16.26
2.3
1.9
—
—
—
0
0
156
762
2.08
16.14
1.8
1.6
0.92
0.75
g/l
0.63
126
583
269
1581
1.74
15.83
1.9
1.6
280.42
293.08
mu/l
0.45
249
1432
309
1898
1.67
15.47
4.8
3.4
25.39
25.31
mmol/l
0.15
302
1832
250
1453
1.76
15.30
2.5
2.6
—
—
—
0
0
929
7161
1.37
15.29
1.8
1.7
1140.91
1168.71
nmol/l
0.39
717
5463
108
465
2.35
15.24
1.6
1.3
6.38
6.87
g/l
0.68
86
326
1693
14254
1.29
14.88
4.2
4.2
7.61
8.76
mg/mmol
0.48
1027
8782
53
159
3.36
14.74
1.1
1.1
56.62
282.42
ng/l
1.13
13
40
228
1308
1.78
14.60
3.8
2.6
3.49
3.58
g/l
0.42
219
1246
229
1319
1.77
14.47
1.3
1.3
5.74
2.94
u/ml
0.53
19
128
106
464
2.31
14.43
1.6
1.3
3.08
2.90
g/l
0.51
84
328
106
464
2.31
14.43
1.6
1.3
0.32
0.41
g/l
2.48
82
326
228
1320
1.76
14.16
1.3
1.3
9.65
7.14
u/ml
0.18
25
197
403
2700
1.54
14.03
2.2
1.9
1.40
1.38
g/l
0.07
374
2490
66
234
2.85
13.86
2.0
2.8
587.70
1007.86
u/ml
2.29
66
234
104
461
2.28
13.77
1.7
1.3
—
—
—
0
0
165
878
1.91
13.46
4.8
7.5
10.80
11.34
mmol/l
1.54
143
782
165
879
1.91
13.42
4.8
7.5
105.24
105.02
mmol/l
0.22
143
783
214
1239
1.76
13.30
2.4
1.9
—
—
—
0
0
444
3070
1.49
13.30
2.4
2.3
12.16
12.72
nmol/l
0.71
400
2768
220
1292
1.74
13.02
1.9
2.0
4.51
8.32
iu/l
0.41
80
535
259
1597
1.66
12.80
1.1
1.1
—
—
—
0
0
150
790
1.93
12.64
1.7
1.9
5.44
4.93
mmol/24h
1.00
135
692
121
591
2.07
12.61
1.2
1.2
—
—
—
0
0
58
204
2.87
12.40
1.1
1.3
50.17
69.08
%
—
6
25
688
5224
1.37
12.22
1.8
1.6
—
—
—
0
0
88
386
2.30
11.99
2.3
2.4
1234.61
1199.15
e6/l
0.16
77
338
304
1982
1.57
11.95
1.3
1.2
—
—
—
0
0
205
1212
1.72
11.87
1.5
1.4
10.68
10.39
u/l
0.10
167
994
1521
12911
1.26
11.82
5.2
4.1
0.00
0.00
estimate
0.08
517
4597
1494
12657
1.26
11.80
4.0
3.4
0.13
0.17
estimate
0.12
440
3905
67
261
2.59
11.80
2.4
2.7
266.29
207.85
e6/l
1.50
59
220
66
261
2.55
11.29
2.4
2.5
472.71
540.75
e6/l
0.59
55
208
63
247
2.57
10.98
1.5
1.6
7.86
7.00
u/l
0.11
52
216
197
1182
1.69
10.84
1.2
1.1
—
—
—
0
0
729
5689
1.33
10.73
3.5
3.2
4.18
4.57
e9/l
1.56
638
4942
109
548
2.01
10.56
1.3
1.3
0.19
0.21
nmol/l
0.32
76
430
231
1460
1.61
10.39
4.1
4.1
24.62
24.90
mmol/l
0.73
217
1350
271
1781
1.55
10.31
2.8
2.3
6580.85
5972.20
u/l
0.10
102
725
902
7295
1.29
10.18
1.9
1.7
—
—
—
0
0
121
644
1.90
9.97
1.3
1.3
0.16
0.28
nmol/l
—
7
32
319
2192
1.49
9.86
1.4
1.4
24.32
27.75
iu/l
1.17
271
1885
388
2793
1.42
9.40
3.8
3.8
5.11
5.16
kpa
0.58
372
2683
57
231
2.49
9.33
1.2
1.3
134.13
133.49
nmol/l
0.04
57
231
70
318
2.22
8.88
1.7
2.1
17.83
19.31
nmol/l
0.74
65
295
293
2024
1.48
8.84
1.1
1.1
—
—
—
0
0
465
3501
1.36
8.62
1.5
1.5
—
—
—
0
0
39
137
2.86
8.46
1.0
1.2
34.43
15.33
%
—
7
18
104
564
1.86
8.16
4.9
5.6
329.58
361.52
umol/l
1.57
93
499
370
2711
1.40
8.11
3.8
3.8
7.41
7.42
ph
0.26
328
2249
176
1110
1.61
8.06
1.1
1.1
—
—
—
0
0
183
1166
1.59
8.03
1.1
1.1
4.87
7.66
eliau/ml
0.61
17
152
61
275
2.23
7.93
2.9
1.8
145.69
109.35
ng/l
0.59
61
275
1264
10893
1.22
7.89
5.7
5.4
2.89
2.74
ug/l
0.08
1170
9868
1471
12887
1.20
7.70
1.5
1.5
—
—
—
0
0
269
1879
1.46
7.70
4.1
4.0
—
—
—
0
0
588
4658
1.30
7.65
1.9
1.8
—
—
—
0
0
107
598
1.81
7.65
1.6
2.2
10.00
5.51
umol/l
0.43
78
440
69
332
2.09
7.64
1.2
1.3
0.47
1.54
u/ml
1.72
47
184
67
319
2.12
7.62
2.3
2.2
72.26
73.31
%
0.23
62
302
220
1485
1.50
7.48
1.2
1.2
—
—
—
0
0
97
533
1.84
7.34
1.2
1.3
—
—
nmol/l
—
0
0
1026
8723
1.22
7.24
4.5
4.4
22.19
21.84
%
0.29
476
4221
300
2169
1.41
7.13
1.1
1.1
229.09
119.34
titre
0.41
11
61
520
4099
1.30
7.02
4.4
4.3
7.36
7.35
ph
0.58
379
2918
1161
10034
1.21
6.90
5.5
4.7
—
—
—
0
0
37
142
2.62
6.86
1.4
1.2
28.30
28.53
s
0.06
37
142
122
732
1.68
6.85
1.3
1.4
—
14.91
—
0
15
55
254
2.18
6.80
1.2
1.1
1.05
1.06
ratio
0.25
46
201
52
238
2.20
6.58
3.3
2.6
43.77
42.31
%
0.22
26
131
31
111
2.80
6.57
2.4
1.9
12.30
63.28
u/l
1.58
25
106
1055
9077
1.21
6.53
1.8
1.7
64054218.67
34433342.25
pmol/l
0.60
893
7609
76
404
1.90
6.43
2.4
3.1
17.84
13.16
index
1.27
44
226
31
113
2.75
6.36
3.1
2.5
0.10
0.17
e9/l
1.03
14
53
238
1693
1.43
6.23
1.8
1.6
13.29
15.41
u/ml
0.20
57
398
274
1998
1.39
6.23
1.9
1.7
1.51
1.55
g/l
0.28
243
1730
237
1687
1.43
6.19
1.9
1.9
1.44
2.02
ug/l
0.49
202
1514
123
763
1.63
6.12
1.1
1.1
26.59
17.96
au/ml
0.32
23
180
140
898
1.58
6.07
1.2
1.3
278.71
266.13
u/ml
0.20
95
542
253
1829
1.40
6.06
1.7
1.7
0.28
0.31
mg/l
0.41
105
849
96
559
1.73
6.06
2.5
2.6
—
—
—
0
0
129
813
1.60
6.02
1.6
1.4
65.21
61.53
mmol/l
0.46
107
657
98
580
1.70
5.85
1.4
1.3
282.04
302.82
pmol/l
0.38
85
495
23
75
3.08
5.76
1.1
1.1
0.61
0.72
umol/24h
0.88
14
37
289
2165
1.36
5.59
2.4
2.1
0.00
0.36
estimate
0.51
93
715
709
5951
1.22
5.58
1.3
1.3
—
—
—
0
0
127
814
1.58
5.55
1.3
1.4
157.59
153.57
au/ml
0.13
34
231
138
905
1.54
5.46
1.4
1.4
—
—
—
0
0
102
623
1.65
5.44
1.6
1.4
70.25
62.58
mu/l
0.11
96
555
77
436
1.78
5.39
3.1
2.4
1.21
1.20
mmol/l
1.44
77
430
140
924
1.53
5.39
1.2
1.1
1.06
2.24
u/ml
1.98
79
488
16
43
3.73
5.36
1.3
3.0
—
—
—
0
0
49
239
2.06
5.35
1.1
1.1
1509.51
1480.31
miu/ml
0.06
49
239
164
1123
1.48
5.30
1.3
1.2
—
—
—
0
0
207
1481
1.42
5.30
1.3
1.3
195.98
223.69
miu/ml
0.53
94
709
173
1206
1.45
5.11
2.4
2.8
—
—
—
0
0
187
1326
1.43
5.05
10.2
9.8
—
—
—
0
0
762
6508
1.20
5.00
3.1
3.2
0.78
0.76
ug/l
0.16
500
4209
111
709
1.58
4.97
1.3
1.2
—
—
—
0
0
77
450
1.72
4.87
3.1
2.3
4.04
4.03
mmol/l
0.04
77
444
77
450
1.72
4.87
3.1
2.3
106.58
105.14
mmol/l
2.38
77
444
98
611
1.62
4.86
1.1
1.1
5.55
3.52
eliau/ml
0.31
31
288
159
1106
1.45
4.78
1.8
1.7
8455.04
12010.89
e6/l
1.17
121
763
113
734
1.55
4.72
3.1
2.8
—
—
—
0
0
99
624
1.60
4.71
1.2
1.2
—
—
—
0
0
49
252
1.95
4.67
1.1
1.2
—
—
—
0
0
36
165
2.19
4.64
1.6
2.0
25.81
30.69
%
1.55
36
165
83
503
1.66
4.62
1.6
1.4
281.52
277.26
mosm/kgh2o
0.82
60
391
16
48
3.34
4.60
1.1
1.1
0.03
0.03
u/ml
0.07
16
48
12
22
5.47
4.59
1.3
1.9
1.27
2.00
mpas
—
7
10
30
128
2.35
4.56
1.1
1.3
133.78
129.63
nmol/l
0.06
21
92
34
155
2.20
4.45
1.2
1.1
—
—
—
0
0
101
649
1.57
4.45
1.5
1.4
26.43
27.34
u/l
0.10
79
536
41
203
2.03
4.36
1.9
1.7
2.01
1.93
umol/l
0.27
35
185
91
577
1.59
4.26
1.5
1.4
—
—
—
0
0
25
102
2.46
4.20
1.8
1.4
0.17
0.30
mmol/l
—
6
20
468
3875
1.23
4.20
5.3
4.7
0.17
0.19
%
0.06
107
937
517
4328
1.22
4.17
2.5
2.2
0.22
0.21
g/l
1.73
480
4067
18
62
2.91
4.16
1.6
1.5
99.18
125.93
ug/l
0.47
11
57
54
299
1.82
4.16
1.1
1.1
10.97
16.04
u/ml
0.76
14
127
55
308
1.79
4.09
1.2
1.2
—
—
—
0
0
90
577
1.57
4.04
1.5
1.4
—
—
—
0
0
90
577
1.57
4.04
1.5
1.4
—
—
—
0
0
90
577
1.57
4.04
1.5
1.4
—
—
—
0
0
57
324
1.77
4.04
1.1
1.1
9.95
8.46
iu/ml
—
10
96
544
4599
1.21
3.97
3.9
4.3
14.42
19.69
ug/l
0.25
429
3707
71
432
1.65
3.95
1.1
1.1
—
—
—
0
0
562
4770
1.20
3.94
1.5
1.5
—
—
—
0
0
113
767
1.48
3.92
1.1
1.1
0.80
1.13
u/ml
0.51
54
327
14
37
3.79
3.88
1.1
1.2
1.64
1.81
umol/24h
0.38
14
37
175
1289
1.37
3.87
3.3
3.4
3.57
2.54
ratio
0.18
91
729
129
901
1.44
3.87
1.6
1.7
—
—
—
0
0
74
458
1.63
3.86
3.6
3.0
10.40
10.77
mmol/l
0.42
74
452
16
54
2.97
3.84
1.0
1.2
68.71
52.15
%
—
7
20
137
969
1.43
3.84
5.3
4.3
—
—
—
0
0
35
172
2.04
3.84
7.5
3.7
82.96
67.43
mg/l
0.57
27
125
71
436
1.64
3.82
1.9
2.2
—
—
—
0
0
42
221
1.91
3.81
1.3
1.6
1.81
7.93
nmol/l
1.70
31
175
40
208
1.93
3.76
3.0
2.0
163.00
128.81
umol/l
0.30
20
116
50
280
1.79
3.74
1.3
1.4
88.00
62.27
titre
—
5
22
109
744
1.48
3.69
1.2
1.1
1.23
1.49
u/ml
0.21
64
372
81
522
1.56
3.60
1.9
1.7
481.45
349.51
mu/l
0.69
62
410
115
798
1.45
3.59
1.1
1.1
3.61
5.30
u/ml
0.92
66
423
221
1709
1.31
3.55
2.6
2.0
—
—
—
0
0
222
1724
1.30
3.47
2.6
2.0
—
—
—
0
0
208
1602
1.31
3.45
2.7
2.1
—
—
—
0
0
128
915
1.41
3.42
1.7
2.8
28.44
35.42
umol/l
3.37
111
826
222
1730
1.30
3.39
2.6
2.0
—
—
—
0
0
223
1739
1.30
3.38
2.6
2.0
—
—
—
0
0
181
1372
1.33
3.37
2.7
2.1
—
—
—
0
0
473
4020
1.20
3.29
4.9
4.5
1.34
0.91
%
1.00
118
1179
190
1462
1.31
3.20
3.7
3.5
36.63
59.20
mg/l
1.08
168
1247
26
123
2.12
3.19
1.2
1.2
—
—
—
0
0
105
738
1.43
3.12
1.3
1.2
25.15
42.09
u/l
1.22
93
635
33
173
1.91
3.08
1.7
2.3
—
—
—
0
0
189
1464
1.30
3.05
3.7
3.5
38.14
91.67
mg/l
0.83
167
1248
172
1318
1.32
3.01
2.5
3.7
1.51
1.51
mg/l
0.03
156
1206
55
339
1.63
2.99
4.4
2.6
25.75
29.08
mg/l
0.29
40
241
19
81
2.35
2.98
2.9
2.1
16.41
15.31
umol/l
0.22
19
81
88
606
1.46
2.93
1.2
1.1
2.89
3.56
u/ml
0.29
47
266
446
3820
1.18
2.87
4.7
4.3
0.95
0.70
%
0.33
122
1103
34
185
1.84
2.86
1.2
1.3
146.68
162.64
mmol/24h
0.73
34
185
62
399
1.56
2.84
1.0
1.1
—
—
—
0
0
449
3851
1.18
2.84
5.0
4.6
0.18
0.12
%
0.39
94
1010
66
431
1.54
2.84
6.4
5.2
72.27
62.10
u/ml
0.09
24
138
20
92
2.18
2.66
1.2
1.3
100.58
85.79
mg/l
0.05
15
66
29
154
1.89
2.65
1.3
1.4
66.78
303.74
nmol/24h
0.70
29
154
204
1630
1.26
2.63
3.2
3.6
83.82
2756.91
u/ml
0.95
166
1406
45
275
1.64
2.58
1.4
1.5
69.91
80.17
umol/l
2.51
45
275
15
62
2.42
2.53
1.2
1.3
68.33
66.84
ug/l
0.09
15
62
10
31
3.23
2.51
1.0
1.0
0.08
0.27
u/ml
—
5
17
35
204
1.72
2.40
1.2
1.1
6.50
22.18
u/ml
—
6
22
90
652
1.39
2.34
1.2
1.1
1.46
3.08
u/ml
1.29
50
315
19
91
2.09
2.32
2.9
2.3
—
—
—
0
0
9
28
3.22
2.30
1.7
1.5
40.51
14.92
pmol/l
—
9
23
46
292
1.58
2.30
1.2
1.2
32.09
35.32
mmol/l
0.60
40
257
64
437
1.47
2.30
1.4
1.4
1.44
1.55
nmol/l
0.32
55
401
64
438
1.47
2.27
2.2
3.6
57.48
57.68
%
0.02
52
382
100
741
1.36
2.27
1.5
1.8
—
—
—
0
0
49
318
1.55
2.24
2.0
1.9
7.05
6.51
mmol/l
0.51
37
216
14
60
2.34
2.21
1.6
1.5
—
—
—
0
0
47
304
1.55
2.18
1.0
1.1
—
—
—
0
0
36
218
1.66
2.18
1.3
1.9
—
—
—
0
0
73
519
1.41
2.14
2.2
1.8
90.98
89.77
%
1.17
73
510
22
116
1.90
2.10
1.0
1.1
1.49
2.31
u/ml
0.22
14
62
21
109
1.93
2.10
1.2
1.2
—
—
—
0
0
339
3918
0.86
2.08
1.3
1.3
—
—
—
0
0
77
556
1.39
2.08
1.1
1.1
0.35
0.22
u/ml
0.26
28
177
17
83
2.05
2.00
1.4
1.2
139.55
138.69
mmol/l
0.51
11
65
27
155
1.75
1.99
2.9
2.7
0.61
0.62
mmol/l
0.25
27
155
108
834
1.30
1.91
3.6
3.3
0.80
0.81
nmol/l
0.09
91
678
70
508
1.38
1.87
2.1
2.2
0.77
0.57
mmol/l
0.16
65
488
19
101
1.88
1.80
1.1
1.1
—
—
—
0
0
25
146
1.72
1.77
1.1
1.1
—
—
—
0
0
39
258
1.52
1.70
1.1
1.1
0.37
1.87
u/ml
0.95
17
88
6
19
3.16
1.66
1.2
1.8
0.77
0.89
umol/l
—
6
14
56
401
1.40
1.65
1.4
1.4
108841.66
90817.83
e6/l
0.07
38
270
89
686
1.30
1.64
2.8
3.7
1.44
1.50
%
0.05
76
620
110
876
1.26
1.58
3.4
4.2
1.84
2.68
mmol/l
4.66
77
591
7
26
2.69
1.58
1.1
1.0
—
—
—
0
0
8
33
2.43
1.53
1.4
1.2
—
—
—
0
0
14
71
1.97
1.53
1.5
1.8
71.77
31.91
pmol/l
—
9
59
130
1061
1.23
1.52
1.9
2.3
131.57
128.40
g/l
0.72
94
839
6
21
2.86
1.50
1.0
1.3
23.00
9.00
%
—
6
14
98
776
1.27
1.49
1.1
1.1
—
—
—
0
0
9
37
2.44
1.47
5.0
2.3
—
—
—
0
0
30
195
1.54
1.45
2.6
2.1
104.00
128.29
ug/min
—
5
45
108
869
1.25
1.45
2.1
1.9
0.84
0.86
nmol/l
0.14
90
738
122
1487
0.82
1.44
1.1
1.1
0.68
0.63
ratio
0.35
18
186
21
125
1.68
1.43
3.3
2.6
26.79
29.40
umol/l
0.67
14
88
9
40
2.25
1.40
2.1
2.3
1.20
1.42
mg/l
—
9
34
59
441
1.34
1.38
1.3
1.4
29757.15
78358.62
e6/l
1.35
33
242
6
23
2.61
1.36
1.7
1.3
0.17
0.16
umol/l
—
6
23
5
17
2.94
1.36
1.0
1.2
1.00
0.90
%
—
5
10
5
17
2.94
1.36
1.0
1.1
269.60
251.96
nmol/l
—
5
17
49
357
1.38
1.35
1.4
1.5
1.29
1.18
promille
0.19
38
287
18
105
1.72
1.33
1.4
1.4
—
—
—
0
0
11
54
2.04
1.32
1.3
1.1
—
—
—
0
0
39
274
1.43
1.32
9.3
7.1
28.25
152.48
ug/l
0.85
21
175
6
24
2.50
1.30
1.0
2.3
—
—
—
0
0
36
251
1.44
1.28
1.2
1.4
1.08
1.24
nmol/l
0.39
26
184
66
509
1.30
1.27
1.5
1.4
1688.02
3609.78
e6/l
0.56
47
355
26
170
1.53
1.25
3.4
2.9
—
—
—
0
0
6
25
2.40
1.24
1.8
1.7
—
—
—
0
0
8
36
2.22
1.24
1.1
1.0
—
—
—
0
0
8
36
2.22
1.24
1.5
1.4
21.49
21.29
%
—
8
24
15
85
1.77
1.22
33.0
8.2
6.15
5.51
kpa
0.59
15
85
5
19
2.63
1.21
1.2
1.4
680.50
464.68
nmol/l
—
5
19
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
36
257
1.40
1.15
1.5
1.3
—
—
—
0
0
5
20
2.50
1.15
2.0
2.1
184.60
200.30
ng/l
—
5
20
5
21
2.38
1.09
1.0
1.1
0.08
0.05
u/ml
—
5
21
49
372
1.32
1.09
1.2
1.2
102.86
109.61
pmol/l
0.44
49
372
19
120
1.59
1.08
1.1
1.0
—
—
—
0
0
7
32
2.19
1.08
1.0
1.3
—
—
—
0
0
7
32
2.19
1.08
1.0
1.5
—
—
—
0
0
5
22
2.27
1.03
2.4
1.5
32.64
32.66
nmol/l
—
5
22
9
46
1.96
1.03
3.9
1.7
38.22
46.04
umol/l
—
9
46
84
689
1.22
1.02
1.1
1.1
33.78
970.23
iu/ml
0.53
13
140
93
771
1.21
1.02
1.1
1.1
—
—
—
0
0
45
342
1.32
1.01
1.1
1.1
365.14
377.30
nmol/l
0.16
40
299
15
91
1.65
1.00
1.1
1.1
240.30
266.00
pmol/l
—
10
65
62
494
1.26
0.98
1.4
1.3
—
—
—
0
0
385
3537
1.10
0.97
3.9
3.9
1.23
1.23
mmol/l
0.06
344
3042
170
1491
1.15
0.96
3.1
3.3
652.57
365.03
mg/l
0.40
75
637
88
731
1.21
0.96
1.5
1.5
0.45
0.38
nmol/l
0.27
66
569
137
1580
0.86
0.95
1.1
1.1
1.51
1.55
g/l
0.66
137
1580
54
426
1.27
0.94
1.1
1.2
—
—
—
0
0
37
277
1.34
0.93
2.1
1.5
12.22
12.99
u/l
0.29
37
268
32
234
1.37
0.93
1.8
1.6
—
—
—
0
0
29
209
1.39
0.92
3.3
3.2
—
—
—
0
0
13
78
1.67
0.91
1.0
1.9
—
—
—
0
0
34
451
0.75
0.89
1.3
1.2
—
—
—
0
0
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
18
119
1.51
0.88
1.4
1.4
—
—
—
0
0
18
119
1.51
0.88
1.2
1.1
—
—
—
0
0
18
119
1.51
0.88
1.2
1.1
—
—
—
0
0
18
119
1.51
0.88
1.2
1.1
—
—
—
0
0
10
56
1.79
0.87
11.1
13.2
4.73
5.42
mmol/l
—
10
56
62
503
1.24
0.87
2.9
2.2
30.17
22.57
mg/l
0.54
24
190
92
778
1.19
0.85
1.1
1.1
—
—
—
0
0
33
247
1.34
0.85
1.1
1.0
0.15
1.56
u/ml
1.06
11
64
12
72
1.67
0.85
1.1
1.2
—
—
—
0
0
12
72
1.67
0.85
1.1
1.2
—
—
—
0
0
12
72
1.67
0.85
1.1
1.2
—
—
—
0
0
92
779
1.18
0.84
1.1
1.1
—
—
—
0
0
8
45
1.78
0.84
1.4
1.3
—
640.53
—
0
9
23
162
1.42
0.84
1.6
1.6
0.55
0.48
e9/l
0.75
23
162
76
633
1.20
0.83
1.7
1.5
2.85
4.10
ug/l
1.67
70
567
16
237
0.67
0.81
1.2
1.1
—
—
—
0
0
46
364
1.27
0.81
3.3
3.1
27.83
43.92
mg/l
0.58
29
269
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
8
48
1.67
0.78
1.8
1.6
—
—
—
0
0
5
24
2.08
0.74
7.6
9.9
57.20
102.06
e6/l
—
5
17
5
24
2.08
0.74
1.0
2.0
—
—
—
0
0
41
513
0.80
0.73
1.1
1.1
—
—
—
0
0
68
571
1.19
0.72
1.4
1.3
—
—
—
0
0
147
1310
1.13
0.71
1.2
1.2
102.67
98.56
titre
0.03
15
111
124
1094
1.14
0.70
1.5
1.5
91.16
174.63
pmol/l
2.88
124
1069
277
2554
1.09
0.70
3.5
3.6
49.89
65.61
u/ml
0.35
270
2461
28
212
1.32
0.70
1.3
1.2
—
—
—
0
0
7
42
1.67
0.68
1.1
1.1
137.14
96.00
titre
—
7
42
5
28
1.79
0.66
1.0
1.5
2.26
1.75
nmol/l
—
5
28
110
970
1.14
0.65
2.5
3.8
—
—
—
0
0
17
236
0.72
0.64
1.7
2.3
544.00
493.40
min
0.80
12
176
8
127
0.63
0.64
1.1
1.6
5.38
2.96
%
—
8
107
64
542
1.18
0.63
2.1
2.4
1.34
1.39
g/24h
0.07
33
313
24
314
0.76
0.62
2.3
2.4
767.31
628.60
ml
0.83
16
214
242
2233
1.09
0.62
1.7
1.7
—
—
—
0
0
29
226
1.28
0.61
1.1
1.0
0.13
1.92
u/ml
—
9
54
25
191
1.31
0.60
3.5
3.4
—
—
—
0
0
142
1282
1.11
0.58
1.5
1.5
59.47
61.00
ug/l
0.17
115
1078
6
35
1.72
0.57
1.0
1.1
—
248.22
—
0
9
37
301
1.23
0.56
1.0
1.0
440.86
318.83
ng/l
0.33
29
206
37
301
1.23
0.56
1.0
1.0
911.37
731.22
ng/l
1.21
27
203
30
238
1.26
0.56
1.3
1.4
142.66
198.48
pmol/l
0.63
30
238
40
329
1.22
0.55
1.3
1.2
—
—
—
0
0
26
203
1.28
0.55
2.0
1.8
—
—
—
0
0
10
65
1.54
0.55
1.5
1.1
—
—
—
0
0
28
222
1.26
0.53
1.1
1.2
8.82
8.95
mm/h
0.04
28
222
15
108
1.39
0.53
1.2
1.1
—
—
—
0
0
57
488
1.17
0.53
1.6
1.6
54.95
58.16
%
0.26
38
308
1630
16663
0.97
0.52
3.3
3.1
—
—
—
0
0
11
157
0.70
0.51
1.5
1.7
0.00
0.04
estimate
0.80
11
157
62
714
0.87
0.51
1.2
1.2
—
—
—
0
0
6
41
1.46
0.50
1.0
1.1
—
—
—
0
0
50
426
1.18
0.50
1.3
1.5
—
—
—
0
0
340
3594
0.94
0.49
5.0
4.0
—
—
—
0
0
45
381
1.18
0.48
1.2
1.5
34.00
32.93
%
0.07
26
234
13
94
1.38
0.46
1.1
1.0
34.88
36.72
iu/ml
0.04
13
94
55
477
1.15
0.45
1.8
4.4
7.69
7.16
mmol/l
0.26
41
405
8
119
0.67
0.45
1.1
1.6
19.25
24.44
%
—
8
108
10
69
1.45
0.44
1.3
1.3
—
—
—
0
0
14
185
0.76
0.43
1.3
1.7
39.88
40.22
g/l
0.10
14
185
12
88
1.36
0.40
1.4
2.1
—
—
—
0
0
65
579
1.12
0.39
1.4
1.3
6.96
7.19
mmol/l
0.32
58
515
43
373
1.15
0.37
1.0
1.1
283.76
293.26
mg/l
0.34
38
342
64
574
1.12
0.35
1.4
1.5
32.53
32.64
g/l
0.03
58
525
6
45
1.33
0.33
1.0
1.2
—
—
—
0
0
10
74
1.35
0.32
1.0
1.0
—
—
—
0
0
533
5170
1.03
0.31
5.4
4.8
33.52
32.53
%
1.19
368
3440
47
420
1.12
0.29
1.5
1.4
—
—
—
0
0
48
430
1.12
0.29
1.3
1.6
—
—
—
0
0
20
167
1.20
0.28
1.5
2.2
7836.87
869.46
e6/l
0.49
15
115
30
340
0.88
0.24
1.3
1.4
—
—
—
0
0
26
226
1.15
0.24
1.6
2.4
1820.20
1940.58
ml
0.23
20
202
403
3913
1.03
0.24
1.4
1.4
—
—
—
0
0
41
369
1.11
0.24
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
127.00
—
0
11
0
10
0.00
0.21
0.0
1.1
—
174.20
—
0
10
5
43
1.16
0.21
1.2
1.2
6.12
5.92
mmol/l
—
5
43
0
13
0.00
0.21
0.0
1.0
—
2.11
—
0
8
107
1014
1.06
0.20
1.5
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
11.11
—
0
8
49
452
1.08
0.19
3.0
2.7
—
—
—
0
0
17
146
1.16
0.19
1.6
2.0
—
—
—
0
0
58
540
1.07
0.18
2.6
3.0
—
—
—
0
0
19
166
1.15
0.18
1.6
1.6
—
—
—
0
0
46
426
1.08
0.17
2.3
2.1
—
—
—
0
0
5
68
0.74
0.17
5.2
6.1
6.00
8.46
%
—
5
68
5
68
0.74
0.17
2.6
3.0
58.60
46.59
%
—
5
68
10
120
0.83
0.16
1.3
1.1
—
—
—
0
0
104
993
1.05
0.16
1.4
1.5
—
—
—
0
0
6
79
0.76
0.15
1.8
1.6
—
—
—
0
0
84
882
0.95
0.15
4.0
3.5
26.67
26.48
mg/l
0.01
48
610
40
372
1.08
0.14
1.4
1.2
—
—
—
0
0
233
2272
1.03
0.13
1.6
1.6
918.29
1002.29
mu/l
0.78
200
1929
12
138
0.87
0.13
1.0
1.0
9.18
12.77
u/ml
—
5
96
13
115
1.13
0.10
1.3
1.2
46.72
39.63
g/l
—
6
56
101
978
1.03
0.10
1.4
1.5
1.32
1.26
mm
0.59
73
704
14
125
1.12
0.10
1.4
1.2
7.74
10.92
pmol/l
—
5
48
12
106
1.13
0.09
1.2
1.3
16.25
433.05
ug/l
—
6
46
5
48
1.04
0.09
2.2
7.2
64.40
32.96
mg/mmol
—
5
43
6
56
1.07
0.08
1.0
1.0
1.20
6.20
u/ml
—
6
56
5
62
0.81
0.08
1.4
1.1
—
—
—
0
0
31
328
0.94
0.08
2.3
2.1
2.19
1.52
u/field
0.29
21
176
96
934
1.03
0.08
3.1
3.4
88.22
816.74
u/ml
1.74
86
855
7
67
1.04
0.08
3.9
6.4
8.64
8.27
mmol/l
—
7
67
19
205
0.93
0.08
1.9
1.8
2.29
3.83
u/field
0.47
14
147
13
118
1.10
0.07
4.2
3.2
—
—
—
0
0
11
122
0.90
0.07
1.1
1.0
—
—
—
0
0
95
927
1.03
0.06
2.2
2.4
155.13
95.81
ug/min
0.35
62
559
345
3482
0.99
0.05
1.7
1.7
3.38
3.47
mmol/l
0.60
238
2370
35
337
1.04
0.04
1.6
1.6
7.65
7.72
mmol/l
0.09
35
325
10
91
1.10
0.04
3.0
2.3
38.20
70.81
ug/l
—
10
91
122
1203
1.01
0.04
1.3
1.3
—
—
—
0
0
52
508
1.02
0.03
2.5
2.3
—
—
—
0
0
62
632
0.98
0.03
1.4
1.6
—
—
—
0
0
473
4710
1.00
0.02
2.0
1.9
3.43
3.45
ratio
0.14
360
3581
59
600
0.98
0.02
2.1
2.3
1.01
0.90
%
0.81
34
396
12
126
0.95
0.00
1.3
1.4
3.21
3.21
mmol/l
0.00
12
115
14
142
0.99
0.00
1.6
1.6
10.08
8.66
ug/l
1.07
14
142
23
228
1.01
0.00
2.0
2.1
7.68
8.27
mmol/l
0.36
23
228
15
145
1.03
0.00
1.3
2.0
14225.25
22672.16
e6/l
—
8
75
24
245
0.98
0.00
2.0
2.3
16.37
16.29
%
0.05
24
245
14
137
1.02
0.00
1.1
1.1
—
—
—
0
0
6
68
0.88
-0.00
2.8
2.6
16.07
14.56
ml/dl
—
6
62
0
7
0.00
-0.00
0.0
6.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
13
130
1.00
-0.00
6.5
4.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
37.17
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
2590.56
—
0
9
0
7
0.00
-0.00
0.0
1.7
—
344.14
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_VISDISTNAS and mortality.

Females

Parameter HR [95% CI] p-value
H7_VISDISTNAS 1.064 [0.91, 1.25] 0.442
Birth year 0.996 [0.99, 1.01] 0.456

During the follow-up period (1.1.1998 — 31.12.2019), 804 out of 9467 females with H7_VISDISTNAS died.

Males

Parameter HR [95% CI] p-value
H7_VISDISTNAS 1.189 [1.0, 1.42] 0.056
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 663 out of 6009 males with H7_VISDISTNAS died.

Mortality risk

Mortality risk for people of age

years, who have H7_VISDISTNAS.

N-year risk Females Males
1 0.1% 0.212%
5 0.623% 1.269%
10 1.643% 3.219%
15 3.098% 6.222%
20 5.677% 10.411%

Relationships between endpoints

↥

Index endpoint: H7_VISDISTNAS – Other and unspecified visual disturbances

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data